Participant identifier ('eid') <br>
Verbal interview duration <br>
Biometrics duration <br>
Sample collection duration <br>
Conclusion duration <br>
Heel ultrasound method <br>
Weight method <br>
Sex <br>
Year of birth <br>
Blood pressure device ID <br>
Blood pressure manual sphygmomanometer device ID <br>
Hand grip dynamometer device ID <br>
Height measure device ID <br>
Manual scales device ID <br>
Seating box device ID <br>
Spirometer device ID <br>
Impedance device ID <br>
Tape measure device ID <br>
Heel ultrasound device id <br>
Hand grip strength (left) <br>
Hand grip strength (right) <br>
Waist circumference <br>
Hip circumference <br>
Standing height <br>
Seated height <br>
Month of birth <br>
Date of attending assessment centre <br>
UK Biobank assessment centre <br>
Month of attending assessment centre <br>
Heel bone ultrasound T-score, manual entry <br>
Heel bone mineral density (BMD) T-score, automated <br>
Cancer year/age first occurred <br>
Non-cancer illness year/age first occurred <br>
Operation year/age first occurred <br>
Systolic blood pressure, manual reading <br>
Diastolic blood pressure, manual reading <br>
Pulse rate (during blood-pressure measurement) <br>
Time since interview start at which blood pressure screen(s) shown <br>
Pulse rate, automated reading <br>
Birth weight known <br>
Place of birth in UK - north co-ordinate <br>
Place of birth in UK - east co-ordinate <br>
Number of self-reported cancers <br>
Number of self-reported non-cancer illnesses <br>
Number of operations, self-reported <br>
Number of treatments/medications taken <br>
Townsend deprivation index at recruitment <br>
Reason lost to follow-up <br>
Date lost to follow-up <br>
Touchscreen duration <br>
Type of accommodation lived in <br>
Own or rent accommodation lived in <br>
Length of time at current address <br>
Number in household <br>
Number of vehicles in household <br>
Average total household income before tax <br>
Time employed in main current job <br>
Length of working week for main job <br>
Frequency of travelling from home to job workplace <br>
Distance between home and job workplace <br>
Job involves mainly walking or standing <br>
Job involves heavy manual or physical work <br>
Job involves shift work <br>
Age completed full time education <br>
Number of days/week walked 10+ minutes <br>
Duration of walks <br>
Number of days/week of moderate physical activity 10+ minutes <br>
Duration of moderate activity <br>
Number of days/week of vigorous physical activity 10+ minutes <br>
Duration of vigorous activity <br>
Usual walking pace <br>
Frequency of stair climbing in last 4 weeks <br>
Frequency of walking for pleasure in last 4 weeks <br>
Duration walking for pleasure <br>
Frequency of strenuous sports in last 4 weeks <br>
Duration of strenuous sports <br>
Frequency of light DIY in last 4 weeks <br>
Duration of light DIY <br>
Frequency of friend/family visits <br>
Time spend outdoors in summer <br>
Time spent outdoors in winter <br>
Time spent watching television (TV) <br>
Time spent using computer <br>
Time spent driving <br>
Drive faster than motorway speed limit <br>
Length of mobile phone use <br>
Weekly usage of mobile phone in last 3 months <br>
Hands-free device/speakerphone use with mobile phone in last 3 month <br>
Difference in mobile phone use compared to two years previously <br>
Usual side of head for mobile phone use <br>
Sleep duration <br>
Getting up in morning <br>
Morning/evening person (chronotype) <br>
Nap during day <br>
Sleeplessness / insomnia <br>
Snoring <br>
Daytime dozing / sleeping <br>
Current tobacco smoking <br>
Past tobacco smoking <br>
Smoking/smokers in household <br>
Exposure to tobacco smoke at home <br>
Exposure to tobacco smoke outside home <br>
Cooked vegetable intake <br>
Salad / raw vegetable intake <br>
Fresh fruit intake <br>
Dried fruit intake <br>
Oily fish intake <br>
Non-oily fish intake <br>
Processed meat intake <br>
Poultry intake <br>
Beef intake <br>
Lamb/mutton intake <br>
Pork intake <br>
Cheese intake <br>
Milk type used <br>
Spread type <br>
Bread intake <br>
Bread type <br>
Cereal intake <br>
Cereal type <br>
Salt added to food <br>
Tea intake <br>
Coffee type <br>
Hot drink temperature <br>
Water intake <br>
Major dietary changes in the last 5 years <br>
Variation in diet <br>
Alcohol intake frequency. <br>
Average weekly red wine intake <br>
Average weekly champagne plus white wine intake <br>
Average weekly beer plus cider intake <br>
Average weekly spirits intake <br>
Average weekly fortified wine intake <br>
Alcohol usually taken with meals <br>
Alcohol intake versus 10 years previously <br>
Country of birth (UK/elsewhere) <br>
Breastfed as a baby <br>
Comparative body size at age 10 <br>
Comparative height size at age 10 <br>
Handedness (chirality/laterality) <br>
Skin colour <br>
Ease of skin tanning <br>
Childhood sunburn occasions <br>
Hair colour (natural, before greying) <br>
Facial ageing <br>
Adopted as a child <br>
Part of a multiple birth <br>
Maternal smoking around birth <br>
Father still alive <br>
Father's age at death <br>
Mother still alive <br>
Mother's age <br>
Number of full brothers <br>
Number of full sisters <br>
Mood swings <br>
Miserableness <br>
Irritability <br>
Sensitivity / hurt feelings <br>
Fed-up feelings <br>
Nervous feelings <br>
Worrier / anxious feelings <br>
Tense / 'highly strung' <br>
Worry too long after embarrassment <br>
Suffer from 'nerves' <br>
Loneliness, isolation <br>
Guilty feelings <br>
Risk taking <br>
Frequency of depressed mood in last 2 weeks <br>
Frequency of unenthusiasm / disinterest in last 2 weeks <br>
Frequency of tenseness / restlessness in last 2 weeks <br>
Frequency of tiredness / lethargy in last 2 weeks <br>
Seen doctor (GP) for nerves, anxiety, tension or depression <br>
Seen a psychiatrist for nerves, anxiety, tension or depression <br>
Able to confide <br>
Answered sexual history questions <br>
Age first had sexual intercourse <br>
Lifetime number of sexual partners <br>
Ever had same-sex intercourse <br>
Overall health rating <br>
Long-standing illness, disability or infirmity <br>
Wears glasses or contact lenses <br>
Age started wearing glasses or contact lenses <br>
Other eye problems <br>
Plays computer games <br>
Hearing difficulty/problems <br>
Hearing difficulty/problems with background noise <br>
Use of sun/uv protection <br>
Frequency of solarium/sunlamp use <br>
Falls in the last year <br>
Weight change compared with 1 year ago <br>
Wheeze or whistling in the chest in last year <br>
Chest pain or discomfort <br>
Ever had bowel cancer screening <br>
Most recent bowel cancer screening <br>
Ever had prostate specific antigen (PSA) test <br>
Relative age of first facial hair <br>
Relative age voice broke <br>
Hair/balding pattern <br>
Number of children fathered <br>
Had major operations <br>
Diabetes diagnosed by doctor <br>
Cancer diagnosed by doctor <br>
Fractured/broken bones in last 5 years <br>
Other serious medical condition/disability diagnosed by doctor <br>
Taking other prescription medications <br>
Frequency of heavy DIY in last 4 weeks <br>
Duration of heavy DIY <br>
Light smokers, at least 100 smokes in lifetime <br>
Non-butter spread type details <br>
Reason for reducing amount of alcohol drunk <br>
Ever had breast cancer screening / mammogram <br>
Years since last breast cancer screening / mammogram <br>
Ever had cervical smear test <br>
Years since last cervical smear test <br>
Age when periods started (menarche) <br>
Had menopause <br>
Number of live births <br>
Birth weight of first child <br>
Age at first live birth <br>
Age at last live birth <br>
Ever had stillbirth, spontaneous miscarriage or termination <br>
Ever taken oral contraceptive pill <br>
Age started oral contraceptive pill <br>
Age when last used oral contraceptive pill <br>
Ever used hormone-replacement therapy (HRT) <br>
Age at hysterectomy <br>
Bilateral oophorectomy (both ovaries removed) <br>
Had other major operations <br>
Age started smoking in former smokers <br>
Type of tobacco previously smoked <br>
Number of cigarettes previously smoked daily <br>
Age stopped smoking <br>
Ever stopped smoking for 6+ months <br>
Number of unsuccessful stop-smoking attempts <br>
Father's age <br>
General pain for 3+ months <br>
Age high blood pressure diagnosed <br>
Age diabetes diagnosed <br>
Fracture resulting from simple fall <br>
Result ranking <br>
Time of blow measurement <br>
Acceptability of each blow result <br>
Forced vital capacity (FVC) <br>
Forced expiratory volume in 1-second (FEV1) <br>
Peak expiratory flow (PEF) <br>
Ordering of blows <br>
Data points for blow <br>
Seating box height <br>
Pace-maker <br>
Foot measured for bone density <br>
Fractured heel <br>
Heel quantitative ultrasound index (QUI), manual entry <br>
Heel bone mineral density (BMD), manual entry <br>
Heel Broadband ultrasound attenuation (BUA), manual entry <br>
Speed of sound through heel, manual entry <br>
Contra-indications for spirometry <br>
Caffeine drink within last hour <br>
Used an inhaler for chest within last hour <br>
Spirometry device serial number <br>
Number of measurements made <br>
Pregnant <br>
Ankle spacing width <br>
Heel Broadband ultrasound attenuation, direct entry <br>
Speed of sound through heel <br>
Heel quantitative ultrasound index (QUI), direct entry <br>
Heel bone mineral density (BMD) <br>
Smoked cigarette or pipe within last hour <br>
Weight, manual entry <br>
Hearing aid user <br>
Neck/shoulder pain for 3+ months <br>
Hip pain for 3+ months <br>
Job involves night shift work <br>
Age started smoking in current smokers <br>
Type of tobacco currently smoked <br>
Number of cigarettes currently smoked daily (current cigarette smokers) <br>
Time from waking to first cigarette <br>
Smoking compared to 10 years previous <br>
Mother's age at death <br>
Age started hormone-replacement therapy (HRT) <br>
Age last used hormone-replacement therapy (HRT) <br>
Back pain for 3+ months <br>
Ever had hysterectomy (womb removed) <br>
Chest pain or discomfort walking normally <br>
Chest pain due to walking ceases when standing still <br>
Age angina diagnosed <br>
Frequency of other exercises in last 4 weeks <br>
Duration of other exercises <br>
Year immigrated to UK (United Kingdom) <br>
Lifetime number of same-sex sexual partners <br>
Age when last ate meat <br>
Time since last menstrual period <br>
Length of menstrual cycle <br>
Menstruating today <br>
Former alcohol drinker <br>
Stomach/abdominal pain for 3+ months <br>
Chest pain or discomfort when walking uphill or hurrying <br>
Age hay fever, rhinitis or eczema diagnosed <br>
Knee pain for 3+ months <br>
Age asthma diagnosed <br>
Headaches for 3+ months <br>
Time since last prostate specific antigen (PSA) test <br>
Number of stillbirths <br>
Number of spontaneous miscarriages <br>
Number of pregnancy terminations <br>
Reason former drinker stopped drinking alcohol <br>
Age of primiparous women at birth of child <br>
Age at bilateral oophorectomy (both ovaries removed) <br>
Age heart attack diagnosed <br>
Adopted father still alive <br>
Adopted mother still alive <br>
Number of adopted brothers <br>
Number of adopted sisters <br>
Age emphysema/chronic bronchitis diagnosed <br>
Age deep-vein thrombosis (DVT, blood clot in leg) diagnosed <br>
Age pulmonary embolism (blood clot in lung) diagnosed <br>
Gestational diabetes only <br>
Age stroke diagnosed <br>
Facial pains for 3+ months <br>
Diastolic blood pressure, automated reading <br>
Systolic blood pressure, automated reading <br>
Method of measuring blood pressure <br>
Heel ultrasound method (left) <br>
Fractured heel (left) <br>
Heel ultrasound method (right) <br>
Fractured heel (right) <br>
Ankle spacing width (left) <br>
Heel broadband ultrasound attenuation (left) <br>
Speed of sound through heel (left) <br>
Heel quantitative ultrasound index (QUI), direct entry (left) <br>
Heel bone mineral density (BMD) (left) <br>
Heel bone mineral density (BMD) T-score, automated (left) <br>
Ankle spacing width (right) <br>
Heel broadband ultrasound attenuation (right) <br>
Speed of sound through heel (right) <br>
Heel quantitative ultrasound index (QUI), direct entry (right) <br>
Heel bone mineral density (BMD) (right) <br>
Heel bone mineral density (BMD) T-score, automated (right) <br>
Arterial pulse-wave stiffness device ID <br>
Heel bone mineral density (BMD) T-score, manual entry (left) <br>
Heel quantitative ultrasound index (QUI), manual entry (left) <br>
Heel bone mineral density (BMD), manual entry (left) <br>
Heel broadband ultrasound attenuation (BUA), manual entry (left) <br>
Speed of sound through heel, manual entry (left) <br>
Heel bone mineral density (BMD) T-score, manual entry (right) <br>
Heel quantitative ultrasound index (QUI), manual entry (right) <br>
Heel bone mineral density (BMD), manual entry (right) <br>
Heel broadband ultrasound attenuation (BUA), manual entry (right) <br>
Speed of sound through heel, manual entry (right) <br>
Stiffness method <br>
Pulse rate <br>
Pulse wave reflection index <br>
Pulse wave peak to peak time <br>
Position of the pulse wave peak <br>
Position of pulse wave notch <br>
Position of the shoulder on the pulse waveform <br>
Absence of notch position in the pulse waveform <br>
Pulse wave pressure versus time response curve <br>
Arterial stiffness device ID <br>
Pulse wave velocity (manual entry) <br>
Triplet played (left) <br>
Signal-to-noise-ratio (SNR) of triplet (left) <br>
Triplet correct (left) <br>
Mean signal-to-noise ratio (SNR), (left) <br>
Time to press first digit (left) <br>
Time to press last digit (left) <br>
Triplet entered (left) <br>
Time to press 'next' (left) <br>
Keystroke history (left) <br>
Number of times 'clear' was pressed (left) <br>
Triplet played (right) <br>
Signal-to-noise-ratio (SNR) of triplet (right) <br>
Triplet entered (right) <br>
Triplet correct (right) <br>
Mean signal-to-noise ratio (SNR), (right) <br>
Time to press first digit (right) <br>
Time to press last digit (right) <br>
Time to press 'next' (right) <br>
Keystroke history (right) <br>
Number of times 'clear' was pressed (right) <br>
Completion status (left) <br>
Number of triplets attempted (left) <br>
Volume level set by participant (left) <br>
Duration of hearing test (left) <br>
Completion status (right) <br>
Number of triplets attempted (right) <br>
Volume level set by participant (right) <br>
Duration of hearing test (right) <br>
Average monthly red wine intake <br>
Average monthly champagne plus white wine intake <br>
Average monthly beer plus cider intake <br>
Average monthly spirits intake <br>
Average monthly fortified wine intake <br>
Average monthly intake of other alcoholic drinks <br>
Non-accidental death in close genetic family <br>
Ever depressed for a whole week <br>
Longest period of depression <br>
Number of depression episodes <br>
Ever unenthusiastic/disinterested for a whole week <br>
Ever manic/hyper for 2 days <br>
Ever highly irritable/argumentative for 2 days <br>
Private healthcare <br>
Age glaucoma diagnosed <br>
Age cataract diagnosed <br>
Shortness of breath walking on level ground <br>
Leg pain on walking <br>
Cochlear implant <br>
Tinnitus <br>
Tinnitus severity/nuisance <br>
Noisy workplace <br>
Loud music exposure frequency <br>
Hearing test done <br>
Number of older siblings <br>
Number of letters shown in round (left) <br>
Number of letters shown in round (right) <br>
Number of letters correct in round (right) <br>
Number of letters correct in round (left) <br>
logMAR in round (left) <br>
logMAR in round (right) <br>
Displayed letters in round (right) <br>
Displayed letters in round (left) <br>
Visual acuity result in round (left) <br>
Visual acuity result in round (right) <br>
Spherical power (right) <br>
Spherical power (left) <br>
Cylindrical power (left) <br>
Cylindrical power (right) <br>
Astigmatism angle (right) <br>
Astigmatism angle (left) <br>
Refractometry result unreliable (left) <br>
Refractometry result unreliable (right) <br>
3mm weak meridian (left) <br>
6mm weak meridian (left) <br>
6mm weak meridian (right) <br>
3mm weak meridian (right) <br>
3mm weak meridian angle (right) <br>
6mm weak meridian angle (right) <br>
6mm weak meridian angle (left) <br>
3mm weak meridian angle (left) <br>
3mm strong meridian angle (left) <br>
6mm strong meridian angle (right) <br>
3mm strong meridian angle (right) <br>
3mm asymmetry angle (right) <br>
6mm asymmetry angle (right) <br>
6mm asymmetry angle (left) <br>
3mm asymmetry angle (left) <br>
3mm cylindrical power angle (left) <br>
6mm cylindrical power angle (left) <br>
6mm cylindrical power angle (right) <br>
3mm cylindrical power angle (right) <br>
3mm cylindrical power (right) <br>
6mm cylindrical power (right) <br>
6mm cylindrical power (left) <br>
3mm cylindrical power (left) <br>
3mm strong meridian (right) <br>
6mm strong meridian (right) <br>
6mm strong meridian (left) <br>
3mm strong meridian (left) <br>
3mm keratometry result unreliable (left) <br>
6mm keratometry result unreliable (left) <br>
6mm keratometry result unreliable (right) <br>
3mm keratometry result unreliable (right) <br>
3mm asymmetry index unreliable (left) <br>
6mm asymmetry index unreliable (left) <br>
6mm asymmetry index unreliable (right) <br>
3mm asymmetry index unreliable (right) <br>
3mm regularity index unreliable (right) <br>
6mm regularity index unreliable (right) <br>
6mm regularity index unreliable (left) <br>
3mm regularity index unreliable (left) <br>
3mm regularity index for irregular astigmatism level (left) <br>
3mm asymmetry index for irregular astigmatism level (right) <br>
3mm asymmetry index for irregular astigmatism level (left) <br>
3mm asymmetry index (left) <br>
6mm asymmetry index (left) <br>
6mm asymmetry index (right) <br>
3mm asymmetry index (right) <br>
3mm regularity index (right) <br>
6mm regularity index (right) <br>
6mm regularity index (left) <br>
3mm regularity index (left) <br>
3mm regularity index for irregular astigmatism level (right) <br>
Ever had eye surgery <br>
Both eyes present <br>
Current eye infection <br>
Visual acuity measured (right) <br>
Duration visual-acuity screen displayed (right) <br>
Visual acuity measured (left) <br>
Duration visual-acuity screen displayed (left) <br>
Refractometry method (right) <br>
Duration at which refractometer first shown (right) <br>
Refractometry method (left) <br>
Duration at which refractometer first shown (left) <br>
Intra-ocular pressure (IOP) method (right) <br>
Intra-ocular pressure (IOP) method (left) <br>
Eye measures duration <br>
logMAR, initial (right) <br>
Final number of letters displayed (right) <br>
logMAR, final (right) <br>
Number of rounds to result (right) <br>
Distance of viewer to screen (right) <br>
Direct or mirror view (right) <br>
logMAR, initial (left) <br>
Final number of letters displayed (left) <br>
logMAR, final (left) <br>
Number of rounds to result (left) <br>
Distance of viewer to screen (left) <br>
Direct or mirror view (left) <br>
Auto-refractor device ID (right) <br>
Vertex distance (right) <br>
Index of best refractometry result (right) <br>
3mm index of best keratometry results (right) <br>
6mm index of best keratometry results (right) <br>
Intra-ocular pressure device ID (right) <br>
Intra-ocular pressure, corneal-compensated (right) <br>
Intra-ocular pressure, Goldmann-correlated (right) <br>
Corneal hysteresis (right) <br>
Corneal resistance factor (right) <br>
Applanation curve (right) <br>
Pressure curve (right) <br>
Intra-ocular pressure device ID (left) <br>
Intra-ocular pressure, corneal-compensated (left) <br>
Intra-ocular pressure, Goldmann-correlated (left) <br>
Corneal hysteresis (left) <br>
Corneal resistance factor (left) <br>
Applanation curve (left) <br>
Pressure curve (left) <br>
Optical-coherence tomography device ID <br>
Auto-refractor device ID (left) <br>
Vertex distance (left) <br>
Index of best refractometry result (left) <br>
3mm index of best keratometry results (left) <br>
6mm index of best keratometry results (left) <br>
Ever had cataract surgery <br>
Ever had refractive laser eye surgery <br>
Ever had surgery for glaucoma or high eye pressure <br>
Ever had laser treatment for glaucoma or high eye pressure <br>
Ever had corneal graft surgery <br>
Average weekly intake of other alcoholic drinks <br>
Longest period of unenthusiasm / disinterest <br>
Number of unenthusiastic/disinterested episodes <br>
Which eye(s) affected by amblyopia (lazy eye) <br>
Which eye(s) affected by injury or trauma resulting in loss of vision <br>
Age when loss of vision due to injury or trauma diagnosed <br>
Which eye(s) are affected by cataract <br>
Leg pain when standing still or sitting <br>
Leg pain in calf/calves <br>
Leg pain when walking uphill or hurrying <br>
Leg pain when walking normally <br>
Leg pain when walking ever disappears while walking <br>
Leg pain on walking : action taken <br>
Leg pain on walking : effect of standing still <br>
Surgery on leg arteries (other than for varicose veins) <br>
Surgery/amputation of toe or leg <br>
Which eye(s) affected by presbyopia <br>
Length of longest manic/irritable episode <br>
Severity of manic/irritable episodes <br>
Which eye(s) affected by hypermetropia (long sight) <br>
Which eye(s) affected by myopia (short sight) <br>
Which eye(s) affected by astigmatism <br>
Which eye(s) affected by other eye condition <br>
Which eye(s) affected by diabetes-related eye disease <br>
Age when diabetes-related eye disease diagnosed <br>
Which eye(s) affected by macular degeneration <br>
Age macular degeneration diagnosed <br>
Which eye(s) affected by other serious eye condition <br>
Age other serious eye condition diagnosed <br>
Previously smoked cigarettes on most/all days <br>
ECG, heart rate <br>
ECG, load <br>
Bicycle speed <br>
ECG, phase time <br>
ECG, trend phase name <br>
ECG, stage name <br>
ECG, phase name <br>
ECG, phase duration <br>
ECG, number of stages in a phase <br>
Doctor restricts physical activity due to heart condition <br>
Chest pain felt during physical activity <br>
Chest pain felt outside physical activity <br>
Able to walk or cycle unaided for 10 minutes <br>
ECG/bike method for fitness test <br>
Completion status of test <br>
ECG during exercise duration <br>
Description of exercise protocol recommended <br>
Fitness test results, including ECG data <br>
Maximum workload during fitness test <br>
Maximum heart rate during fitness test <br>
Target heart rate achieved <br>
Number of trend entries <br>
Duration of fitness test <br>
OCT measured (right) <br>
Duration at which OCT screen shown (right) <br>
OCT measured (left) <br>
Duration at which OCT screen shown (left) <br>
Glasses worn/required (right) <br>
Glasses worn/required (left) <br>
Which eye(s) affected by glaucoma <br>
Qualifications <br>
Gas or solid-fuel cooking/heating <br>
Heating type(s) in home <br>
How are people in household related to participant <br>
Current employment status <br>
Transport type for commuting to job workplace <br>
Never eat eggs, dairy, wheat, sugar <br>
Illness, injury, bereavement, stress in last 2 years <br>
Attendance/disability/mobility allowance <br>
Reason for glasses/contact lenses <br>
Eye problems/disorders <br>
Mouth/teeth dental problems <br>
Vascular/heart problems diagnosed by doctor <br>
Fractured bone site(s) <br>
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor <br>
Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones <br>
Medication for pain relief, constipation, heartburn <br>
Vitamin and mineral supplements <br>
Manic/hyper symptoms <br>
Why stopped smoking <br>
Why reduced smoking <br>
Pain type(s) experienced in last month <br>
Leisure/social activities <br>
Types of transport used (excluding work) <br>
Types of physical activity in last 4 weeks <br>
Medication for cholesterol, blood pressure or diabetes <br>
Mineral and other dietary supplements <br>
Number of cigarettes previously smoked daily (current cigar/pipe smokers) <br>
Age stopped smoking cigarettes (current cigar/pipe or previous cigarette smoker) <br>
Which eye(s) affected by strabismus (squint) <br>
Impedance of whole body, manual entry <br>
Impedance of leg, manual entry (right) <br>
Impedance of leg, manual entry (left) <br>
Impedance of arm, manual entry (right) <br>
Impedance of arm, manual entry (left) <br>
Number of antibiotics taken in last 3 months <br>
Medication for pain relief, constipation, heartburn (pilot) <br>
Medication for smoking cessation, constipation, heartburn, allergies (pilot) <br>
Mouth/teeth dental problems (pilot) <br>
Vitamin and mineral supplements (pilot) <br>
Regular use of hands-free device/speakerphone with mobile phone (pilot) <br>
Internet user (pilot) <br>
Willing to be contacted by email (pilot) <br>
Why stopped smoking (pilot) <br>
Type of progestan-only oral contraceptive used (pilot) <br>
Result ranking (pilot) <br>
Acceptability of each blow result (pilot) <br>
Forced vital capacity (FVC) (pilot) <br>
Forced expiratory volume in 1-second (FEV1) (pilot) <br>
Peak expiratory flow (PEF) (pilot) <br>
Data points for blow (pilot) <br>
Spirometry method (pilot) <br>
Spirometry device serial number (pilot) <br>
Number of measurements made (pilot) <br>
Illness, injury, bereavement, stress in last 2 years (pilot) <br>
Qualifications (pilot) <br>
Vitamin supplements (pilot) <br>
Frequency of friend/family visits (pilot) <br>
Time using mobile phone in last 3 months (pilot) <br>
Spread type (pilot) <br>
Bread type/intake (pilot) <br>
Hearing difficulty/problems (pilot) <br>
Reason for reducing amount of alcohol drunk (pilot) <br>
Ever stopped smoking for 6+ months (pilot) <br>
Gestational diabetes only (pilot) <br>
Reason former drinker stopped drinking alcohol (pilot) <br>
Other dietary supplements (pilot) <br>
Never eat eggs, dairy, wheat, sugar (pilot) <br>
Gas or solid-fuel cooking/heating (pilot) <br>
Average total household income before tax (pilot) <br>
Difference in mobile phone use compared to one year previously (pilot) <br>
Light smokers, at least 100 smokes in lifetime (pilot) <br>
Variation in diet (pilot) <br>
Duration of walks (pilot) <br>
Duration of moderate physical activity (pilot) <br>
Duration of vigorous physical activity (pilot) <br>
Believed safe to perform brain MRI scan <br>
Believed safe to perform abdominal MRI scan <br>
Believed safe to perform DXA scan <br>
Weight (pre-imaging) <br>
Height <br>
Brain MRI measuring method <br>
Operator indicated brain MRI measurement completed <br>
Abdominal MRI measuring method <br>
Abdominal MRI measurement completed <br>
DXA measuring method <br>
DXA measurement completed <br>
Carotid ultrasound measuring method <br>
Carotid ultrasound measurement completed <br>
12-lead ECG measuring method <br>
Ventricular rate <br>
P duration <br>
QRS duration <br>
Identifier for blood pressure device <br>
Duration of eprime test <br>
ECG automated diagnoses <br>
Number of automated diagnostic comments recorded during 12-lead ECG <br>
Suspicious flag for 12-lead ECG <br>
Identifier for 12-lead ECG device <br>
PWA start time <br>
Heart rate during PWA <br>
Systolic brachial blood pressure during PWA <br>
Diastolic brachial blood pressure during PWA <br>
Peripheral pulse pressure during PWA <br>
Central systolic blood pressure during PWA <br>
Central pulse pressure during PWA <br>
Number of beats in waveform average for PWA <br>
Central augmentation pressure during PWA <br>
Augmentation index for PWA <br>
Cardiac output during PWA <br>
End systolic pressure during PWA <br>
End systolic pressure index during PWA <br>
Total peripheral resistance during PWA <br>
Stroke volume during PWA <br>
Mean arterial pressure during PWA <br>
Vicorder trace <br>
Blood pressure test start time <br>
Systolic brachial blood pressure <br>
Number of PWA tests performed <br>
Vicorder results plausible <br>
Cardiac index during PWA <br>
Eprime error flag <br>
Cancer code, self-reported <br>
Non-cancer illness code, self-reported <br>
Treatment/medication code <br>
Operation code <br>
Email access <br>
Interpolated Year when cancer first diagnosed <br>
Interpolated Age of participant when cancer first diagnosed <br>
Interpolated Year when non-cancer illness first diagnosed <br>
Interpolated Age of participant when non-cancer illness first diagnosed <br>
Interpolated Year when operation took place <br>
Interpolated Age of participant when operation took place <br>
Method of recording time when cancer first diagnosed <br>
Method of recording time when non-cancer illness first diagnosed <br>
Method of recording time when operation occurred <br>
Sitting height <br>
Speech-reception-threshold (SRT) estimate (left) <br>
Speech-reception-threshold (SRT) estimate (right) <br>
Birth weight <br>
Acceptability of each blow result (text) <br>
Acceptability of each blow result (text) (pilot) <br>
Reason for skipping weight <br>
Reason for skipping spirometry <br>
Reason for skipping grip strength (right) <br>
Reason for skipping grip strength (left) <br>
Reason for skipping waist <br>
Reason for skipping hip measurement <br>
Reason for skipping standing height <br>
Reason for skipping sitting height <br>
Reason for skipping arterial stiffness <br>
Reason for skipping refractometry (left) <br>
Reason for skipping IOP (right) <br>
Reason for skipping IOP (left) <br>
Reason for skipping refractometry (right) <br>
Reason for skipping visual acuity (right) <br>
Reason for skipping visual acuity (left) <br>
Reason for skipping ECG <br>
Reason ECG not completed <br>
Reason at-rest ECG performed without bicycle <br>
Reason for skipping OCT (right) <br>
Reason for skipping OCT (left) <br>
NA <br>
Number of diet questionnaires completed <br>
When diet questionnaire completion requested <br>
Day-of-week questionnaire completion requested <br>
Day-of-week questionnaire completed <br>
Hour-of-day questionnaire completed <br>
Duration of questionnaire <br>
Delay between questionnaire request and completion <br>
Vitamin and/or mineral supplement use <br>
Reason for not eating or drinking normally <br>
Type of special diet followed <br>
Types of spread used on bread/crackers <br>
Type of meals eaten <br>
Type of sliced bread eaten <br>
Type of baguette eaten <br>
Type of large bap eaten <br>
Type of bread roll eaten <br>
Size of white wine glass drunk <br>
Size of red wine glass drunk <br>
Size of rose wine glass drunk <br>
Thickness of butter/margarine spread on sliced bread <br>
Thickness of butter/margarine spread on baguettes <br>
Thickness of butter/margarine spread on large baps <br>
Thickness of butter/margarine spread on bread rolls <br>
Thickness of butter/margarine spread on crackers/crispbreads <br>
Thickness of butter/margarine spread on oatcakes <br>
Thickness of butter/margarine spread on other bread <br>
Liquid used to make porridge <br>
Type of yogurt eaten <br>
Illnesses of father <br>
Ingredients in canned soup <br>
Ingredients in homemade soup <br>
Illnesses of mother <br>
Illnesses of siblings <br>
Illnesses of adopted father <br>
Illnesses of adopted mother <br>
Illnesses of adopted siblings <br>
Country of Birth (non-UK origin) <br>
Smoking status <br>
Alcohol drinker status <br>
Home area population density - urban or rural <br>
Current employment status - corrected <br>
Cascot confidence score <br>
Bipolar disorder status <br>
Single episode of probable major depression <br>
Probable recurrent major depression (moderate) <br>
Probable recurrent major depression (severe) <br>
Bipolar and major depression status <br>
Neuroticism score <br>
Number of columns displayed in round <br>
Number of rows displayed in round <br>
Number of correct matches in round <br>
Number of incorrect matches in round <br>
Time to complete round <br>
When pairs test completed <br>
When fluid intelligence test completed <br>
When trail making test completed <br>
When symbol digit substitution test completed <br>
When numeric memory test completed <br>
When device described <br>
Errors before selecting correct item in numeric path (trail #1) <br>
Errors before selecting correct item in alphanumeric path (trail #2) <br>
Interval between previous point and current one in numeric path (trail #1) <br>
Forced expiratory volume in 1-second (FEV1), Best measure <br>
Forced vital capacity (FVC), Best measure <br>
Reproduciblity of spirometry measurement using ERS/ATS criteria <br>
Forced expiratory volume in 1-second (FEV1), predicted <br>
Forced expiratory volume in 1-second (FEV1), predicted percentage <br>
Interval between previous point and current one in alphanumeric path (trail #2) <br>
Duration to complete numeric path (trail #1) <br>
Duration to complete alphanumeric path (trail #2) <br>
DXA images <br>
Number of symbol digit matches made correctly <br>
Ever smoked <br>
Pack years of smoking <br>
Pack years adult smoking as proportion of life span exposed to smoking <br>
FI1 : numeric addition test <br>
FI2 : identify largest number <br>
FI3 : word interpolation <br>
FI4 : positional arithmetic <br>
FI5 : family relationship calculation <br>
FI6 : conditional arithmetic <br>
FI7 : synonym <br>
FI8 : chained arithmetic <br>
FI9 : concept interpolation <br>
FI10 : arithmetic sequence recognition <br>
FI11 : antonym <br>
FI12 : square sequence recognition <br>
FI13 : subset inclusion logic <br>
Fluid intelligence score <br>
FI14 : alphanumeric substitution <br>
Number of symbol digit matches attempted <br>
First code array presented <br>
Test array presented <br>
Antibiotic codes for last 3 months <br>
Values wanted <br>
Dixon technique for internal fat - DICOM <br>
Pancreatic fat - DICOM <br>
Liver imaging - gradient echo - DICOM <br>
Liver Imaging - T1 ShMoLLI - DICOM <br>
ECG datasets <br>
Measurements of pancreas volume - DICOM <br>
Scout images for heart MRI - DICOM <br>
Long axis heart images - DICOM <br>
Short axis heart images - DICOM <br>
Aortic distensibilty images - DICOM <br>
Cine tagging images - DICOM <br>
Left ventricular outflow tract images - DICOM <br>
Blood flow images - DICOM <br>
Experimental shMOLLI sequence images - DICOM <br>
Functional brain images - task - DICOM <br>
Multiband diffusion brain images - DICOM <br>
Susceptibility weighted brain images - DICOM <br>
Carotid artery ultrasound image (left) <br>
Carotid artery ultrasound image (right) <br>
Phoenix - DICOM <br>
Functional brain images - resting - DICOM <br>
Carotid artery ultrasound report <br>
Functional brain images - resting - NIFTI <br>
Values entered <br>
Duration to entering symbol choice <br>
Maximum digits remembered correctly <br>
Fluid intelligence completion status <br>
Pairs matching completion status <br>
Symbol digit completion status <br>
Trail making completion status <br>
Total errors traversing numeric path (trail #1) <br>
Total errors traversing alphanumeric path (trail #2) <br>
Functional brain images - task - NIFTI <br>
Multiband diffusion brain images - NIFTI <br>
Susceptibility weighted brain images - NIFTI <br>
T1 structural brain images - NIFTI <br>
T2 FLAIR structural brain images - NIFTI <br>
Liver imaging - IDEAL protocol - DICOM <br>
Spirometry QC measure <br>
Forced expiratory volume in 1-second (FEV1) Z-score <br>
Forced vital capacity (FVC) Z-score <br>
FEV1/ FVC ratio Z-score <br>
Pancreas Images - ShMoLLI - DICOM <br>
Pancreas Images - gradient echo - DICOM <br>
avMSE <br>
Myopia diagnosis <br>
Date of completing mental health questionnaire <br>
Ever addicted to any substance or behaviour <br>
Amount of alcohol drunk on a typical drinking day <br>
Ever physically dependent on alcohol <br>
Ever had known person concerned about, or recommend reduction of, alcohol consumption <br>
Ever addicted to alcohol <br>
Frequency of failure to fulfil normal expectations due to drinking alcohol in last year <br>
Frequency of memory loss due to drinking alcohol in last year <br>
Frequency of feeling guilt or remorse after drinking alcohol in last year <br>
Age when known person last commented about drinking habits <br>
Ever been injured or injured someone else through drinking alcohol <br>
Frequency of needing morning drink of alcohol after heavy drinking session in last year <br>
Frequency of drinking alcohol <br>
Ongoing addiction to alcohol <br>
Frequency of consuming six or more units of alcohol <br>
Tense, sore, or aching muscles during worst period of anxiety <br>
Impact on normal roles during worst period of anxiety <br>
Difficulty concentrating during worst period of anxiety <br>
Longest period spent worried or anxious <br>
Ever felt worried, tense, or anxious for most of a month or longer <br>
More irritable than usual during worst period of anxiety <br>
Keyed up or on edge during worst period of anxiety <br>
Ever worried more than most people would in similar situation <br>
Restless during period of worst anxiety <br>
Frequent trouble falling or staying asleep during worst period of anxiety <br>
Professional informed about anxiety <br>
Easily tired during worst period of anxiety <br>
Ever addicted to a behaviour or miscellanous <br>
Ongoing behavioural or miscellanous addiction <br>
Age at first episode of depression <br>
Age at last episode of depression <br>
Difficulty concentrating during worst depression <br>
Fraction of day affected during worst episode of depression <br>
Thoughts of death during worst depression <br>
Duration of worst depression <br>
Frequency of depressed days during worst episode of depression <br>
Impact on normal roles during worst period of depression <br>
Ever had prolonged loss of interest in normal activities <br>
Lifetime number of depressed periods <br>
Depression possibly related to childbirth <br>
Ever had prolonged feelings of sadness or depression <br>
Depression possibly related to stressful or traumatic event <br>
Professional informed about depression <br>
Feelings of tiredness during worst episode of depression <br>
Feelings of worthlessness during worst period of depression <br>
Ever taken cannabis <br>
Maximum frequency of taking cannabis <br>
Age when last took cannabis <br>
Ever addicted to illicit or recreational drugs <br>
Ongoing addiction or dependence on illicit or recreational drugs <br>
General happiness <br>
General happiness with own health <br>
Belief that own life is meaningful <br>
Ever heard an un-real voice <br>
Number of times heard an un-real voice <br>
Ever prescribed a medication for unusual or psychotic experiences <br>
Frequency of unusual or psychotic experiences in past year <br>
Ever believed in an un-real conspiracy against self <br>
Number of times believed in an un-real conspiracy against self <br>
Ever seen an un-real vision <br>
Number of times seen an un-real vision <br>
Ever believed in un-real communications or signs <br>
Number of times believed in un-real communications or signs <br>
Ever talked to a health professional about unusual or psychotic experiences <br>
Ever thought that life not worth living <br>
Ever self-harmed <br>
Self-harmed in past year <br>
Number of times self-harmed <br>
Ever attempted suicide <br>
Attempted suicide in past year <br>
Ever contemplated self-harm <br>
Contemplated self-harm in past year <br>
Felt hated by family member as a child <br>
Physically abused by family as a child <br>
Felt loved as a child <br>
Sexually molested as a child <br>
Someone to take to doctor when needed as a child <br>
Longest period of mania or irritability <br>
Severity of problems due to mania or irritability <br>
Felt irritable or had angry outbursts in past month <br>
Avoided activities or situations because of previous stressful experience in past month <br>
Felt distant from other people in past month <br>
Repeated disturbing thoughts of stressful experience in past month <br>
Felt very upset when reminded of stressful experience in past month <br>
Ever sought or received professional help for mental distress <br>
Ever suffered mental distress preventing usual activities <br>
Ever had period of mania / excitability <br>
Ever had period extreme irritability <br>
Recent easy annoyance or irritability <br>
Recent feelings or nervousness or anxiety <br>
Recent feelings of inadequacy <br>
Recent trouble concentrating on things <br>
Recent inability to stop or control worrying <br>
Recent feelings of depression <br>
Recent poor appetite or overeating <br>
Recent feelings of foreboding <br>
Recent thoughts of suicide or self-harm <br>
Recent lack of interest or pleasure in doing things <br>
Recent trouble relaxing <br>
Recent restlessness <br>
Trouble falling or staying asleep, or sleeping too much <br>
Recent changes in speed/amount of moving or speaking <br>
Recent feelings of tiredness or low energy <br>
Recent worrying too much about different things <br>
Belittlement by partner or ex-partner as an adult <br>
Been in a confiding relationship as an adult <br>
Physical violence by partner or ex-partner as an adult <br>
Sexual interference by partner or ex-partner without consent as an adult <br>
Able to pay rent/mortgage as an adult <br>
Been in serious accident believed to be life-threatening <br>
Been involved in combat or exposed to war-zone <br>
Diagnosed with life-threatening illness <br>
Victim of physically violent crime <br>
Witnessed sudden violent death <br>
Victim of sexual assault <br>
Did your sleep change? <br>
Trouble falling asleep <br>
Sleeping too much <br>
Waking too early <br>
Weight change during worst episode of depression <br>
Frequency of difficulty controlling worry during worst period of anxiety <br>
Worried most days during period of worst anxiety <br>
Frequency of inability to stop worrying during worst period of anxiety <br>
Multiple worries during worst period of anxiety <br>
Difficulty stopping worrying during worst period of anxiety <br>
Stronger worrying (than other people) during period of worst anxiety <br>
Number of things worried about during worst period of anxiety <br>
Mental health problems ever diagnosed by a professional <br>
Substances taken for depression <br>
Activities undertaken to treat depression <br>
Manifestations of mania or irritability <br>
Substances taken for anxiety <br>
Activities undertaken to treat anxiety <br>
Substance of prescription or over-the-counter medication addiction <br>
Methods of self-harm used <br>
Actions taken following self-harm <br>
Ethnic background <br>
Body mass index (BMI) <br>
Weight <br>
Age when attended assessment centre <br>
FDA data file (left) <br>
FDS data file (left) <br>
FDA data file (right) <br>
FDS data file (right) <br>
Fundus retinal eye image (left) <br>
Fundus retinal eye image (right) <br>
OCT image slices (left) <br>
OCT image slices (right) <br>
Pulse wave Arterial Stiffness index <br>
Age at recruitment <br>
When digestive health questionnaire completed <br>
Ever diagnosed with IBS <br>
Frequency of discomfort/pain in abdomen in last 3 months <br>
Discomfort/pain occurring only during menstrual bleed <br>
Abdominal discomfort/pain for 6 months or longer <br>
Frequency of discomfort/pain getting better or stopping after a bowel movement <br>
More frequent bowel movements when abdominal discomfort/pain started <br>
Less frequent bowel movements when abdominal discomfort/pain started <br>
Stools looser when abdominal discomfort/pain started <br>
Frequency of harder stools when abdominal discomfort/pain started <br>
Frequency of hard/lumpy stools in the last 3 months <br>
Frequency of loose/mushy/watery stools in the last 3 months <br>
Currently (in last 3 months) suffer from abdominal pain <br>
Severity of current abdominal pain <br>
Number of days (out of 10) with abdominal pain <br>
Currently suffer from abdominal distension <br>
Severity of current abdominal distension/tightness <br>
Satisfaction with bowel habits <br>
Degree to which abdominal pain/discomfort/altered bowel habits affect/interfere with life in general <br>
Greatest number of times bowels opened per day <br>
Least number of times bowels opened per week <br>
Average number of times bowels opened per day <br>
Number of weeks absent from work due to IBS, in the last year <br>
When gave up work due to IBS <br>
Number of weeks (in the last year) at work suffering because of IBS <br>
Degree bothered by back pain in the past 3 months <br>
Degree bothered by pain in arms/legs/joints in the past 3 months <br>
Degree bothered by menstrual cramps or other problems with period in the last 3 months <br>
Degree bothered by headaches in the last 3 months <br>
Degree bothered by chest pain in the last 3 months <br>
Degree bothered by dizziness in the last 3 months <br>
Degree bothered by fainting spells in the last 3 months <br>
Degree bothered by feeling heart pound/race in the last 3 months <br>
Degree bothered by shortness of breath in the last 3 months <br>
Degree bothered by pain/problems during intercourse in the last 3 months <br>
Degree bothered by urinary frequency/bladder irritability in the last 3 months <br>
Degree bothered by nausea in the last 3 months <br>
Degree bothered by feeling tired all the time in the last 3 months <br>
Degree bothered by trouble sleeping in the last 3 months <br>
Ever been offered/sought treatment for anxiety <br>
Ever been offered/sought treatment for depression <br>
Sensitive stomach <br>
Family history of IBS <br>
Born by caesarian section <br>
Long-term/recurrent antibiotics as child or teenager <br>
Diagnosed with coeliac disease or gluten sensitivity <br>
Method of coeliac disease/gluten sensitivity diagnosis <br>
Speed of onset of IBS symptoms <br>
Infectious illness diagnosis status when IBS symptoms first began <br>
Infection diagnosed alongside IBS when IBS symptoms began <br>
Fever when IBS symptoms first began <br>
Diarrhoea when IBS symptoms first began <br>
Bloody diarrhoea when IBS symptoms first began <br>
Vomiting when IBS symptoms first began <br>
Reception authorisation <br>
Consent authorisation <br>
Touchscreen authorisation <br>
Touchscreen cognitive authorisation (pilot) <br>
Touchscreen cognitive authorisation <br>
Verbal interview authorisation <br>
Pilot Spirometry authorisation <br>
Measurement/Impedance authorisation (pilot) <br>
Biometrics authorisation <br>
Eye measures authorisation <br>
ECG during exercise authorisation <br>
Urine collection authorisation <br>
Sample collection authorisation <br>
Conclusion authorisation <br>
Imaging screening authorisation <br>
Brain MRI authorisation <br>
Chest MRI authorisation <br>
DXA assessment authorisation <br>
Carotid ultrasound authorisation <br>
ECG at rest authorisation <br>
Cardiac monitor authorisation <br>
Reception sign-off timestamp <br>
Consent sign-off timestamp <br>
Touchscreen sign-off timestamp <br>
Touchscreen cognitive sign-off timestamp (pilot) <br>
Touchscreen cognitive sign-off timestamp <br>
Verbal nterview sign-off timestamp <br>
Pilot Spirometry sign-off timestamp <br>
Measurement/Impedance sign-off timestamp (pilot) <br>
Biometrics sign-off timestamp <br>
Eye measures sign-off timestamp <br>
ECG during exercise sign-off timestamp <br>
Urine collection sign-off timestamp <br>
Sample collection sign-off timestamp <br>
Conclusion sign-off timestamp <br>
Imaging screening sign-off timestamp <br>
Brain MRI sign-off timestamp <br>
Chest MRI sign-off timestamp <br>
DXA assessment sign-off timestamp <br>
Carotid ultrasound sign-off timestamp <br>
ECG at rest sign-off timestamp <br>
Cardiac monitor sign-off timestamp <br>
Genotype measurement batch <br>
Genetic sex <br>
Heterozygosity <br>
Heterozygosity, PCA corrected <br>
Missingness <br>
Genetic ethnic grouping <br>
Genotype measurement plate <br>
Genotype measurement well <br>
Genetic principal components <br>
Invitation to complete online cognitive function questionnaire, date sent <br>
Sex chromosome aneuploidy <br>
Used in genetic principal components <br>
Genetic kinship to other participants <br>
Sex inference X probe-intensity <br>
Sex inference Y probe-intensity <br>
DNA concentration <br>
Affymetrix quality control metric "Cluster.CR" <br>
Affymetrix quality control metric "dQC" <br>
Outliers for heterozygosity or missing rate <br>
Use in phasing Chromosomes 1-22 <br>
Use in phasing Chromosome X <br>
Use in phasing Chromosome XY <br>
IPAQ activity group <br>
Summed days activity <br>
Summed minutes activity <br>
Above moderate/vigorous recommendation <br>
Above moderate/vigorous/walking recommendation <br>
MET minutes per week for walking <br>
MET minutes per week for moderate activity <br>
MET minutes per week for vigorous activity <br>
Doctor diagnosed hayfever or allergic rhinitis <br>
Doctor diagnosed asthma <br>
Doctor diagnosed emphysema <br>
Doctor diagnosed chronic bronchitis <br>
Doctor diagnosed COPD (chronic obstructive pulmonary disease) <br>
Doctor diagnosed cystic fibrosis <br>
Doctor diagnosed alpha-1 antitrypsin deficiency <br>
Doctor diagnosed sarcoidosis <br>
Doctor diagnosed bronchiectasis <br>
Doctor diagnosed idiopathic pulmonary fibrosis <br>
Doctor diagnosed fibrosing alveolitis/unspecified alveolitis <br>
Doctor diagnosed tuberculosis <br>
Doctor diagnosed silicosis <br>
Doctor diagnosed asbestosis <br>
Doctor diagnosed lung cancer (not mesothelioma) <br>
Doctor diagnosed mesothelioma of the lung <br>
Age hayfever or allergic rhinitis diagnosed by doctor <br>
Age asthma diagnosed by doctor <br>
Age emphysema diagnosed by doctor <br>
Age chronic bronchitis diagnosed by doctor <br>
Age COPD (Chronic Obstructive Pulmonary Disease) diagnosed by doctor <br>
Age cystic fibrosis diagnosed by doctor <br>
Age alpha-1 antitrypsin deficiency diagnosed by doctor <br>
Age sarcoidosis diagnosed by doctor <br>
Age bronchiectasis diagnosed by doctor <br>
Age idiopathic pulmonary fibrosis diagnosed by doctor <br>
Age fibrosing alveolitis/unspecified alveolitis diagnosed by doctor <br>
Age tuberculosis diagnosed by doctor <br>
Age silicosis diagnosed by doctor <br>
Age asbestosis diagnosed by doctor <br>
Age lung cancer (not mesothelioma) diagnosed by doctor <br>
Age mesothelioma of the lung diagnosed by doctor <br>
Recent medication for hayfever or allergic rhinitis <br>
Recent medication for asthma <br>
Recent medication for emphysema <br>
Recent medication for chronic bronchitis <br>
Recent medication for COPD (Chronic Obstructive Pulmonary Disease) <br>
Recent medication for cystic fibrosis <br>
Recent medication for alpha-1 antitrypsin deficiency <br>
Recent medication for sarcoidosis <br>
Recent medication for bronchiectasis <br>
Recent medication for idiopathic pulmonary fibrosis <br>
Recent medication for fibrosing alveolitis/unspecified alveolitis <br>
Recent medication for tuberculosis <br>
Recent medication for silicosis <br>
Recent medication for asbestosis <br>
Recent medication for lung cancer (not mesothelioma) <br>
Recent medication for mesothelioma of the lung <br>
HLA imputation values <br>
PQ interval <br>
QT interval <br>
QTC interval <br>
RR interval <br>
PP interval <br>
P axis <br>
R axis <br>
T axis <br>
QRS num <br>
Anterior thigh fat-free muscle volume (right) <br>
Posterior thigh fat-free muscle volume (right) <br>
Anterior thigh fat-free muscle volume (left) <br>
Posterior thigh fat-free muscle volume (left) <br>
Visceral adipose tissue volume (VAT) <br>
Abdominal subcutaneous adipose tissue volume (ASAT) <br>
Total thigh fat-free muscle volume <br>
Total trunk fat volume <br>
LV ejection fraction <br>
LV end diastolic volume <br>
LV end systolic volume <br>
LV stroke volume <br>
Cardiac output <br>
Cardiac index <br>
Average heart rate <br>
Body surface area <br>
Device used to enter occupational data <br>
When occupational data entered <br>
Year ended full time education <br>
Cough on most days <br>
Years of cough on most days <br>
Bring up phlegm/sputum/mucus on most days <br>
Years of bringing up phlegm/sputum/mucus on most days <br>
Tobacco smoking <br>
Age of stopping smoking <br>
Amount of tobacco currently smoked <br>
Number of jobs held <br>
Job coding <br>
Year job started <br>
Year job ended <br>
Work hours - lumped category <br>
Work hours per week - exact value <br>
Workplace very noisy <br>
Workplace very cold <br>
Workplace very hot <br>
Workplace very dusty <br>
Workplace full of chemical or other fumes <br>
Workplace had a lot of cigarette smoke from other people smoking <br>
Worked with materials containing asbestos <br>
Worked with paints, thinners or glues <br>
Worked with pesticides <br>
Workplace had a lot of diesel exhaust <br>
Breathing problems during period of job <br>
Job code - historical <br>
Breathing problems improved/stopped away from workplace or on holiday <br>
Breathing problems responsible for leaving job <br>
Job involved shift work <br>
Day shifts worked <br>
Period spent working day shifts <br>
Mixture of day and night shifts worked <br>
Period spent working mix of day and night shifts <br>
Usual length of each night shift during mixed shift periods <br>
Number of night shifts worked monthly during mixed shift periods <br>
Consecutive night shifts during mixed shift periods <br>
Rest days during mixed shift periods <br>
Night shifts worked <br>
Period spent working night shifts <br>
Usual length of each night shift during night shift periods <br>
Number of night shifts worked monthly during night shift periods <br>
Consecutive night shifts during night shift periods <br>
Rest days during night shift periods <br>
Gap coding <br>
Number of gap periods <br>
Title for other gap <br>
Year gap started <br>
Year gap ended <br>
Minimum carotid IMT (intima-medial thickness) at 120 degrees <br>
Mean carotid IMT (intima-medial thickness) at 120 degrees <br>
Maximum carotid IMT (intima-medial thickness) at 120 degrees <br>
Minimum carotid IMT (intima-medial thickness) at 150 degrees <br>
Mean carotid IMT (intima-medial thickness) at 150 degrees <br>
Maximum carotid IMT (intima-medial thickness) at 150 degrees <br>
Minimum carotid IMT (intima-medial thickness) at 210 degrees <br>
Mean carotid IMT (intima-medial thickness) at 210 degrees <br>
Maximum carotid IMT (intima-medial thickness) at 210 degrees <br>
Minimum carotid IMT (intima-medial thickness) at 240 degrees <br>
Mean carotid IMT (intima-medial thickness) at 240 degrees <br>
Maximum carotid IMT (intima-medial thickness) at 240 degrees <br>
Quality control indicator for IMT at 120 degrees <br>
Quality control indicator for IMT at 150 degrees <br>
Quality control indicator for IMT at 210 degrees <br>
Quality control indicator for IMT at 240 degrees <br>
Date first recorded at location <br>
Home location - east co-ordinate (1km resolution) <br>
Home location - north co-ordinate (1km resolution) <br>
1gG antigen for Herpes Simplex virus-1 <br>
2mgG unique antigen for Herpes Simplex virus-2 <br>
gE / gI antigen for Varicella Zoster Virus <br>
VCA p18 antigen for Epstein-Barr Virus <br>
EBNA-1 antigen for Epstein-Barr Virus <br>
ZEBRA antigen for Epstein-Barr Virus <br>
EA-D antigen for Epstein-Barr Virus <br>
pp150 Nter antigen for Human Cytomegalovirus <br>
pp 52 antigen for Human Cytomegalovirus <br>
pp 28 antigen for Human Cytomegalovirus <br>
IE1A antigen for Human Herpesvirus-6 <br>
IE1B antigen for Human Herpesvirus-6 <br>
p101 k antigen for Human Herpesvirus-6 <br>
U14 antigen for Human Herpesvirus-7 <br>
LANA antigen for Kaposi's Sarcoma-Associated Herpesvirus <br>
K8.1 antigen for Kaposi's Sarcoma-Associated Herpesvirus <br>
HBc antigen for Hepatitis B Virus <br>
HBe antigen for Hepatitis B Virus <br>
Core antigen for Hepatitis C Virus <br>
NS3 antigen for Hepatitis C Virus <br>
p22 antigen for Toxoplasma gondii <br>
sag1 antigen for Toxoplasma gondii <br>
HTLV-1 gag antigen for Human T-Lymphotropic Virus 1 <br>
HTLV-1 env antigen for Human T-Lymphotropic Virus 1 <br>
HIV-1 gag antigen for Human Immunodeficiency Virus <br>
HIV-1 env antigen for Human Immunodeficiency Virus <br>
BK VP1 antigen for Human Polyomavirus BKV <br>
JC VP1 antigen for Human Polyomavirus JCV <br>
MC VP1 antigen for Merkel Cell Polyomavirus <br>
L1 antigen for Human Papillomavirus type-16 <br>
E6 antigen for Human Papillomavirus type-16 <br>
E7 antigen for Human Papillomavirus type-16 <br>
L1 antigen for Human Papillomavirus type-18 <br>
momp D antigen for Chlamydia trachomatis <br>
momp A antigen for Chlamydia trachomatis <br>
tarp-D F1 antigen for Chlamydia trachomatis <br>
tarp-D F2 antigen for Chlamydia trachomatis <br>
PorB antigen for Chlamydia trachomatis <br>
pGP3 antigen for Chlamydia trachomatis <br>
CagA antigen for Helicobacter pylori <br>
VacA antigen for Helicobacter pylori <br>
OMP antigen for Helicobacter pylori <br>
GroEL antigen for Helicobacter pylori <br>
Catalase antigen for Helicobacter pylori <br>
UreA antigen for Helicobacter pylori <br>
Antigen assay date <br>
Antigen assay QC indicator <br>
HSV-1 seropositivity for Herpes Simplex virus-1 <br>
HSV-2 seropositivity for Herpes Simplex virus-2 <br>
VZV seropositivity for Varicella Zoster Virus <br>
EBV seropositivity for Epstein-Barr Virus <br>
CMV seropositivity for Human Cytomegalovirus <br>
HHV-6 overall seropositivity for Human Herpesvirus-6 <br>
HHV-6A seropositivity for Human Herpesvirus-6 <br>
HHV-6B seropositivity for Human Herpesvirus-6 <br>
HHV-7 seropositivity for Human Herpesvirus-7 <br>
KSHV seropositivity for Kaposi's Sarcoma-Associated Herpesvirus <br>
HBV seropositivity for Hepatitis B Virus <br>
HCV seropositivity for Hepatitis C Virus <br>
T. gondii seropositivity for Toxoplasma gondii <br>
HTLV-1 seropositivity for Human T-Lymphotropic Virus 1 <br>
HIV-1 seropositivity for Human Immunodeficiency Virus <br>
BKV seropositivity for Human Polyomavirus BKV <br>
JCV seropositivity for Human Polyomavirus JCV <br>
MCV seropositivity for Merkel Cell Polyomavirus <br>
HPV 16 Definition I seropositivity for Human Papillomavirus type-16 <br>
HPV 18 seropositivity for Human Papillomavirus type-18 <br>
C. trachomatis Definition I seropositivity for Chlamydia trachomatis <br>
C. trachomatis Definition II seropositivity for Chlamydia trachomatis <br>
H. pylori Definition I seropositivity for Helicobacter pylori <br>
H. pylori Definition II seropositivity for Helicobacter pylori <br>
HPV 16 Definition II seropositivity for Human Papillomavirus type-16 <br>
Body fat percentage <br>
Whole body fat mass <br>
Whole body fat-free mass <br>
Whole body water mass <br>
Impedance of whole body <br>
Impedance of leg (right) <br>
Impedance of leg (left) <br>
Impedance of arm (right) <br>
Impedance of arm (left) <br>
Leg fat percentage (right) <br>
Leg fat mass (right) <br>
Leg fat-free mass (right) <br>
Leg predicted mass (right) <br>
Leg fat percentage (left) <br>
Leg fat mass (left) <br>
Leg fat-free mass (left) <br>
Leg predicted mass (left) <br>
Arm fat percentage (right) <br>
Arm fat mass (right) <br>
Arm fat-free mass (right) <br>
Arm predicted mass (right) <br>
Arm fat percentage (left) <br>
Arm fat mass (left) <br>
Arm fat-free mass (left) <br>
Arm predicted mass (left) <br>
Trunk fat percentage <br>
Trunk fat mass <br>
Trunk fat-free mass <br>
Trunk predicted mass <br>
L1-L4 area <br>
L1-L4 average height <br>
L1-L4 average width <br>
L1-L4 BMC (bone mineral content) <br>
L1-L4 BMD (bone mineral density) <br>
L1-L4 BMD (bone mineral density) T-score <br>
Femur lower neck BMD (bone mineral density) (right) <br>
Femur neck BMD (bone mineral density) (right) <br>
Femur neck BMD (bone mineral density) T-score (right) <br>
Femur shaft BMD (bone mineral density) (right) <br>
Femur total BMD (bone mineral density) (right) <br>
Femur total BMD (bone mineral density) T-score (right) <br>
Femur troch BMD (bone mineral density) (right) <br>
Femur troch BMD (bone mineral density) T-score (right) <br>
Femur upper neck BMD (bone mineral density) (right) <br>
Femur upper neck BMD (bone mineral density) T-score (right) <br>
Femur wards BMD (bone mineral density) (right) <br>
Femur wards BMD (bone mineral density) T-score (right) <br>
Arm BMC (bone mineral content) (left) <br>
Arm BMD (bone mineral density) (left) <br>
Arm BMC (bone mineral content) (right) <br>
Arm BMD (bone mineral density) (right) <br>
Arms BMC (bone mineral content) <br>
Arms BMD (bone mineral density) <br>
Head BMD (bone mineral density) <br>
Leg BMD (bone mineral density) (left) <br>
Leg BMC (bone mineral content) (right) <br>
Leg BMD (bone mineral density) (right) <br>
Legs BMC (bone mineral content) <br>
Legs BMD (bone mineral density) <br>
Pelvis BMD (bone mineral density) <br>
Ribs BMD (bone mineral density) <br>
Spine BMD (bone mineral density) <br>
Total BMC (bone mineral content) <br>
Total BMD (bone mineral density) <br>
Total BMD (bone mineral density) (left) <br>
Total BMD (bone mineral density) (right) <br>
Total BMD (bone mineral density) T-score <br>
Trunk BMC (bone mineral content) <br>
Trunk BMD (bone mineral density) <br>
Trunk BMD (bone mineral density) (left) <br>
Trunk BMD (bone mineral density) (right) <br>
Android bone mass <br>
Android fat mass <br>
Android lean mass <br>
Android tissue fat percentage <br>
Android total mass <br>
Arm lean mass (left) <br>
Arm tissue fat percentage (left) <br>
Arm total mass (left) <br>
Arm lean mass (right) <br>
Arm tissue fat percentage (right) <br>
Arm total mass (right) <br>
Arms fat mass <br>
Arms lean mass <br>
Arms tissue fat percentage <br>
Arms total mass <br>
Gynoid bone mass <br>
Gynoid fat mass <br>
Gynoid lean mass <br>
Gynoid tissue fat percentage <br>
Gynoid total mass <br>
Leg lean mass (left) <br>
Leg tissue fat percentage (left) <br>
Leg total mass (left) <br>
Leg lean mass (right) <br>
Leg tissue fat percentage (right) <br>
Leg total mass (right) <br>
Legs fat mass <br>
Legs lean mass <br>
Legs tissue fat percentage <br>
Legs total mass <br>
Total fat mass <br>
Total fat-free mass <br>
Total lean mass <br>
Total tissue fat percentage <br>
Total tissue mass <br>
Total mass <br>
Trunk lean mass <br>
Trunk tissue fat percentage <br>
Trunk total mass <br>
VAT (visceral adipose tissue) mass <br>
VAT (visceral adipose tissue) volume <br>
Femur shaft BMD (bone mineral density) (left) <br>
Femur total BMD (bone mineral density) (left) <br>
Femur upper neck BMD (bone mineral density) (left) <br>
Femur total BMD (bone mineral density) T-score (left) <br>
Femur troch BMD (bone mineral density) (left) <br>
Femur upper neck BMD (bone mineral density) T-score (left) <br>
Femur wards BMD (bone mineral density) (left) <br>
Femur troch BMD (bone mineral density) T-score (left) <br>
Femur neck BMD (bone mineral density) (left) <br>
Femur neck BMD (bone mineral density) T-score (left) <br>
Femur wards BMD (bone mineral density) T-score (left) <br>
Femur lower neck BMD (bone mineral density) (left) <br>
Trunk bone area <br>
Head bone area <br>
Head BMC (bone mineral content) <br>
Pelvis bone area <br>
Pelvis BMC (bone mineral content) <br>
Ribs bone area <br>
Ribs BMC (bone mineral content) <br>
Spine bone area <br>
Spine BMC (bone mineral content) <br>
Arm bone area (left) <br>
Arm bone area (right) <br>
Leg bone area (left) <br>
Leg bone area (right) <br>
Arms combined bone area <br>
Legs combined bone area <br>
Leg BMC (bone mineral content) (left) <br>
Nitrogen dioxide air pollution; 2010 <br>
Nitrogen oxides air pollution; 2010 <br>
Particulate matter air pollution (pm10); 2010 <br>
Particulate matter air pollution (pm2.5); 2010 <br>
Particulate matter air pollution (pm2.5) absorbance; 2010 <br>
Particulate matter air pollution 2.5-10um; 2010 <br>
Traffic intensity on the nearest road <br>
Inverse distance to the nearest road <br>
Traffic intensity on the nearest major road <br>
Inverse distance to the nearest major road <br>
Total traffic load on major roads <br>
Close to major road <br>
Sum of road length of major roads within 100m <br>
Nitrogen dioxide air pollution; 2005 <br>
Nitrogen dioxide air pollution; 2006 <br>
Nitrogen dioxide air pollution; 2007 <br>
Particulate matter air pollution (pm10); 2007 <br>
Average daytime sound level of noise pollution <br>
Average evening sound level of noise pollution <br>
Average night-time sound level of noise pollution <br>
Greenspace percentage, buffer 1000m <br>
Domestic garden percentage, buffer 1000m <br>
Water percentage, buffer 1000m <br>
Greenspace percentage, buffer 300m <br>
Domestic garden percentage, buffer 300m <br>
Water percentage, buffer 300m <br>
Natural environment percentage, buffer 1000m <br>
Natural environment percentage, buffer 300m <br>
Distance (Euclidean) to coast <br>
Volumetric scaling from T1 head image to standard space <br>
Volume of peripheral cortical grey matter (normalised for head size) <br>
Volume of peripheral cortical grey matter <br>
Volume of ventricular cerebrospinal fluid (normalised for head size) <br>
Volume of ventricular cerebrospinal fluid <br>
Volume of grey matter (normalised for head size) <br>
Volume of grey matter <br>
Volume of white matter (normalised for head size) <br>
Volume of white matter <br>
Volume of brain, grey+white matter (normalised for head size) <br>
Volume of brain, grey+white matter <br>
Volume of thalamus (left) <br>
Volume of thalamus (right) <br>
Volume of caudate (left) <br>
Volume of caudate (right) <br>
Volume of putamen (left) <br>
Volume of putamen (right) <br>
Volume of pallidum (left) <br>
Volume of pallidum (right) <br>
Volume of hippocampus (left) <br>
Volume of hippocampus (right) <br>
Volume of amygdala (left) <br>
Volume of amygdala (right) <br>
Volume of accumbens (left) <br>
Volume of accumbens (right) <br>
Volume of brain stem + 4th ventricle <br>
Median T2star in thalamus (left) <br>
Median T2star in thalamus (right) <br>
Median T2star in caudate (left) <br>
Median T2star in caudate (right) <br>
Median T2star in putamen (left) <br>
Median T2star in putamen (right) <br>
Median T2star in pallidum (left) <br>
Median T2star in pallidum (right) <br>
Median T2star in hippocampus (left) <br>
Median T2star in hippocampus (right) <br>
Median T2star in amygdala (left) <br>
Median T2star in amygdala (right) <br>
Median T2star in accumbens (left) <br>
Median T2star in accumbens (right) <br>
Median BOLD effect (in group-defined mask) for shapes activation <br>
Median z-statistic (in group-defined mask) for shapes activation <br>
Median BOLD effect (in group-defined mask) for faces activation <br>
Median z-statistic (in group-defined mask) for faces activation <br>
Median BOLD effect (in group-defined mask) for faces-shapes contrast <br>
Median z-statistic (in group-defined mask) for faces-shapes contrast <br>
Median BOLD effect (in group-defined amygdala activation mask) for faces-shapes contrast <br>
Median z-statistic (in group-defined amygdala activation mask) for faces-shapes contrast <br>
Mean FA in middle cerebellar peduncle on FA skeleton <br>
Mean FA in pontine crossing tract on FA skeleton <br>
Mean FA in genu of corpus callosum on FA skeleton <br>
Mean FA in body of corpus callosum on FA skeleton <br>
Mean FA in splenium of corpus callosum on FA skeleton <br>
Mean FA in fornix on FA skeleton <br>
Mean FA in corticospinal tract on FA skeleton (right) <br>
Mean FA in corticospinal tract on FA skeleton (left) <br>
Mean FA in medial lemniscus on FA skeleton (right) <br>
Mean FA in medial lemniscus on FA skeleton (left) <br>
Mean FA in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean FA in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean FA in superior cerebellar peduncle on FA skeleton (right) <br>
Mean FA in superior cerebellar peduncle on FA skeleton (left) <br>
Mean FA in cerebral peduncle on FA skeleton (right) <br>
Mean FA in cerebral peduncle on FA skeleton (left) <br>
Mean FA in anterior limb of internal capsule on FA skeleton (right) <br>
Mean FA in anterior limb of internal capsule on FA skeleton (left) <br>
Mean FA in posterior limb of internal capsule on FA skeleton (right) <br>
Mean FA in posterior limb of internal capsule on FA skeleton (left) <br>
Mean FA in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean FA in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean FA in anterior corona radiata on FA skeleton (right) <br>
Mean FA in anterior corona radiata on FA skeleton (left) <br>
Mean FA in superior corona radiata on FA skeleton (right) <br>
Mean FA in superior corona radiata on FA skeleton (left) <br>
Mean FA in posterior corona radiata on FA skeleton (right) <br>
Mean FA in posterior corona radiata on FA skeleton (left) <br>
Mean FA in posterior thalamic radiation on FA skeleton (right) <br>
Mean FA in posterior thalamic radiation on FA skeleton (left) <br>
Mean FA in sagittal stratum on FA skeleton (right) <br>
Mean FA in sagittal stratum on FA skeleton (left) <br>
Mean FA in external capsule on FA skeleton (right) <br>
Mean FA in external capsule on FA skeleton (left) <br>
Mean FA in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean FA in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean FA in cingulum hippocampus on FA skeleton (right) <br>
Mean FA in cingulum hippocampus on FA skeleton (left) <br>
Mean FA in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean FA in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean FA in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean FA in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean FA in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean FA in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean FA in uncinate fasciculus on FA skeleton (right) <br>
Mean FA in uncinate fasciculus on FA skeleton (left) <br>
Mean FA in tapetum on FA skeleton (right) <br>
Mean FA in tapetum on FA skeleton (left) <br>
Mean MD in middle cerebellar peduncle on FA skeleton <br>
Mean MD in pontine crossing tract on FA skeleton <br>
Mean MD in genu of corpus callosum on FA skeleton <br>
Mean MD in body of corpus callosum on FA skeleton <br>
Mean MD in splenium of corpus callosum on FA skeleton <br>
Mean MD in fornix on FA skeleton <br>
Mean MD in corticospinal tract on FA skeleton (right) <br>
Mean MD in corticospinal tract on FA skeleton (left) <br>
Mean MD in medial lemniscus on FA skeleton (right) <br>
Mean MD in medial lemniscus on FA skeleton (left) <br>
Mean MD in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean MD in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean MD in superior cerebellar peduncle on FA skeleton (right) <br>
Mean MD in superior cerebellar peduncle on FA skeleton (left) <br>
Mean MD in cerebral peduncle on FA skeleton (right) <br>
Mean MD in cerebral peduncle on FA skeleton (left) <br>
Mean MD in anterior limb of internal capsule on FA skeleton (right) <br>
Mean MD in anterior limb of internal capsule on FA skeleton (left) <br>
Mean MD in posterior limb of internal capsule on FA skeleton (right) <br>
Mean MD in posterior limb of internal capsule on FA skeleton (left) <br>
Mean MD in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean MD in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean MD in anterior corona radiata on FA skeleton (right) <br>
Mean MD in anterior corona radiata on FA skeleton (left) <br>
Mean MD in superior corona radiata on FA skeleton (right) <br>
Mean MD in superior corona radiata on FA skeleton (left) <br>
Mean MD in posterior corona radiata on FA skeleton (right) <br>
Mean MD in posterior corona radiata on FA skeleton (left) <br>
Mean MD in posterior thalamic radiation on FA skeleton (right) <br>
Mean MD in posterior thalamic radiation on FA skeleton (left) <br>
Mean MD in sagittal stratum on FA skeleton (right) <br>
Mean MD in sagittal stratum on FA skeleton (left) <br>
Mean MD in external capsule on FA skeleton (right) <br>
Mean MD in external capsule on FA skeleton (left) <br>
Mean MD in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean MD in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean MD in cingulum hippocampus on FA skeleton (right) <br>
Mean MD in cingulum hippocampus on FA skeleton (left) <br>
Mean MD in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean MD in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean MD in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean MD in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean MD in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean MD in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean MD in uncinate fasciculus on FA skeleton (right) <br>
Mean MD in uncinate fasciculus on FA skeleton (left) <br>
Mean MD in tapetum on FA skeleton (right) <br>
Mean MD in tapetum on FA skeleton (left) <br>
Mean MO in middle cerebellar peduncle on FA skeleton <br>
Mean MO in pontine crossing tract on FA skeleton <br>
Mean MO in genu of corpus callosum on FA skeleton <br>
Mean MO in body of corpus callosum on FA skeleton <br>
Mean MO in splenium of corpus callosum on FA skeleton <br>
Mean MO in fornix on FA skeleton <br>
Mean MO in corticospinal tract on FA skeleton (right) <br>
Mean MO in corticospinal tract on FA skeleton (left) <br>
Mean MO in medial lemniscus on FA skeleton (right) <br>
Mean MO in medial lemniscus on FA skeleton (left) <br>
Mean MO in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean MO in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean MO in superior cerebellar peduncle on FA skeleton (right) <br>
Mean MO in superior cerebellar peduncle on FA skeleton (left) <br>
Mean MO in cerebral peduncle on FA skeleton (right) <br>
Mean MO in cerebral peduncle on FA skeleton (left) <br>
Mean MO in anterior limb of internal capsule on FA skeleton (right) <br>
Mean MO in anterior limb of internal capsule on FA skeleton (left) <br>
Mean MO in posterior limb of internal capsule on FA skeleton (right) <br>
Mean MO in posterior limb of internal capsule on FA skeleton (left) <br>
Mean MO in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean MO in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean MO in anterior corona radiata on FA skeleton (right) <br>
Mean MO in anterior corona radiata on FA skeleton (left) <br>
Mean MO in superior corona radiata on FA skeleton (right) <br>
Mean MO in superior corona radiata on FA skeleton (left) <br>
Mean MO in posterior corona radiata on FA skeleton (right) <br>
Mean MO in posterior corona radiata on FA skeleton (left) <br>
Mean MO in posterior thalamic radiation on FA skeleton (right) <br>
Mean MO in posterior thalamic radiation on FA skeleton (left) <br>
Mean MO in sagittal stratum on FA skeleton (right) <br>
Mean MO in sagittal stratum on FA skeleton (left) <br>
Mean MO in external capsule on FA skeleton (right) <br>
Mean MO in external capsule on FA skeleton (left) <br>
Mean MO in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean MO in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean MO in cingulum hippocampus on FA skeleton (right) <br>
Mean MO in cingulum hippocampus on FA skeleton (left) <br>
Mean MO in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean MO in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean MO in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean MO in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean MO in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean MO in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean MO in uncinate fasciculus on FA skeleton (right) <br>
Mean MO in uncinate fasciculus on FA skeleton (left) <br>
Mean MO in tapetum on FA skeleton (right) <br>
Mean MO in tapetum on FA skeleton (left) <br>
Mean L1 in middle cerebellar peduncle on FA skeleton <br>
Mean L1 in pontine crossing tract on FA skeleton <br>
Mean L1 in genu of corpus callosum on FA skeleton <br>
Mean L1 in body of corpus callosum on FA skeleton <br>
Mean L1 in splenium of corpus callosum on FA skeleton <br>
Mean L1 in fornix on FA skeleton <br>
Mean L1 in corticospinal tract on FA skeleton (right) <br>
Mean L1 in corticospinal tract on FA skeleton (left) <br>
Mean L1 in medial lemniscus on FA skeleton (right) <br>
Mean L1 in medial lemniscus on FA skeleton (left) <br>
Mean L1 in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean L1 in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean L1 in superior cerebellar peduncle on FA skeleton (right) <br>
Mean L1 in superior cerebellar peduncle on FA skeleton (left) <br>
Mean L1 in cerebral peduncle on FA skeleton (right) <br>
Mean L1 in cerebral peduncle on FA skeleton (left) <br>
Mean L1 in anterior limb of internal capsule on FA skeleton (right) <br>
Mean L1 in anterior limb of internal capsule on FA skeleton (left) <br>
Mean L1 in posterior limb of internal capsule on FA skeleton (right) <br>
Mean L1 in posterior limb of internal capsule on FA skeleton (left) <br>
Mean L1 in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean L1 in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean L1 in anterior corona radiata on FA skeleton (right) <br>
Mean L1 in anterior corona radiata on FA skeleton (left) <br>
Mean L1 in superior corona radiata on FA skeleton (right) <br>
Mean L1 in superior corona radiata on FA skeleton (left) <br>
Mean L1 in posterior corona radiata on FA skeleton (right) <br>
Mean L1 in posterior corona radiata on FA skeleton (left) <br>
Mean L1 in posterior thalamic radiation on FA skeleton (right) <br>
Mean L1 in posterior thalamic radiation on FA skeleton (left) <br>
Mean L1 in sagittal stratum on FA skeleton (right) <br>
Mean L1 in sagittal stratum on FA skeleton (left) <br>
Mean L1 in external capsule on FA skeleton (right) <br>
Mean L1 in external capsule on FA skeleton (left) <br>
Mean L1 in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean L1 in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean L1 in cingulum hippocampus on FA skeleton (right) <br>
Mean L1 in cingulum hippocampus on FA skeleton (left) <br>
Mean L1 in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean L1 in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean L1 in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean L1 in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean L1 in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean L1 in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean L1 in uncinate fasciculus on FA skeleton (right) <br>
Mean L1 in uncinate fasciculus on FA skeleton (left) <br>
Mean L1 in tapetum on FA skeleton (right) <br>
Mean L1 in tapetum on FA skeleton (left) <br>
Mean L2 in middle cerebellar peduncle on FA skeleton <br>
Mean L2 in pontine crossing tract on FA skeleton <br>
Mean L2 in genu of corpus callosum on FA skeleton <br>
Mean L2 in body of corpus callosum on FA skeleton <br>
Mean L2 in splenium of corpus callosum on FA skeleton <br>
Mean L2 in fornix on FA skeleton <br>
Mean L2 in corticospinal tract on FA skeleton (right) <br>
Mean L2 in corticospinal tract on FA skeleton (left) <br>
Mean L2 in medial lemniscus on FA skeleton (right) <br>
Mean L2 in medial lemniscus on FA skeleton (left) <br>
Mean L2 in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean L2 in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean L2 in superior cerebellar peduncle on FA skeleton (right) <br>
Mean L2 in superior cerebellar peduncle on FA skeleton (left) <br>
Mean L2 in cerebral peduncle on FA skeleton (right) <br>
Mean L2 in cerebral peduncle on FA skeleton (left) <br>
Mean L2 in anterior limb of internal capsule on FA skeleton (right) <br>
Mean L2 in anterior limb of internal capsule on FA skeleton (left) <br>
Mean L2 in posterior limb of internal capsule on FA skeleton (right) <br>
Mean L2 in posterior limb of internal capsule on FA skeleton (left) <br>
Mean L2 in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean L2 in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean L2 in anterior corona radiata on FA skeleton (right) <br>
Mean L2 in anterior corona radiata on FA skeleton (left) <br>
Mean L2 in superior corona radiata on FA skeleton (right) <br>
Mean L2 in superior corona radiata on FA skeleton (left) <br>
Mean L2 in posterior corona radiata on FA skeleton (right) <br>
Mean L2 in posterior corona radiata on FA skeleton (left) <br>
Mean L2 in posterior thalamic radiation on FA skeleton (right) <br>
Mean L2 in posterior thalamic radiation on FA skeleton (left) <br>
Mean L2 in sagittal stratum on FA skeleton (right) <br>
Mean L2 in sagittal stratum on FA skeleton (left) <br>
Mean L2 in external capsule on FA skeleton (right) <br>
Mean L2 in external capsule on FA skeleton (left) <br>
Mean L2 in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean L2 in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean L2 in cingulum hippocampus on FA skeleton (right) <br>
Mean L2 in cingulum hippocampus on FA skeleton (left) <br>
Mean L2 in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean L2 in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean L2 in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean L2 in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean L2 in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean L2 in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean L2 in uncinate fasciculus on FA skeleton (right) <br>
Mean L2 in uncinate fasciculus on FA skeleton (left) <br>
Mean L2 in tapetum on FA skeleton (right) <br>
Mean L2 in tapetum on FA skeleton (left) <br>
Mean L3 in middle cerebellar peduncle on FA skeleton <br>
Mean L3 in pontine crossing tract on FA skeleton <br>
Mean L3 in genu of corpus callosum on FA skeleton <br>
Mean L3 in body of corpus callosum on FA skeleton <br>
Mean L3 in splenium of corpus callosum on FA skeleton <br>
Mean L3 in fornix on FA skeleton <br>
Mean L3 in corticospinal tract on FA skeleton (right) <br>
Mean L3 in corticospinal tract on FA skeleton (left) <br>
Mean L3 in medial lemniscus on FA skeleton (right) <br>
Mean L3 in medial lemniscus on FA skeleton (left) <br>
Mean L3 in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean L3 in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean L3 in superior cerebellar peduncle on FA skeleton (right) <br>
Mean L3 in superior cerebellar peduncle on FA skeleton (left) <br>
Mean L3 in cerebral peduncle on FA skeleton (right) <br>
Mean L3 in cerebral peduncle on FA skeleton (left) <br>
Mean L3 in anterior limb of internal capsule on FA skeleton (right) <br>
Mean L3 in anterior limb of internal capsule on FA skeleton (left) <br>
Mean L3 in posterior limb of internal capsule on FA skeleton (right) <br>
Mean L3 in posterior limb of internal capsule on FA skeleton (left) <br>
Mean L3 in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean L3 in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean L3 in anterior corona radiata on FA skeleton (right) <br>
Mean L3 in anterior corona radiata on FA skeleton (left) <br>
Mean L3 in superior corona radiata on FA skeleton (right) <br>
Mean L3 in superior corona radiata on FA skeleton (left) <br>
Mean L3 in posterior corona radiata on FA skeleton (right) <br>
Mean L3 in posterior corona radiata on FA skeleton (left) <br>
Mean L3 in posterior thalamic radiation on FA skeleton (right) <br>
Mean L3 in posterior thalamic radiation on FA skeleton (left) <br>
Mean L3 in sagittal stratum on FA skeleton (right) <br>
Mean L3 in sagittal stratum on FA skeleton (left) <br>
Mean L3 in external capsule on FA skeleton (right) <br>
Mean L3 in external capsule on FA skeleton (left) <br>
Mean L3 in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean L3 in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean L3 in cingulum hippocampus on FA skeleton (right) <br>
Mean L3 in cingulum hippocampus on FA skeleton (left) <br>
Mean L3 in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean L3 in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean L3 in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean L3 in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean L3 in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean L3 in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean L3 in uncinate fasciculus on FA skeleton (right) <br>
Mean L3 in uncinate fasciculus on FA skeleton (left) <br>
Mean L3 in tapetum on FA skeleton (right) <br>
Mean L3 in tapetum on FA skeleton (left) <br>
Mean ICVF in middle cerebellar peduncle on FA skeleton <br>
Mean ICVF in pontine crossing tract on FA skeleton <br>
Mean ICVF in genu of corpus callosum on FA skeleton <br>
Mean ICVF in body of corpus callosum on FA skeleton <br>
Mean ICVF in splenium of corpus callosum on FA skeleton <br>
Mean ICVF in fornix on FA skeleton <br>
Mean ICVF in corticospinal tract on FA skeleton (right) <br>
Mean ICVF in corticospinal tract on FA skeleton (left) <br>
Mean ICVF in medial lemniscus on FA skeleton (right) <br>
Mean ICVF in medial lemniscus on FA skeleton (left) <br>
Mean ICVF in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean ICVF in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean ICVF in superior cerebellar peduncle on FA skeleton (right) <br>
Mean ICVF in superior cerebellar peduncle on FA skeleton (left) <br>
Mean ICVF in cerebral peduncle on FA skeleton (right) <br>
Mean ICVF in cerebral peduncle on FA skeleton (left) <br>
Mean ICVF in anterior limb of internal capsule on FA skeleton (right) <br>
Mean ICVF in anterior limb of internal capsule on FA skeleton (left) <br>
Mean ICVF in posterior limb of internal capsule on FA skeleton (right) <br>
Mean ICVF in posterior limb of internal capsule on FA skeleton (left) <br>
Mean ICVF in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean ICVF in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean ICVF in anterior corona radiata on FA skeleton (right) <br>
Mean ICVF in anterior corona radiata on FA skeleton (left) <br>
Mean ICVF in superior corona radiata on FA skeleton (right) <br>
Mean ICVF in superior corona radiata on FA skeleton (left) <br>
Mean ICVF in posterior corona radiata on FA skeleton (right) <br>
Mean ICVF in posterior corona radiata on FA skeleton (left) <br>
Mean ICVF in posterior thalamic radiation on FA skeleton (right) <br>
Mean ICVF in posterior thalamic radiation on FA skeleton (left) <br>
Mean ICVF in sagittal stratum on FA skeleton (right) <br>
Mean ICVF in sagittal stratum on FA skeleton (left) <br>
Mean ICVF in external capsule on FA skeleton (right) <br>
Mean ICVF in external capsule on FA skeleton (left) <br>
Mean ICVF in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean ICVF in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean ICVF in cingulum hippocampus on FA skeleton (right) <br>
Mean ICVF in cingulum hippocampus on FA skeleton (left) <br>
Mean ICVF in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean ICVF in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean ICVF in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean ICVF in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean ICVF in uncinate fasciculus on FA skeleton (right) <br>
Mean ICVF in uncinate fasciculus on FA skeleton (left) <br>
Mean ICVF in tapetum on FA skeleton (right) <br>
Mean ICVF in tapetum on FA skeleton (left) <br>
Mean OD in middle cerebellar peduncle on FA skeleton <br>
Mean OD in pontine crossing tract on FA skeleton <br>
Mean OD in genu of corpus callosum on FA skeleton <br>
Mean OD in body of corpus callosum on FA skeleton <br>
Mean OD in splenium of corpus callosum on FA skeleton <br>
Mean OD in fornix on FA skeleton <br>
Mean OD in corticospinal tract on FA skeleton (right) <br>
Mean OD in corticospinal tract on FA skeleton (left) <br>
Mean OD in medial lemniscus on FA skeleton (right) <br>
Mean OD in medial lemniscus on FA skeleton (left) <br>
Mean OD in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean OD in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean OD in superior cerebellar peduncle on FA skeleton (right) <br>
Mean OD in superior cerebellar peduncle on FA skeleton (left) <br>
Mean OD in cerebral peduncle on FA skeleton (right) <br>
Mean OD in cerebral peduncle on FA skeleton (left) <br>
Mean OD in anterior limb of internal capsule on FA skeleton (right) <br>
Mean OD in anterior limb of internal capsule on FA skeleton (left) <br>
Mean OD in posterior limb of internal capsule on FA skeleton (right) <br>
Mean OD in posterior limb of internal capsule on FA skeleton (left) <br>
Mean OD in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean OD in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean OD in anterior corona radiata on FA skeleton (right) <br>
Mean OD in anterior corona radiata on FA skeleton (left) <br>
Mean OD in superior corona radiata on FA skeleton (right) <br>
Mean OD in superior corona radiata on FA skeleton (left) <br>
Mean OD in posterior corona radiata on FA skeleton (right) <br>
Mean OD in posterior corona radiata on FA skeleton (left) <br>
Mean OD in posterior thalamic radiation on FA skeleton (right) <br>
Mean OD in posterior thalamic radiation on FA skeleton (left) <br>
Mean OD in sagittal stratum on FA skeleton (right) <br>
Mean OD in sagittal stratum on FA skeleton (left) <br>
Mean OD in external capsule on FA skeleton (right) <br>
Mean OD in external capsule on FA skeleton (left) <br>
Mean OD in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean OD in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean OD in cingulum hippocampus on FA skeleton (right) <br>
Mean OD in cingulum hippocampus on FA skeleton (left) <br>
Mean OD in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean OD in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean OD in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean OD in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean OD in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean OD in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean OD in uncinate fasciculus on FA skeleton (right) <br>
Mean OD in uncinate fasciculus on FA skeleton (left) <br>
Mean OD in tapetum on FA skeleton (right) <br>
Mean OD in tapetum on FA skeleton (left) <br>
Mean ISOVF in middle cerebellar peduncle on FA skeleton <br>
Mean ISOVF in pontine crossing tract on FA skeleton <br>
Mean ISOVF in genu of corpus callosum on FA skeleton <br>
Mean ISOVF in body of corpus callosum on FA skeleton <br>
Mean ISOVF in splenium of corpus callosum on FA skeleton <br>
Mean ISOVF in fornix on FA skeleton <br>
Mean ISOVF in corticospinal tract on FA skeleton (right) <br>
Mean ISOVF in corticospinal tract on FA skeleton (left) <br>
Mean ISOVF in medial lemniscus on FA skeleton (right) <br>
Mean ISOVF in medial lemniscus on FA skeleton (left) <br>
Mean ISOVF in inferior cerebellar peduncle on FA skeleton (right) <br>
Mean ISOVF in inferior cerebellar peduncle on FA skeleton (left) <br>
Mean ISOVF in superior cerebellar peduncle on FA skeleton (right) <br>
Mean ISOVF in superior cerebellar peduncle on FA skeleton (left) <br>
Mean ISOVF in cerebral peduncle on FA skeleton (right) <br>
Mean ISOVF in cerebral peduncle on FA skeleton (left) <br>
Mean ISOVF in anterior limb of internal capsule on FA skeleton (right) <br>
Mean ISOVF in anterior limb of internal capsule on FA skeleton (left) <br>
Mean ISOVF in posterior limb of internal capsule on FA skeleton (right) <br>
Mean ISOVF in posterior limb of internal capsule on FA skeleton (left) <br>
Mean ISOVF in retrolenticular part of internal capsule on FA skeleton (right) <br>
Mean ISOVF in retrolenticular part of internal capsule on FA skeleton (left) <br>
Mean ISOVF in anterior corona radiata on FA skeleton (right) <br>
Mean ISOVF in anterior corona radiata on FA skeleton (left) <br>
Mean ISOVF in superior corona radiata on FA skeleton (right) <br>
Mean ISOVF in superior corona radiata on FA skeleton (left) <br>
Mean ISOVF in posterior corona radiata on FA skeleton (right) <br>
Mean ISOVF in posterior corona radiata on FA skeleton (left) <br>
Mean ISOVF in posterior thalamic radiation on FA skeleton (right) <br>
Mean ISOVF in posterior thalamic radiation on FA skeleton (left) <br>
Mean ISOVF in sagittal stratum on FA skeleton (right) <br>
Mean ISOVF in sagittal stratum on FA skeleton (left) <br>
Mean ISOVF in external capsule on FA skeleton (right) <br>
Mean ISOVF in external capsule on FA skeleton (left) <br>
Mean ISOVF in cingulum cingulate gyrus on FA skeleton (right) <br>
Mean ISOVF in cingulum cingulate gyrus on FA skeleton (left) <br>
Mean ISOVF in cingulum hippocampus on FA skeleton (right) <br>
Mean ISOVF in cingulum hippocampus on FA skeleton (left) <br>
Mean ISOVF in fornix cres+stria terminalis on FA skeleton (right) <br>
Mean ISOVF in fornix cres+stria terminalis on FA skeleton (left) <br>
Mean ISOVF in superior longitudinal fasciculus on FA skeleton (right) <br>
Mean ISOVF in superior longitudinal fasciculus on FA skeleton (left) <br>
Mean ISOVF in superior fronto-occipital fasciculus on FA skeleton (right) <br>
Mean ISOVF in superior fronto-occipital fasciculus on FA skeleton (left) <br>
Mean ISOVF in uncinate fasciculus on FA skeleton (right) <br>
Mean ISOVF in uncinate fasciculus on FA skeleton (left) <br>
Mean ISOVF in tapetum on FA skeleton (right) <br>
Mean ISOVF in tapetum on FA skeleton (left) <br>
Weighted-mean FA in tract acoustic radiation (left) <br>
Weighted-mean FA in tract acoustic radiation (right) <br>
Weighted-mean FA in tract anterior thalamic radiation (left) <br>
Weighted-mean FA in tract anterior thalamic radiation (right) <br>
Weighted-mean FA in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean FA in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean FA in tract parahippocampal part of cingulum (left) <br>
Weighted-mean FA in tract parahippocampal part of cingulum (right) <br>
Weighted-mean FA in tract corticospinal tract (left) <br>
Weighted-mean FA in tract corticospinal tract (right) <br>
Weighted-mean FA in tract forceps major <br>
Weighted-mean FA in tract forceps minor <br>
Weighted-mean FA in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean FA in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean FA in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean FA in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean FA in tract middle cerebellar peduncle <br>
Weighted-mean FA in tract medial lemniscus (left) <br>
Weighted-mean FA in tract medial lemniscus (right) <br>
Weighted-mean FA in tract posterior thalamic radiation (left) <br>
Weighted-mean FA in tract posterior thalamic radiation (right) <br>
Weighted-mean FA in tract superior longitudinal fasciculus (left) <br>
Weighted-mean FA in tract superior longitudinal fasciculus (right) <br>
Weighted-mean FA in tract superior thalamic radiation (left) <br>
Weighted-mean FA in tract superior thalamic radiation (right) <br>
Weighted-mean FA in tract uncinate fasciculus (left) <br>
Weighted-mean FA in tract uncinate fasciculus (right) <br>
Weighted-mean MD in tract acoustic radiation (left) <br>
Weighted-mean MD in tract acoustic radiation (right) <br>
Weighted-mean MD in tract anterior thalamic radiation (left) <br>
Weighted-mean MD in tract anterior thalamic radiation (right) <br>
Weighted-mean MD in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean MD in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean MD in tract parahippocampal part of cingulum (left) <br>
Weighted-mean MD in tract parahippocampal part of cingulum (right) <br>
Weighted-mean MD in tract corticospinal tract (left) <br>
Weighted-mean MD in tract corticospinal tract (right) <br>
Weighted-mean MD in tract forceps major <br>
Weighted-mean MD in tract forceps minor <br>
Weighted-mean MD in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean MD in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean MD in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean MD in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean MD in tract middle cerebellar peduncle <br>
Weighted-mean MD in tract medial lemniscus (left) <br>
Weighted-mean MD in tract medial lemniscus (right) <br>
Weighted-mean MD in tract posterior thalamic radiation (left) <br>
Weighted-mean MD in tract posterior thalamic radiation (right) <br>
Weighted-mean MD in tract superior longitudinal fasciculus (left) <br>
Weighted-mean MD in tract superior longitudinal fasciculus (right) <br>
Weighted-mean MD in tract superior thalamic radiation (left) <br>
Weighted-mean MD in tract superior thalamic radiation (right) <br>
Weighted-mean MD in tract uncinate fasciculus (left) <br>
Weighted-mean MD in tract uncinate fasciculus (right) <br>
Weighted-mean MO in tract acoustic radiation (left) <br>
Weighted-mean MO in tract acoustic radiation (right) <br>
Weighted-mean MO in tract anterior thalamic radiation (left) <br>
Weighted-mean MO in tract anterior thalamic radiation (right) <br>
Weighted-mean MO in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean MO in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean MO in tract parahippocampal part of cingulum (left) <br>
Weighted-mean MO in tract parahippocampal part of cingulum (right) <br>
Weighted-mean MO in tract corticospinal tract (left) <br>
Weighted-mean MO in tract corticospinal tract (right) <br>
Weighted-mean MO in tract forceps major <br>
Weighted-mean MO in tract forceps minor <br>
Weighted-mean MO in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean MO in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean MO in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean MO in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean MO in tract middle cerebellar peduncle <br>
Weighted-mean MO in tract medial lemniscus (left) <br>
Weighted-mean MO in tract medial lemniscus (right) <br>
Weighted-mean MO in tract posterior thalamic radiation (left) <br>
Weighted-mean MO in tract posterior thalamic radiation (right) <br>
Weighted-mean MO in tract superior longitudinal fasciculus (left) <br>
Weighted-mean MO in tract superior longitudinal fasciculus (right) <br>
Weighted-mean MO in tract superior thalamic radiation (left) <br>
Weighted-mean MO in tract superior thalamic radiation (right) <br>
Weighted-mean MO in tract uncinate fasciculus (left) <br>
Weighted-mean MO in tract uncinate fasciculus (right) <br>
Weighted-mean L1 in tract acoustic radiation (left) <br>
Weighted-mean L1 in tract acoustic radiation (right) <br>
Weighted-mean L1 in tract anterior thalamic radiation (left) <br>
Weighted-mean L1 in tract anterior thalamic radiation (right) <br>
Weighted-mean L1 in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean L1 in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean L1 in tract parahippocampal part of cingulum (left) <br>
Weighted-mean L1 in tract parahippocampal part of cingulum (right) <br>
Weighted-mean L1 in tract corticospinal tract (left) <br>
Weighted-mean L1 in tract corticospinal tract (right) <br>
Weighted-mean L1 in tract forceps major <br>
Weighted-mean L1 in tract forceps minor <br>
Weighted-mean L1 in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean L1 in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean L1 in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean L1 in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean L1 in tract middle cerebellar peduncle <br>
Weighted-mean L1 in tract medial lemniscus (left) <br>
Weighted-mean L1 in tract medial lemniscus (right) <br>
Weighted-mean L1 in tract posterior thalamic radiation (left) <br>
Weighted-mean L1 in tract posterior thalamic radiation (right) <br>
Weighted-mean L1 in tract superior longitudinal fasciculus (left) <br>
Weighted-mean L1 in tract superior longitudinal fasciculus (right) <br>
Weighted-mean L1 in tract superior thalamic radiation (left) <br>
Weighted-mean L1 in tract superior thalamic radiation (right) <br>
Weighted-mean L1 in tract uncinate fasciculus (left) <br>
Weighted-mean L1 in tract uncinate fasciculus (right) <br>
Weighted-mean L2 in tract acoustic radiation (left) <br>
Weighted-mean L2 in tract acoustic radiation (right) <br>
Weighted-mean L2 in tract anterior thalamic radiation (left) <br>
Weighted-mean L2 in tract anterior thalamic radiation (right) <br>
Weighted-mean L2 in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean L2 in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean L2 in tract parahippocampal part of cingulum (left) <br>
Weighted-mean L2 in tract parahippocampal part of cingulum (right) <br>
Weighted-mean L2 in tract corticospinal tract (left) <br>
Weighted-mean L2 in tract corticospinal tract (right) <br>
Weighted-mean L2 in tract forceps major <br>
Weighted-mean L2 in tract forceps minor <br>
Weighted-mean L2 in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean L2 in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean L2 in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean L2 in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean L2 in tract middle cerebellar peduncle <br>
Weighted-mean L2 in tract medial lemniscus (left) <br>
Weighted-mean L2 in tract medial lemniscus (right) <br>
Weighted-mean L2 in tract posterior thalamic radiation (left) <br>
Weighted-mean L2 in tract posterior thalamic radiation (right) <br>
Weighted-mean L2 in tract superior longitudinal fasciculus (left) <br>
Weighted-mean L2 in tract superior longitudinal fasciculus (right) <br>
Weighted-mean L2 in tract superior thalamic radiation (left) <br>
Weighted-mean L2 in tract superior thalamic radiation (right) <br>
Weighted-mean L2 in tract uncinate fasciculus (left) <br>
Weighted-mean L2 in tract uncinate fasciculus (right) <br>
Weighted-mean L3 in tract acoustic radiation (left) <br>
Weighted-mean L3 in tract acoustic radiation (right) <br>
Weighted-mean L3 in tract anterior thalamic radiation (left) <br>
Weighted-mean L3 in tract anterior thalamic radiation (right) <br>
Weighted-mean L3 in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean L3 in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean L3 in tract parahippocampal part of cingulum (left) <br>
Weighted-mean L3 in tract parahippocampal part of cingulum (right) <br>
Weighted-mean L3 in tract corticospinal tract (left) <br>
Weighted-mean L3 in tract corticospinal tract (right) <br>
Weighted-mean L3 in tract forceps major <br>
Weighted-mean L3 in tract forceps minor <br>
Weighted-mean L3 in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean L3 in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean L3 in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean L3 in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean L3 in tract middle cerebellar peduncle <br>
Weighted-mean L3 in tract medial lemniscus (left) <br>
Weighted-mean L3 in tract medial lemniscus (right) <br>
Weighted-mean L3 in tract posterior thalamic radiation (left) <br>
Weighted-mean L3 in tract posterior thalamic radiation (right) <br>
Weighted-mean L3 in tract superior longitudinal fasciculus (left) <br>
Weighted-mean L3 in tract superior longitudinal fasciculus (right) <br>
Weighted-mean L3 in tract superior thalamic radiation (left) <br>
Weighted-mean L3 in tract superior thalamic radiation (right) <br>
Weighted-mean L3 in tract uncinate fasciculus (left) <br>
Weighted-mean L3 in tract uncinate fasciculus (right) <br>
Weighted-mean ICVF in tract acoustic radiation (left) <br>
Weighted-mean ICVF in tract acoustic radiation (right) <br>
Weighted-mean ICVF in tract anterior thalamic radiation (left) <br>
Weighted-mean ICVF in tract anterior thalamic radiation (right) <br>
Weighted-mean ICVF in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean ICVF in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean ICVF in tract parahippocampal part of cingulum (left) <br>
Weighted-mean ICVF in tract parahippocampal part of cingulum (right) <br>
Weighted-mean ICVF in tract corticospinal tract (left) <br>
Weighted-mean ICVF in tract corticospinal tract (right) <br>
Weighted-mean ICVF in tract forceps major <br>
Weighted-mean ICVF in tract forceps minor <br>
Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean ICVF in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean ICVF in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean ICVF in tract middle cerebellar peduncle <br>
Weighted-mean ICVF in tract medial lemniscus (left) <br>
Weighted-mean ICVF in tract medial lemniscus (right) <br>
Weighted-mean ICVF in tract posterior thalamic radiation (left) <br>
Weighted-mean ICVF in tract posterior thalamic radiation (right) <br>
Weighted-mean ICVF in tract superior longitudinal fasciculus (left) <br>
Weighted-mean ICVF in tract superior longitudinal fasciculus (right) <br>
Weighted-mean ICVF in tract superior thalamic radiation (left) <br>
Weighted-mean ICVF in tract superior thalamic radiation (right) <br>
Weighted-mean ICVF in tract uncinate fasciculus (left) <br>
Weighted-mean ICVF in tract uncinate fasciculus (right) <br>
Weighted-mean OD in tract acoustic radiation (left) <br>
Weighted-mean OD in tract acoustic radiation (right) <br>
Weighted-mean OD in tract anterior thalamic radiation (left) <br>
Weighted-mean OD in tract anterior thalamic radiation (right) <br>
Weighted-mean OD in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean OD in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean OD in tract parahippocampal part of cingulum (left) <br>
Weighted-mean OD in tract parahippocampal part of cingulum (right) <br>
Weighted-mean OD in tract corticospinal tract (left) <br>
Weighted-mean OD in tract corticospinal tract (right) <br>
Weighted-mean OD in tract forceps major <br>
Weighted-mean OD in tract forceps minor <br>
Weighted-mean OD in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean OD in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean OD in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean OD in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean OD in tract middle cerebellar peduncle <br>
Weighted-mean OD in tract medial lemniscus (left) <br>
Weighted-mean OD in tract medial lemniscus (right) <br>
Weighted-mean OD in tract posterior thalamic radiation (left) <br>
Weighted-mean OD in tract posterior thalamic radiation (right) <br>
Weighted-mean OD in tract superior longitudinal fasciculus (left) <br>
Weighted-mean OD in tract superior longitudinal fasciculus (right) <br>
Weighted-mean OD in tract superior thalamic radiation (left) <br>
Weighted-mean OD in tract superior thalamic radiation (right) <br>
Weighted-mean OD in tract uncinate fasciculus (left) <br>
Weighted-mean OD in tract uncinate fasciculus (right) <br>
Weighted-mean ISOVF in tract acoustic radiation (left) <br>
Weighted-mean ISOVF in tract acoustic radiation (right) <br>
Weighted-mean ISOVF in tract anterior thalamic radiation (left) <br>
Weighted-mean ISOVF in tract anterior thalamic radiation (right) <br>
Weighted-mean ISOVF in tract cingulate gyrus part of cingulum (left) <br>
Weighted-mean ISOVF in tract cingulate gyrus part of cingulum (right) <br>
Weighted-mean ISOVF in tract parahippocampal part of cingulum (left) <br>
Weighted-mean ISOVF in tract parahippocampal part of cingulum (right) <br>
Weighted-mean ISOVF in tract corticospinal tract (left) <br>
Weighted-mean ISOVF in tract corticospinal tract (right) <br>
Weighted-mean ISOVF in tract forceps major <br>
Weighted-mean ISOVF in tract forceps minor <br>
Weighted-mean ISOVF in tract inferior fronto-occipital fasciculus (left) <br>
Weighted-mean ISOVF in tract inferior fronto-occipital fasciculus (right) <br>
Weighted-mean ISOVF in tract inferior longitudinal fasciculus (left) <br>
Weighted-mean ISOVF in tract inferior longitudinal fasciculus (right) <br>
Weighted-mean ISOVF in tract middle cerebellar peduncle <br>
Weighted-mean ISOVF in tract medial lemniscus (left) <br>
Weighted-mean ISOVF in tract medial lemniscus (right) <br>
Weighted-mean ISOVF in tract posterior thalamic radiation (left) <br>
Weighted-mean ISOVF in tract posterior thalamic radiation (right) <br>
Weighted-mean ISOVF in tract superior longitudinal fasciculus (left) <br>
Weighted-mean ISOVF in tract superior longitudinal fasciculus (right) <br>
Weighted-mean ISOVF in tract superior thalamic radiation (left) <br>
Weighted-mean ISOVF in tract superior thalamic radiation (right) <br>
Weighted-mean ISOVF in tract uncinate fasciculus (left) <br>
Weighted-mean ISOVF in tract uncinate fasciculus (right) <br>
Discrepancy between T1 brain image and standard-space brain template (linearly-aligned) <br>
Discrepancy between T1 brain image and standard-space brain template (nonlinearly-aligned) <br>
Amount of warping applied to non-linearly align T1 brain image to standard-space <br>
Inverted signal-to-noise ratio in T1 <br>
Inverted contrast-to-noise ratio in T1 <br>
Discrepancy between T2 FLAIR brain image and T1 brain image <br>
Discrepancy between SWI brain image and T1 brain image <br>
Discrepancy between rfMRI brain image and T1 brain image <br>
Discrepancy between tfMRI brain image and T1 brain image <br>
Mean tfMRI head motion, averaged across space and time points <br>
Inverted temporal signal-to-noise ratio in pre-processed rfMRI <br>
Inverted temporal signal-to-noise ratio in artefact-cleaned pre-processed rfMRI <br>
Number of dMRI outlier slices detected and corrected <br>
Eprime advisor file <br>
Eprime txt file <br>
Eprime ed2 file <br>
rfMRI full correlation matrix, dimension 25 <br>
rfMRI full correlation matrix, dimension 100 <br>
rfMRI partial correlation matrix, dimension 25 <br>
rfMRI partial correlation matrix, dimension 100 <br>
rfMRI component amplitudes, dimension 25 <br>
rfMRI component amplitudes, dimension 100 <br>
Scanner lateral (X) brain position <br>
Scanner transverse (Y) brain position <br>
Scanner longitudinal (Z) brain position <br>
Scanner table position <br>
90th percentile of BOLD effect (in group-defined mask) for shapes activation <br>
90th percentile of z-statistic (in group-defined mask) for shapes activation <br>
90th percentile of BOLD effect (in group-defined mask) for faces activation <br>
90th percentile of z-statistic (in group-defined mask) for faces activation <br>
90th percentile of BOLD effect (in group-defined mask) for faces-shapes contrast <br>
90th percentile of z-statistic (in group-defined mask) for faces-shapes contrast <br>
90th percentile of BOLD effect (in group-defined amygdala activation mask) for faces-shapes contrast <br>
90th percentile of z-statistic (in group-defined amygdala activation mask) for faces-shapes contrast <br>
Acquisition protocol phase. <br>
Total volume of white matter hyperintensities (from T1 and T2_FLAIR images) <br>
Volume of grey matter in Frontal Pole (left) <br>
Volume of grey matter in Frontal Pole (right) <br>
Volume of grey matter in Insular Cortex (left) <br>
Volume of grey matter in Insular Cortex (right) <br>
Volume of grey matter in Superior Frontal Gyrus (left) <br>
Volume of grey matter in Superior Frontal Gyrus (right) <br>
Volume of grey matter in Middle Frontal Gyrus (left) <br>
Volume of grey matter in Middle Frontal Gyrus (right) <br>
Volume of grey matter in Inferior Frontal Gyrus, pars triangularis (left) <br>
Volume of grey matter in Inferior Frontal Gyrus, pars triangularis (right) <br>
Volume of grey matter in Inferior Frontal Gyrus, pars opercularis (left) <br>
Volume of grey matter in Inferior Frontal Gyrus, pars opercularis (right) <br>
Volume of grey matter in Precentral Gyrus (left) <br>
Volume of grey matter in Precentral Gyrus (right) <br>
Volume of grey matter in Temporal Pole (left) <br>
Volume of grey matter in Temporal Pole (right) <br>
Volume of grey matter in Superior Temporal Gyrus, anterior division (left) <br>
Volume of grey matter in Superior Temporal Gyrus, anterior division (right) <br>
Volume of grey matter in Superior Temporal Gyrus, posterior division (left) <br>
Volume of grey matter in Superior Temporal Gyrus, posterior division (right) <br>
Volume of grey matter in Middle Temporal Gyrus, anterior division (left) <br>
Volume of grey matter in Middle Temporal Gyrus, anterior division (right) <br>
Volume of grey matter in Middle Temporal Gyrus, posterior division (left) <br>
Volume of grey matter in Middle Temporal Gyrus, posterior division (right) <br>
Volume of grey matter in Middle Temporal Gyrus, temporooccipital part (left) <br>
Volume of grey matter in Middle Temporal Gyrus, temporooccipital part (right) <br>
Volume of grey matter in Inferior Temporal Gyrus, anterior division (left) <br>
Volume of grey matter in Inferior Temporal Gyrus, anterior division (right) <br>
Volume of grey matter in Inferior Temporal Gyrus, posterior division (left) <br>
Volume of grey matter in Inferior Temporal Gyrus, posterior division (right) <br>
Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (left) <br>
Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (right) <br>
Volume of grey matter in Postcentral Gyrus (left) <br>
Volume of grey matter in Postcentral Gyrus (right) <br>
Volume of grey matter in Superior Parietal Lobule (left) <br>
Volume of grey matter in Superior Parietal Lobule (right) <br>
Volume of grey matter in Supramarginal Gyrus, anterior division (left) <br>
Volume of grey matter in Supramarginal Gyrus, anterior division (right) <br>
Volume of grey matter in Supramarginal Gyrus, posterior division (left) <br>
Volume of grey matter in Supramarginal Gyrus, posterior division (right) <br>
Volume of grey matter in Angular Gyrus (left) <br>
Volume of grey matter in Angular Gyrus (right) <br>
Volume of grey matter in Lateral Occipital Cortex, superior division (left) <br>
Volume of grey matter in Lateral Occipital Cortex, superior division (right) <br>
Volume of grey matter in Lateral Occipital Cortex, inferior division (left) <br>
Volume of grey matter in Lateral Occipital Cortex, inferior division (right) <br>
Volume of grey matter in Intracalcarine Cortex (left) <br>
Volume of grey matter in Intracalcarine Cortex (right) <br>
Volume of grey matter in Frontal Medial Cortex (left) <br>
Volume of grey matter in Frontal Medial Cortex (right) <br>
Volume of grey matter in Juxtapositional Lobule Cortex (formerly Supplementary Motor Cortex) (left) <br>
Volume of grey matter in Juxtapositional Lobule Cortex (formerly Supplementary Motor Cortex) (right) <br>
Volume of grey matter in Subcallosal Cortex (left) <br>
Volume of grey matter in Subcallosal Cortex (right) <br>
Volume of grey matter in Paracingulate Gyrus (left) <br>
Volume of grey matter in Paracingulate Gyrus (right) <br>
Volume of grey matter in Cingulate Gyrus, anterior division (left) <br>
Volume of grey matter in Cingulate Gyrus, anterior division (right) <br>
Volume of grey matter in Cingulate Gyrus, posterior division (left) <br>
Volume of grey matter in Cingulate Gyrus, posterior division (right) <br>
Volume of grey matter in Precuneous Cortex (left) <br>
Volume of grey matter in Precuneous Cortex (right) <br>
Volume of grey matter in Cuneal Cortex (left) <br>
Volume of grey matter in Cuneal Cortex (right) <br>
Volume of grey matter in Frontal Orbital Cortex (left) <br>
Volume of grey matter in Frontal Orbital Cortex (right) <br>
Volume of grey matter in Parahippocampal Gyrus, anterior division (left) <br>
Volume of grey matter in Parahippocampal Gyrus, anterior division (right) <br>
Volume of grey matter in Parahippocampal Gyrus, posterior division (left) <br>
Volume of grey matter in Parahippocampal Gyrus, posterior division (right) <br>
Volume of grey matter in Lingual Gyrus (left) <br>
Volume of grey matter in Lingual Gyrus (right) <br>
Volume of grey matter in Temporal Fusiform Cortex, anterior division (left) <br>
Volume of grey matter in Temporal Fusiform Cortex, anterior division (right) <br>
Volume of grey matter in Temporal Fusiform Cortex, posterior division (left) <br>
Volume of grey matter in Temporal Fusiform Cortex, posterior division (right) <br>
Volume of grey matter in Temporal Occipital Fusiform Cortex (left) <br>
Volume of grey matter in Temporal Occipital Fusiform Cortex (right) <br>
Volume of grey matter in Occipital Fusiform Gyrus (left) <br>
Volume of grey matter in Occipital Fusiform Gyrus (right) <br>
Volume of grey matter in Frontal Operculum Cortex (left) <br>
Volume of grey matter in Frontal Operculum Cortex (right) <br>
Volume of grey matter in Central Opercular Cortex (left) <br>
Volume of grey matter in Central Opercular Cortex (right) <br>
Volume of grey matter in Parietal Operculum Cortex (left) <br>
Volume of grey matter in Parietal Operculum Cortex (right) <br>
Volume of grey matter in Planum Polare (left) <br>
Volume of grey matter in Planum Polare (right) <br>
Volume of grey matter in Heschl's Gyrus (includes H1 and H2) (left) <br>
Volume of grey matter in Heschl's Gyrus (includes H1 and H2) (right) <br>
Volume of grey matter in Planum Temporale (left) <br>
Volume of grey matter in Planum Temporale (right) <br>
Volume of grey matter in Supracalcarine Cortex (left) <br>
Volume of grey matter in Supracalcarine Cortex (right) <br>
Volume of grey matter in Occipital Pole (left) <br>
Volume of grey matter in Occipital Pole (right) <br>
Volume of grey matter in Thalamus (left) <br>
Volume of grey matter in Thalamus (right) <br>
Volume of grey matter in Caudate (left) <br>
Volume of grey matter in Caudate (right) <br>
Volume of grey matter in Putamen (left) <br>
Volume of grey matter in Putamen (right) <br>
Volume of grey matter in Pallidum (left) <br>
Volume of grey matter in Pallidum (right) <br>
Volume of grey matter in Hippocampus (left) <br>
Volume of grey matter in Hippocampus (right) <br>
Volume of grey matter in Amygdala (left) <br>
Volume of grey matter in Amygdala (right) <br>
Volume of grey matter in Ventral Striatum (left) <br>
Volume of grey matter in Ventral Striatum (right) <br>
Volume of grey matter in Brain-Stem <br>
Volume of grey matter in I-IV Cerebellum (left) <br>
Volume of grey matter in I-IV Cerebellum (right) <br>
Volume of grey matter in V Cerebellum (left) <br>
Volume of grey matter in V Cerebellum (right) <br>
Volume of grey matter in VI Cerebellum (left) <br>
Volume of grey matter in VI Cerebellum (vermis) <br>
Volume of grey matter in VI Cerebellum (right) <br>
Volume of grey matter in Crus I Cerebellum (left) <br>
Volume of grey matter in Crus I Cerebellum (vermis) <br>
Volume of grey matter in Crus I Cerebellum (right) <br>
Volume of grey matter in Crus II Cerebellum (left) <br>
Volume of grey matter in Crus II Cerebellum (vermis) <br>
Volume of grey matter in Crus II Cerebellum (right) <br>
Volume of grey matter in VIIb Cerebellum (left) <br>
Volume of grey matter in VIIb Cerebellum (vermis) <br>
Volume of grey matter in VIIb Cerebellum (right) <br>
Volume of grey matter in VIIIa Cerebellum (left) <br>
Volume of grey matter in VIIIa Cerebellum (vermis) <br>
Volume of grey matter in VIIIa Cerebellum (right) <br>
Volume of grey matter in VIIIb Cerebellum (left) <br>
Volume of grey matter in VIIIb Cerebellum (vermis) <br>
Volume of grey matter in VIIIb Cerebellum (right) <br>
Volume of grey matter in IX Cerebellum (left) <br>
Volume of grey matter in IX Cerebellum (vermis) <br>
Volume of grey matter in IX Cerebellum (right) <br>
Volume of grey matter in X Cerebellum (left) <br>
Volume of grey matter in X Cerebellum (vermis) <br>
Volume of grey matter in X Cerebellum (right) <br>
Index of Multiple Deprivation (England) <br>
Income score (England) <br>
Employment score (England) <br>
Health score (England) <br>
Education score (England) <br>
Housing score (England) <br>
Crime score (England) <br>
Living environment score (England) <br>
Income score (Wales) <br>
Employment score (Wales) <br>
Health score (Wales) <br>
Education score (Wales) <br>
Access to services score (Wales) <br>
Housing score (Wales) <br>
Physical environment score (Wales) <br>
Community safety score (Wales) <br>
Index of Multiple Deprivation (Wales) <br>
Index of Multiple Deprivation (Scotland) <br>
Income score (Scotland) <br>
Health score (Scotland) <br>
Education score (Scotland) <br>
Housing score (Scotland) <br>
Access to services score (Scotland) <br>
Crime score (Scotland) <br>
White blood cell (leukocyte) count <br>
White blood cell (leukocyte) count freeze-thaw cycles <br>
White blood cell (leukocyte) count acquisition time <br>
White blood cell (leukocyte) count device ID <br>
White blood cell (leukocyte) count acquisition route <br>
Red blood cell (erythrocyte) count <br>
Red blood cell (erythrocyte) count freeze-thaw cycles <br>
Red blood cell (erythrocyte) count acquisition time <br>
Red blood cell (erythrocyte) count device ID <br>
Red blood cell (erythrocyte) count acquisition route <br>
Haemoglobin concentration <br>
Haemoglobin concentration freeze-thaw cycles <br>
Haemoglobin concentration acquisition time <br>
Haemoglobin concentration device ID <br>
Haemoglobin concentration acquisition route <br>
Haematocrit percentage <br>
Haematocrit freeze-thaw cycles <br>
Haematocrit acquisition time <br>
Haematocrit percentage device ID <br>
Haematocrit percentage acquisition route <br>
Mean corpuscular volume <br>
Mean corpuscular volume freeze-thaw cycles <br>
Mean corpuscular volume acquisition time <br>
Mean corpuscular volume device ID <br>
Mean corpuscular volume acquisition route <br>
Mean corpuscular haemoglobin <br>
Mean corpuscular haemoglobin freeze-thaw cycles <br>
Mean corpuscular haemoglobin acquisition time <br>
Mean corpuscular haemoglobin device ID <br>
Mean corpuscular haemoglobin acquisition route <br>
Mean corpuscular haemoglobin concentration <br>
Mean corpuscular haemoglobin concentration freeze-thaw cycles <br>
Mean corpuscular haemoglobin concentration acquisition time <br>
Mean corpuscular haemoglobin concentration device ID <br>
Mean corpuscular haemoglobin concentration acquisition route <br>
Red blood cell (erythrocyte) distribution width <br>
Red blood cell (erythrocyte) distribution width freeze-thaw cycles <br>
Red blood cell (erythrocyte) distribution width acquisition time <br>
Red blood cell (erythrocyte) distribution width device ID <br>
Red blood cell (erythrocyte) distribution width acquisition route <br>
Platelet count <br>
Platelet count freeze-thaw cycles <br>
Platelet count acquisition time <br>
Platelet count device ID <br>
Platelet count acquisition route <br>
Platelet crit <br>
Platelet crit freeze-thaw cycles <br>
Platelet crit acquisition time <br>
Platelet crit device ID <br>
Platelet crit acquisition route <br>
Mean platelet (thrombocyte) volume <br>
Mean platelet (thrombocyte) volume freeze-thaw cycles <br>
Mean platelet (thrombocyte) volume acquisition time <br>
Mean platelet (thrombocyte) volume device ID <br>
Mean platelet (thrombocyte) volume acquisition route <br>
Platelet distribution width <br>
Platelet distribution width freeze-thaw cycles <br>
Platelet distribution width acquisition time <br>
Platelet distribution width device ID <br>
Platelet distribution width acquisition route <br>
Lymphocyte count <br>
Lymphocyte count freeze-thaw cycles <br>
Lymphocyte count acquisition time <br>
Lymphocyte count device ID <br>
Lymphocyte count acquisition route <br>
Monocyte count <br>
Monocyte count freeze-thaw cycles <br>
Monocyte count acquisition time <br>
Monocyte count device ID <br>
Monocyte count acquisition route <br>
Neutrophill count <br>
Neutrophill count freeze-thaw cycles <br>
Neutrophill count acquisition time <br>
Neutrophill count device ID <br>
Neutrophill count acquisition route <br>
Eosinophill count <br>
Eosinophill count freeze-thaw cycles <br>
Eosinophill count acquisition time <br>
Eosinophill count device ID <br>
Eosinophill count acquisition route <br>
Basophill count <br>
Basophill count freeze-thaw cycles <br>
Basophill count acquisition time <br>
Basophill count device ID <br>
Basophill count acquisition route <br>
Nucleated red blood cell count <br>
Nucleated red blood cell count freeze-thaw cycles <br>
Nucleated red blood cell count acquisition time <br>
Nucleated red blood cell count device ID <br>
Nucleated red blood cell count acquisition route <br>
Lymphocyte percentage <br>
Lymphocyte percentage freeze-thaw cycles <br>
Lymphocyte percentage acquisition time <br>
Lymphocyte percentage device ID <br>
Lymphocyte percentage acquisition route <br>
Monocyte percentage <br>
Monocyte percentage freeze-thaw cycles <br>
Monocyte percentage acquisition time <br>
Monocyte percentage device ID <br>
Monocyte percentage acquisition route <br>
Neutrophill percentage <br>
Neutrophill percentage freeze-thaw cycles <br>
Neutrophill percentage acquisition time <br>
Neutrophill percentage device ID <br>
Neutrophill percentage acquisition route <br>
Eosinophill percentage <br>
Eosinophill percentage freeze-thaw cycles <br>
Eosinophill percentage acquisition time <br>
Eosinophill percentage device ID <br>
Eosinophill percentage acquisition route <br>
Basophill percentage <br>
Basophill percentage freeze-thaw cycles <br>
Basophill percentage acquisition time <br>
Basophill percentage device ID <br>
Basophill percentage acquisition route <br>
Nucleated red blood cell percentage <br>
Nucleated red blood cell percentage freeze-thaw cycles <br>
Nucleated red blood cell percentage acquisition time <br>
Nucleated red blood cell percentage device ID <br>
Nucleated red blood cell percentage acquisition route <br>
Reticulocyte percentage <br>
Reticulocyte percentage freeze-thaw cycles <br>
Reticulocyte percentage acquisition time <br>
Reticulocyte percentage device ID <br>
Reticulocyte percentage acquisition route <br>
Reticulocyte count <br>
Reticulocyte count freeze-thaw cycles <br>
Reticulocyte count acquisition time <br>
Reticulocyte count device ID <br>
Reticulocyte count acquisition route <br>
Mean reticulocyte volume <br>
Mean reticulocyte volume freeze-thaw cycles <br>
Mean reticulocyte volume acquisition time <br>
Mean reticulocyte volume device ID <br>
Mean reticulocyte volume acquisition route <br>
Mean sphered cell volume <br>
Mean sphered cell volume freeze-thaw cycles <br>
Mean sphered cell volume acquisition time <br>
Mean sphered cell volume device ID <br>
Mean sphered cell volume acquisition route <br>
Immature reticulocyte fraction <br>
Immature reticulocyte fraction freeze-thaw cycles <br>
Immature reticulocyte fraction acquisition time <br>
Immature reticulocyte fraction device ID <br>
Immature reticulocyte fraction acquisition route <br>
High light scatter reticulocyte percentage <br>
High light scatter reticulocyte percentage freeze-thaw cycles <br>
High light scatter reticulocyte percentage acquisition time <br>
High light scatter reticulocyte percentage device ID <br>
High light scatter reticulocyte percentage acquisition route <br>
High light scatter reticulocyte count <br>
High light scatter reticulocyte count freeze-thaw cycles <br>
High light scatter reticulocyte count acquisition time <br>
High light scatter reticulocyte count device ID <br>
High light scatter reticulocyte count acquisition route <br>
Volume of EDTA1 plasma held by UKB <br>
Volume of EDTA1 red cells held by UKB <br>
Volume of EDTA1 buffy held by UKB <br>
Volume of EDTA2 plasma held by UKB <br>
Volume of EDTA2 buffy held by UKB <br>
Volume of EDTA2 red cells held by UKB <br>
Volume of Li-Hep plasma held by UKB <br>
Volume of serum held by UKB <br>
Total volume of urine samples held by UKB <br>
Volume of ACD held by UKB <br>
Volume of RNA held by UKB <br>
Total volume of saliva samples held by UKB <br>
Microalbumin in urine <br>
Microalbumin in urine acquisition time <br>
Microalbumin in urine device ID <br>
Microalbumin in urine result flag <br>
Creatinine (enzymatic) in urine <br>
Creatinine (enzymatic) in urine acquisition time <br>
Creatinine (enzymatic) in urine device ID <br>
Creatinine (enzymatic) in urine result flag <br>
Potassium in urine <br>
Potassium in urine acquisition time <br>
Potassium in urine device ID <br>
Potassium in urine result flag <br>
Sodium in urine <br>
Sodium in urine acquisition time <br>
Sodium in urine device ID <br>
Sodium in urine result flag <br>
Albumin <br>
Albumin assay date <br>
Albumin aliquot <br>
Albumin correction level <br>
Albumin correction reason <br>
Albumin missing reason <br>
Albumin reportability <br>
Alkaline phosphatase <br>
Alkaline phosphatase assay date <br>
Alkaline phosphatase aliquot <br>
Alkaline phosphatase correction level <br>
Alkaline phosphatase correction reason <br>
Alkaline phosphatase missing reason <br>
Alkaline phosphatase reportability <br>
Alanine aminotransferase <br>
Alanine aminotransferase assay date <br>
Alanine aminotransferase aliquot <br>
Alanine aminotransferase correction level <br>
Alanine aminotransferase correction reason <br>
Alanine aminotransferase missing reason <br>
Alanine aminotransferase reportability <br>
Apolipoprotein A <br>
Apolipoprotein A assay date <br>
Apolipoprotein A aliquot <br>
Apolipoprotein A correction level <br>
Apolipoprotein A correction reason <br>
Apolipoprotein A missing reason <br>
Apolipoprotein A reportability <br>
Apolipoprotein B <br>
Apolipoprotein B assay date <br>
Apolipoprotein B aliquot <br>
Apolipoprotein B correction level <br>
Apolipoprotein B correction reason <br>
Apolipoprotein B missing reason <br>
Apolipoprotein B reportability <br>
Aspartate aminotransferase <br>
Aspartate aminotransferase assay date <br>
Aspartate aminotransferase aliquot <br>
Aspartate aminotransferase correction level <br>
Aspartate aminotransferase correction reason <br>
Aspartate aminotransferase missing reason <br>
Aspartate aminotransferase reportability <br>
Direct bilirubin <br>
Direct bilirubin assay date <br>
Direct bilirubin aliquot <br>
Direct bilirubin correction level <br>
Direct bilirubin correction reason <br>
Direct bilirubin missing reason <br>
Direct bilirubin reportability <br>
Urea <br>
Urea assay date <br>
Urea aliquot <br>
Urea correction level <br>
Urea correction reason <br>
Urea missing reason <br>
Urea reportability <br>
Calcium <br>
Calcium assay date <br>
Calcium aliquot <br>
Calcium correction level <br>
Calcium correction reason <br>
Calcium missing reason <br>
Calcium reportability <br>
Cholesterol <br>
Cholesterol assay date <br>
Cholesterol aliquot <br>
Cholesterol correction level <br>
Cholesterol correction reason <br>
Cholesterol missing reason <br>
Cholesterol reportability <br>
Creatinine <br>
Creatinine assay date <br>
Creatinine aliquot <br>
Creatinine correction level <br>
Creatinine correction reason <br>
Creatinine missing reason <br>
Creatinine reportability <br>
C-reactive protein <br>
C-reactive protein assay date <br>
C-reactive protein aliquot <br>
C-reactive protein correction level <br>
C-reactive protein correction reason <br>
C-reactive protein missing reason <br>
C-reactive protein reportability <br>
Cystatin C <br>
Cystatin C assay date <br>
Cystatin C aliquot <br>
Cystatin C correction level <br>
Cystatin C correction reason <br>
Cystatin C missing reason <br>
Cystatin C reportability <br>
Gamma glutamyltransferase <br>
Gamma glutamyltransferase assay date <br>
Gamma glutamyltransferase aliquot <br>
Gamma glutamyltransferase correction level <br>
Gamma glutamyltransferase correction reason <br>
Gamma glutamyltransferase missing reason <br>
Gamma glutamyltransferase reportability <br>
Glucose <br>
Glucose assay date <br>
Glucose aliquot <br>
Glucose correction level <br>
Glucose correction reason <br>
Glucose missing reason <br>
Glucose reportability <br>
Glycated haemoglobin (HbA1c) <br>
Glycated haemoglobin (HbA1c) assay date <br>
Glycated haemoglobin (HbA1c) correction level <br>
Glycated haemoglobin (HbA1c) correction reason <br>
Glycated haemoglobin (HbA1c) missing reason <br>
Glycated haemoglobin (HbA1c) reportability <br>
HDL cholesterol <br>
HDL cholesterol assay date <br>
HDL cholesterol aliquot <br>
HDL cholesterol correction level <br>
HDL cholesterol correction reason <br>
HDL cholesterol missing reason <br>
HDL cholesterol reportability <br>
IGF-1 <br>
IGF-1 assay date <br>
IGF-1 aliquot <br>
IGF-1 correction level <br>
IGF-1 correction reason <br>
IGF-1 missing reason <br>
IGF-1 reportability <br>
LDL direct <br>
LDL direct assay date <br>
LDL direct aliquot <br>
LDL direct correction level <br>
LDL direct correction reason <br>
LDL direct missing reason <br>
LDL direct reportability <br>
Lipoprotein A <br>
Lipoprotein A assay date <br>
Lipoprotein A aliquot <br>
Lipoprotein A correction level <br>
Lipoprotein A correction reason <br>
Lipoprotein A missing reason <br>
Lipoprotein A reportability <br>
Oestradiol <br>
Oestradiol assay date <br>
Oestradiol aliquot <br>
Oestradiol correction level <br>
Oestradiol correction reason <br>
Oestradiol missing reason <br>
Oestradiol reportability <br>
Phosphate <br>
Phosphate assay date <br>
Phosphate aliquot <br>
Phosphate correction level <br>
Phosphate correction reason <br>
Phosphate missing reason <br>
Phosphate reportability <br>
Rheumatoid factor <br>
Rheumatoid factor assay date <br>
Rheumatoid factor aliquot <br>
Rheumatoid factor correction level <br>
Rheumatoid factor correction reason <br>
Rheumatoid factor missing reason <br>
Rheumatoid factor reportability <br>
SHBG <br>
SHBG assay date <br>
SHBG aliquot <br>
SHBG correction level <br>
SHBG correction reason <br>
SHBG missing reason <br>
SHBG reportability <br>
Total bilirubin <br>
Total bilirubin assay date <br>
Total bilirubin aliquot <br>
Total bilirubin correction level <br>
Total bilirubin correction reason <br>
Total bilirubin missing reason <br>
Total bilirubin reportability <br>
Testosterone <br>
Testosterone assay date <br>
Testosterone aliquot <br>
Testosterone correction level <br>
Testosterone correction reason <br>
Testosterone missing reason <br>
Testosterone reportability <br>
Total protein <br>
Total protein assay date <br>
Total protein aliquot <br>
Total protein correction level <br>
Total protein correction reason <br>
Total protein missing reason <br>
Total protein reportability <br>
Triglycerides <br>
Triglycerides assay date <br>
Triglycerides aliquot <br>
Triglycerides correction level <br>
Triglycerides correction reason <br>
Triglycerides missing reason <br>
Triglycerides reportability <br>
Urate <br>
Urate assay date <br>
Urate aliquot <br>
Urate correction level <br>
Urate correction reason <br>
Urate missing reason <br>
Urate reportability <br>
Vitamin D <br>
Vitamin D assay date <br>
Vitamin D aliquot <br>
Vitamin D correction level <br>
Vitamin D correction reason <br>
Vitamin D missing reason <br>
Vitamin D reportability <br>
Estimated sample dilution factor <br>
Date of death <br>
Underlying (primary) cause of death: ICD10 <br>
Contributory (secondary) causes of death: ICD10 <br>
Date of cancer diagnosis <br>
Type of cancer: ICD10 <br>
Age at death <br>
Age at cancer diagnosis <br>
Reported occurrences of cancer <br>
Description of cause of death <br>
Histology of cancer tumour <br>
Behaviour of cancer tumour <br>
Type of cancer: ICD9 <br>
Death record format <br>
Cancer record format <br>
Death record origin <br>
Cancer record origin <br>
Inpatient record origin <br>
Volume of DNA held by UKB <br>
Records in HES inpatient operations dataset <br>
Operative procedures - main OPCS4 <br>
External causes - ICD10 <br>
Diagnoses - main ICD10 <br>
Diagnoses - main ICD9 <br>
Diagnoses - secondary ICD10 <br>
Diagnoses - secondary ICD9 <br>
Intended management of patient (polymorphic) <br>
Main speciality of consultant (polymorphic) <br>
Treatment speciality of consultant (polymorphic) <br>
Patient classification on admission (polymorphic) <br>
Operative procedures - secondary OPCS4 <br>
Destinations on discharge from hospital (polymorphic) <br>
Methods of admission to hospital (polymorphic) <br>
Methods of discharge from hospital (polymorphic) <br>
Carer support indicators <br>
Legal statuses <br>
Mental categories <br>
History of psychiatric care on admission <br>
Anaesthetics administered during delivery <br>
Anaesthetics administered post delivery <br>
Delivery methods <br>
Delivery onset methods <br>
Delivery places <br>
Intended delivery places <br>
Resuscitation methods <br>
Sex of baby <br>
Status of baby at birth <br>
Statuses of person conducting delivery <br>
PCT responsible for patient data <br>
PCT where patients GP was registered <br>
Hospital episode type <br>
Administrative and legal statuses <br>
Sources of admission to hospital (polymorphic) <br>
Records in HES inpatient diagnoses dataset <br>
Spells in hospital <br>
Intended management of patient (recoded) <br>
Main speciality of consultant (recoded) <br>
Treatment speciality of consultant (recoded) <br>
Patient classification on admission (recoded) <br>
Destinations on discharge from hospital (recoded) <br>
Methods of admission to hospital (recoded) <br>
Methods of discharge from hospital (recoded) <br>
Sources of admission to hospital (recoded) <br>
Inpatient record format <br>
Operative procedures - main OPCS3 <br>
Date of first operative procedure - main OPCS3 <br>
Operative procedures - secondary OPCS3 <br>
Records in HES inpatient main dataset <br>
Date of first operative procedure - main OPCS4 <br>
Records in HES inpatient maternity dataset <br>
Date of first in-patient diagnosis - main ICD10 <br>
Date of first in-patient diagnosis - main ICD9 <br>
Records in HES inpatient delivery dataset <br>
Diagnoses - ICD10 <br>
Diagnoses - ICD9 <br>
Operative procedures - OPCS4 <br>
Operative procedures - OPCS3 <br>
Date of first in-patient diagnosis - ICD10 <br>
Date of first in-patient diagnosis - ICD9 <br>
Date of first operative procedure - OPCS4 <br>
Date of first operative procedure - OPCS3 <br>
Records in HES inpatient psychiatric dataset <br>
Records in HES inpatient critical care dataset <br>
Date of myocardial infarction <br>
Source of myocardial infarction report <br>
Date of STEMI <br>
Source of STEMI report <br>
Date of NSTEMI <br>
Source of NSTEMI report <br>
Date of stroke <br>
Source of stroke report <br>
Date of ischaemic stroke <br>
Source of ischaemic stroke report <br>
Date of intracerebral haemorrhage <br>
Source of intracerebral haemorrhage report <br>
Date of subarachnoid haemorrhage <br>
Source of subarachnoid haemorrhage report <br>
Date of asthma report <br>
Source of asthma report <br>
Date of chronic obstructive pulmonary disease report <br>
Source of chronic obstructive pulmonary disease report <br>
Date of all cause dementia report <br>
Source of all cause dementia report <br>
Date of alzheimer's disease report <br>
Source of alzheimer's disease report <br>
Date of vascular dementia report <br>
Source of vascular dementia report <br>
Date of frontotemporal dementia report <br>
Source of frontotemporal dementia report <br>
Date of end stage renal disease report <br>
Source of end stage renal disease report <br>
Date of motor neurone disease report <br>
Source of motor neurone disease report <br>
Date of all cause parkinsonism report <br>
Source of all cause parkinsonism report <br>
Date of parkinson's disease report <br>
Source of parkinson's disease report <br>
Date of progressive supranuclear palsy report <br>
Source of progressive supranuclear palsy report <br>
Date of multiple system atrophy report <br>
Source of multiple system atrophy report <br>
GP registration records <br>
GP prescription records <br>
GP clinical event records <br>
Acceleration data - cwa format <br>
Data problem indicator <br>
Start of requested wear period <br>
Acceleration intensity time-series <br>
Start time of wear <br>
End time of wear <br>
Overall acceleration average <br>
Standard deviation of acceleration <br>
Data quality, good wear time <br>
Data quality, good calibration <br>
Data quality, calibrated on own data <br>
Daylight savings crossover <br>
Monday average acceleration <br>
Tuesday average acceleration <br>
Wednesday average acceleration <br>
Thursday average acceleration <br>
Friday average acceleration <br>
Saturday average acceleration <br>
Sunday average acceleration <br>
First weekday of wear <br>
Average acceleration 00:00 - 00:59 <br>
Average acceleration 01:00 - 01:59 <br>
Average acceleration 02:00 - 02:59 <br>
Average acceleration 03:00 - 03:59 <br>
Average acceleration 04:00 - 04:59 <br>
Average acceleration 05:00 - 05:59 <br>
Average acceleration 06:00 - 06:59 <br>
Average acceleration 07:00 - 07:59 <br>
Average acceleration 08:00 - 08:59 <br>
Average acceleration 09:00 - 09:59 <br>
Average acceleration 10:00 - 10:59 <br>
Average acceleration 11:00 - 11:59 <br>
Average acceleration 12:00 - 12:59 <br>
Average acceleration 13:00 - 13:59 <br>
Average acceleration 14:00 - 14:59 <br>
Average acceleration 15:00 - 15:59 <br>
Average acceleration 16:00 - 16:59 <br>
Average acceleration 17:00 - 17:59 <br>
Average acceleration 18:00 - 18:59 <br>
Average acceleration 19:00 - 19:59 <br>
Average acceleration 20:00 - 20:59 <br>
Average acceleration 21:00 - 21:59 <br>
Average acceleration 22:00 - 22:59 <br>
Average acceleration 23:00 - 23:59 <br>
Wear duration overall <br>
Non wear duration overall <br>
Wear duration during Monday <br>
Wear duration during Tuesday <br>
Wear duration during Wednesday <br>
Wear duration during Thursday <br>
Wear duration during Friday <br>
Wear duration during Saturday <br>
Wear duration during Sunday <br>
Wear duration during 00:00 - 00:59 <br>
Wear duration during 01:00 - 01:59 <br>
Wear duration during 02:00 - 02:59 <br>
Wear duration during 03:00 - 03:59 <br>
Wear duration during 04:00 - 04:59 <br>
Wear duration during 05:00 - 05:59 <br>
Wear duration during 06:00 - 06:59 <br>
Wear duration during 07:00 - 07:59 <br>
Wear duration during 08:00 - 08:59 <br>
Wear duration during 09:00 - 09:59 <br>
Wear duration during 10:00 - 10:59 <br>
Wear duration during 11:00 - 11:59 <br>
Wear duration during 12:00 - 12:59 <br>
Wear duration during 13:00 - 13:59 <br>
Wear duration during 14:00 - 14:59 <br>
Wear duration during 15:00 - 15:59 <br>
Wear duration during 16:00 - 16:59 <br>
Wear duration during 17:00 - 17:59 <br>
Wear duration during 18:00 - 18:59 <br>
Wear duration during 19:00 - 19:59 <br>
Wear duration during 20:00 - 20:59 <br>
Wear duration during 21:00 - 21:59 <br>
Wear duration during 22:00 - 22:59 <br>
Wear duration during 23:00 - 23:59 <br>
Unique hours of wear in a 24 hour cycle (scattered over multiple days) <br>
Unique minutes of wear in a 24 hour cycle (scattered over multiple days) <br>
Non wear episodes over 1 hour duration <br>
No-wear time bias adjusted average acceleration <br>
No-wear time bias adjusted acceleration standard deviation <br>
No-wear time bias adjusted acceleration median <br>
No-wear time bias adjusted acceleration minimum <br>
No-wear time bias adjusted acceleration maximum <br>
Fraction acceleration <= 1 milli-gravities <br>
Fraction acceleration <= 2 milli-gravities <br>
Fraction acceleration <= 3 milli-gravities <br>
Fraction acceleration <= 4 milli-gravities <br>
Fraction acceleration <= 5 milli-gravities <br>
Fraction acceleration <= 6 milli-gravities <br>
Fraction acceleration <= 7 milli-gravities <br>
Fraction acceleration <= 8 milli-gravities <br>
Fraction acceleration <= 9 milli-gravities <br>
Fraction acceleration <= 10 milli-gravities <br>
Fraction acceleration <= 11 milli-gravities <br>
Fraction acceleration <= 12 milli-gravities <br>
Fraction acceleration <= 13 milli-gravities <br>
Fraction acceleration <= 14 milli-gravities <br>
Fraction acceleration <= 15 milli-gravities <br>
Fraction acceleration <= 16 milli-gravities <br>
Fraction acceleration <= 17 milli-gravities <br>
Fraction acceleration <= 18 milli-gravities <br>
Fraction acceleration <= 19 milli-gravities <br>
Fraction acceleration <= 20 milli-gravities <br>
Fraction acceleration <= 25 milli-gravities <br>
Fraction acceleration <= 30 milli-gravities <br>
Fraction acceleration <= 35 milli-gravities <br>
Fraction acceleration <= 40 milli-gravities <br>
Fraction acceleration <= 45 milli-gravities <br>
Fraction acceleration <= 50 milli-gravities <br>
Fraction acceleration <= 55 milli-gravities <br>
Fraction acceleration <= 60 milli-gravities <br>
Fraction acceleration <= 65 milli-gravities <br>
Fraction acceleration <= 70 milli-gravities <br>
Fraction acceleration <= 75 milli-gravities <br>
Fraction acceleration <= 80 milli-gravities <br>
Fraction acceleration <= 85 milli-gravities <br>
Fraction acceleration <= 90 milli-gravities <br>
Fraction acceleration <= 95 milli-gravities <br>
Fraction acceleration <= 100 milli-gravities <br>
Fraction acceleration <= 125 milli-gravities <br>
Fraction acceleration <= 150 milli-gravities <br>
Fraction acceleration <= 175 milli-gravities <br>
Fraction acceleration <= 200 milli-gravities <br>
Fraction acceleration <= 225 milli-gravities <br>
Fraction acceleration <= 250 milli-gravities <br>
Fraction acceleration <= 275 milli-gravities <br>
Fraction acceleration <= 300 milli-gravities <br>
Fraction acceleration <= 325 milli-gravities <br>
Fraction acceleration <= 350 milli-gravities <br>
Fraction acceleration <= 375 milli-gravities <br>
Fraction acceleration <= 400 milli-gravities <br>
Fraction acceleration <= 425 milli-gravities <br>
Fraction acceleration <= 450 milli-gravities <br>
Fraction acceleration <= 475 milli-gravities <br>
Fraction acceleration <= 500 milli-gravities <br>
Fraction acceleration <= 600 milli-gravities <br>
Fraction acceleration <= 700 milli-gravities <br>
Fraction acceleration <= 800 milli-gravities <br>
Fraction acceleration <= 900 milli-gravities <br>
Fraction acceleration <= 1000 milli-gravities <br>
Fraction acceleration <= 1100 milli-gravities <br>
Fraction acceleration <= 1200 milli-gravities <br>
Fraction acceleration <= 1300 milli-gravities <br>
Fraction acceleration <= 1400 milli-gravities <br>
Fraction acceleration <= 1500 milli-gravities <br>
Fraction acceleration <= 1600 milli-gravities <br>
Fraction acceleration <= 1700 milli-gravities <br>
Fraction acceleration <= 1800 milli-gravities <br>
Fraction acceleration <= 1900 milli-gravities <br>
Fraction acceleration <= 2000 milli-gravities <br>
Error tolerance before calibration <br>
Error tolerance after calibration <br>
Calibration coefficients - x offset <br>
Calibration coefficients - y offset <br>
Calibration coefficients - z offset <br>
Calibration coefficients - x slope <br>
Calibration coefficients - y slope <br>
Calibration coefficients - z slope <br>
Calibration coefficients - x temp <br>
Calibration coefficients - y temp <br>
Calibration coefficients - z temp <br>
Calibration coefficients - mean temperature <br>
Calibration - number of static points <br>
Calibration - minimum x stationary value <br>
Calibration - maximum x stationary value <br>
Calibration - minimum y stationary value <br>
Calibration - maximum y stationary value <br>
Calibration - minimum z stationary value <br>
Calibration - maximum z stationary value <br>
Device ID <br>
Interrupted recording periods <br>
Duration of interrupted recording periods <br>
Data recording errors <br>
Readings exceeding +/-8 gravities before calibration <br>
Maximum readings exceeding +/-8 gravities before calibration in a 5 second epoch <br>
Readings exceeding +/-8 gravities after calibration <br>
Maximum readings exceeding +/-8 gravities after calibration in a 5 second epoch <br>
Total data readings <br>
Sample rate average <br>
Sample rate standard deviation <br>
Sample rate minimum <br>
Sample rate maximum <br>
Temperature average <br>
Temperature standard deviation <br>
Temperature minimum <br>
Temperature maximum <br>
Food weight <br>
Energy <br>
Protein <br>
Fat <br>
Carbohydrate <br>
Saturated fat <br>
Polyunsaturated fat <br>
Total sugars <br>
Englyst dietary fibre <br>
Portion size <br>
Iron <br>
Vitamin B6 <br>
Vitamin B12 <br>
Folate <br>
Vitamin C <br>
Potassium <br>
Magnesium <br>
Retinol <br>
Carotene <br>
Typical diet yesterday <br>
Alcohol <br>
Starch <br>
Vitamin E <br>
Drinking water intake <br>
Low calorie drink intake <br>
Fizzy drink intake <br>
Squash intake <br>
Orange juice intake <br>
Grapefruit juice intake <br>
Pure fruit/vegetable juice intake <br>
Fruit smoothie intake <br>
Dairy smoothie intake <br>
Coffee consumed <br>
Instant coffee intake <br>
Added milk to instant coffee <br>
Filtered coffee intake <br>
Added milk to filtered coffee <br>
Cappuccino intake <br>
Latte intake <br>
Espresso intake <br>
Added milk to espresso <br>
Other coffee type <br>
Added milk to other coffee type <br>
Decaffeinated coffee <br>
Intake of sugar added to coffee <br>
Intake of artificial sweetener added to coffee <br>
Tea consumed <br>
Standard tea intake <br>
Rooibos tea intake <br>
Green tea intake <br>
Herbal tea intake <br>
Other tea intake <br>
Added milk to standard tea <br>
Decaffeinated tea <br>
Added milk to rooibos tea <br>
Intake of sugar added to tea <br>
Intake of artificial sweetener added to tea <br>
Other non-alcoholic drinks <br>
Milk intake <br>
Flavoured milk intake <br>
Low calorie hot chocolate intake <br>
Hot chocolate intake <br>
Other drink intake <br>
Alcohol consumed <br>
Red wine intake <br>
Rose wine intake <br>
White wine intake <br>
Beer/cider intake <br>
Fortified wine intake <br>
Spirits intake <br>
Other alcohol intake <br>
Breakfast cereal consumed <br>
Porridge intake <br>
Muesli intake <br>
Oat crunch intake <br>
Sweetened cereal intake <br>
Plain cereal intake <br>
Bran cereal intake <br>
Whole-wheat cereal intake <br>
Other cereal intake <br>
Dried fruit added to cereal <br>
Milk added to cereal <br>
Intake of sugar added to cereal <br>
Intake of artificial sweetener added to cereal <br>
Type milk consumed <br>
Bread consumed <br>
Sliced bread intake <br>
Baguette intake <br>
Bap intake <br>
Bread roll intake <br>
Naan bread intake <br>
Garlic bread intake <br>
Crispbread intake <br>
Oatcakes intake <br>
Other bread intake <br>
Butter/margarine on bread/crackers <br>
Number of bread slices with butter/margarine <br>
Number of baguettes with butter/margarine <br>
Number of baps with  butter/margarine <br>
Number of bread rolls with  butter/margarine <br>
Number of crackers/crispbreads with butter/margarine <br>
Number of oatcakes with  butter/margarine <br>
Number of other bread types with  butter/margarine <br>
Double crust pastry intake <br>
Single crust pastry intake <br>
Crumble intake <br>
Pizza intake <br>
Pancake intake <br>
Scotch pancake intake <br>
Yorkshire pudding intake <br>
Indian snacks intake <br>
Croissant intake <br>
Danish pastry intake <br>
Scone intake <br>
Yogurt/ice-cream consumers <br>
Yogurt intake <br>
Ice-cream intake <br>
Dessert consumers <br>
Milk-based pudding intake <br>
Other milk-based pudding intake <br>
Soya dessert intake <br>
Fruitcake intake <br>
Cake intake <br>
Doughnut intake <br>
Sponge pudding intake <br>
Cheesecake intake <br>
Other dessert intake <br>
Sweet snack consumers <br>
Chocolate bar intake <br>
White chocolate intake <br>
Milk chocolate intake <br>
Dark chocolate intake <br>
Chocolate-covered raisin intake <br>
Chocolate sweet intake <br>
Diet sweets intake <br>
Sweets intake <br>
Chocolate-covered biscuits intake <br>
Chocolate biscuits intake <br>
Sweet biscuits intake <br>
Cereal bar intake <br>
Other sweets intake <br>
Savoury snack consumers <br>
Salted peanuts intake <br>
Unsalted peanuts intake <br>
Salted nuts intake <br>
Unsalted nuts intake <br>
Seeds intake <br>
Crisp intake <br>
Savoury biscuits intake <br>
Cheesy biscuits intake <br>
Olives intake <br>
Other savoury snack intake <br>
Soup consumers <br>
Powdered/instant soup intake <br>
Canned soup intake <br>
Homemade soup intake <br>
Starchy food consumers <br>
White pasta intake <br>
Wholemeal pasta intake <br>
White rice intake <br>
Brown rice intake <br>
Sushi intake <br>
Snackpot intake <br>
Couscous intake <br>
Other grain intake <br>
Cheese consumers <br>
Low fat hard cheese intake <br>
Hard cheese intake <br>
Soft cheese intake <br>
Blue cheese intake <br>
Low fat cheese spread intake <br>
Cheese spread intake <br>
Cottage cheese intake <br>
Feta intake <br>
Mozzarella intake <br>
Goat's cheese intake <br>
Other cheese intake <br>
Egg consumers <br>
Whole egg intake <br>
Omelette intake <br>
Eggs in sandwiches intake <br>
Scotch egg intake <br>
Other egg intake <br>
Meat consumers <br>
Sausage intake <br>
Lamb intake <br>
Crumbed or deep-fried poultry intake <br>
Bacon intake <br>
Ham intake <br>
Liver intake <br>
Other meat intake <br>
Fat removed from meat <br>
Skin removed from poultry <br>
Fish consumer <br>
Tinned tuna intake <br>
Breaded fish intake <br>
Battered fish intake <br>
White fish intake <br>
Prawns intake <br>
Lobster/crab intake <br>
Shellfish intake <br>
Other fish intake <br>
Vegetarian sausages/burgers intake <br>
Tofu intake <br>
Quorn intake <br>
Other vegetarian alternative intake <br>
Vegetable consumers <br>
Baked bean intake <br>
Pulses intake <br>
Fried potatoes intake <br>
Boiled/baked potatoes intake <br>
Butter/margarine added to potatoes <br>
Mashed potato intake <br>
Mixed vegetable intake <br>
Vegetable pieces intake <br>
Coleslaw intake <br>
Side salad intake <br>
Avocado intake <br>
Broad bean intake <br>
Green bean intake <br>
Beetroot intake <br>
Broccoli intake <br>
Butternut squash intake <br>
Cabbage/kale intake <br>
Carrot intake <br>
Cauliflower intake <br>
Celery intake <br>
Courgette intake <br>
Cucumber intake <br>
Garlic intake <br>
Leek intake <br>
Lettuce intake <br>
Mushroom intake <br>
Onion intake <br>
Parsnip intake <br>
Pea intake <br>
Sweet pepper intake <br>
Spinach intake <br>
Sprouts intake <br>
Sweetcorn intake <br>
Sweet potato intake <br>
Fresh tomato intake <br>
Tinned tomato intake <br>
Turnip/swede intake <br>
Watercress intake <br>
Other vegetables intake <br>
Fruit consumers <br>
Stewed fruit intake <br>
Prune intake <br>
Mixed fruit intake <br>
Apple intake <br>
Banana intake <br>
Berry intake <br>
Cherry intake <br>
Grapefruit intake <br>
Grape intake <br>
Mango intake <br>
Melon intake <br>
Orange intake <br>
Satsuma intake <br>
Peach/nectarine intake <br>
Pear intake <br>
Pineapple intake <br>
Plum intake <br>
Other fruit intake <br>
Vitamin supplement user <br>
Time spent doing vigorous physical activity <br>
Time spent doing moderate physical activity <br>
Time spent doing light physical activity <br>
When diet questionnaire completed <br>
When diet questionnaire started <br>
Invitation to physical activity study, acceptance <br>
Invitation to physical activity study, date sent <br>
Date A00 first reported (cholera) <br>
Source of report of A00 (cholera) <br>
Date A01 first reported (typhoid and paratyphoid fevers) <br>
Source of report of A01 (typhoid and paratyphoid fevers) <br>
Date A02 first reported (other salmonella infections) <br>
Source of report of A02 (other salmonella infections) <br>
Date A03 first reported (shigellosis) <br>
Source of report of A03 (shigellosis) <br>
Date A04 first reported (other bacterial intestinal infections) <br>
Source of report of A04 (other bacterial intestinal infections) <br>
Date A05 first reported (other bacterial foodborne intoxications) <br>
Source of report of A05 (other bacterial foodborne intoxications) <br>
Date A06 first reported (amoebiasis) <br>
Source of report of A06 (amoebiasis) <br>
Date A07 first reported (other protozoal intestinal diseases) <br>
Source of report of A07 (other protozoal intestinal diseases) <br>
Date A08 first reported (viral and other specified intestinal infections) <br>
Source of report of A08 (viral and other specified intestinal infections) <br>
Date A09 first reported (diarrhoea and gastro-enteritis of presumed infectious origin) <br>
Source of report of A09 (diarrhoea and gastro-enteritis of presumed infectious origin) <br>
Date A15 first reported (respiratory tuberculosis, bacteriologically and histologically confirmed) <br>
Source of report of A15 (respiratory tuberculosis, bacteriologically and histologically confirmed) <br>
Date A16 first reported (respiratory tuberculosis, not confirmed bacteriologically or histologically) <br>
Source of report of A16 (respiratory tuberculosis, not confirmed bacteriologically or histologically) <br>
Date A17 first reported (tuberculosis of nervous system) <br>
Source of report of A17 (tuberculosis of nervous system) <br>
Date A18 first reported (tuberculosis of other organs) <br>
Source of report of A18 (tuberculosis of other organs) <br>
Date A19 first reported (miliary tuberculosis) <br>
Source of report of A19 (miliary tuberculosis) <br>
Date A20 first reported (plague) <br>
Source of report of A20 (plague) <br>
Date A22 first reported (anthrax) <br>
Source of report of A22 (anthrax) <br>
Date A23 first reported (brucellosis) <br>
Source of report of A23 (brucellosis) <br>
Date A24 first reported (glanders and melioidosis) <br>
Source of report of A24 (glanders and melioidosis) <br>
Date A25 first reported (rat-bite fevers) <br>
Source of report of A25 (rat-bite fevers) <br>
Date A26 first reported (erysipeloid) <br>
Source of report of A26 (erysipeloid) <br>
Date A27 first reported (leptospirosis) <br>
Source of report of A27 (leptospirosis) <br>
Date A28 first reported (other zoonotic bacterial diseases, not elsewhere classified) <br>
Source of report of A28 (other zoonotic bacterial diseases, not elsewhere classified) <br>
Date A30 first reported (leprosy [hansen's disease]) <br>
Source of report of A30 (leprosy [hansen's disease]) <br>
Date A31 first reported (infection due to other mycobacteria) <br>
Source of report of A31 (infection due to other mycobacteria) <br>
Date A32 first reported (listeriosis) <br>
Source of report of A32 (listeriosis) <br>
Date A33 first reported (tetanus neonatorum) <br>
Source of report of A33 (tetanus neonatorum) <br>
Date A35 first reported (other tetanus) <br>
Source of report of A35 (other tetanus) <br>
Date A36 first reported (diphtheria) <br>
Source of report of A36 (diphtheria) <br>
Date A37 first reported (whooping cough) <br>
Source of report of A37 (whooping cough) <br>
Date A38 first reported (scarlet fever) <br>
Source of report of A38 (scarlet fever) <br>
Date A39 first reported (meningococcal infection) <br>
Source of report of A39 (meningococcal infection) <br>
Date A40 first reported (streptococcal septicaemia) <br>
Source of report of A40 (streptococcal septicaemia) <br>
Date A41 first reported (other septicaemia) <br>
Source of report of A41 (other septicaemia) <br>
Date A42 first reported (actinomycosis) <br>
Source of report of A42 (actinomycosis) <br>
Date A43 first reported (nocardiosis) <br>
Source of report of A43 (nocardiosis) <br>
Date A44 first reported (bartonellosis) <br>
Source of report of A44 (bartonellosis) <br>
Date A46 first reported (erysipelas) <br>
Source of report of A46 (erysipelas) <br>
Date A48 first reported (other bacterial diseases, not elsewhere classified) <br>
Source of report of A48 (other bacterial diseases, not elsewhere classified) <br>
Date A49 first reported (bacterial infection of unspecified site) <br>
Source of report of A49 (bacterial infection of unspecified site) <br>
Date A50 first reported (congenital syphilis) <br>
Source of report of A50 (congenital syphilis) <br>
Date A51 first reported (early syphilis) <br>
Source of report of A51 (early syphilis) <br>
Date A52 first reported (late syphilis) <br>
Source of report of A52 (late syphilis) <br>
Date A53 first reported (other and unspecified syphilis) <br>
Source of report of A53 (other and unspecified syphilis) <br>
Date A54 first reported (gonococcal infection) <br>
Source of report of A54 (gonococcal infection) <br>
Date A55 first reported (chlamydial lymphogranuloma (venereum)) <br>
Source of report of A55 (chlamydial lymphogranuloma (venereum)) <br>
Date A56 first reported (other sexually transmitted chlamydial diseases) <br>
Source of report of A56 (other sexually transmitted chlamydial diseases) <br>
Date A58 first reported (granuloma inguinale) <br>
Source of report of A58 (granuloma inguinale) <br>
Date A59 first reported (trichomoniasis) <br>
Source of report of A59 (trichomoniasis) <br>
Date A60 first reported (anogenital herpesviral [herpes simplex] infections) <br>
Source of report of A60 (anogenital herpesviral [herpes simplex] infections) <br>
Date A63 first reported (other predominantly sexually transmitted diseases, not elsewhere classified) <br>
Source of report of A63 (other predominantly sexually transmitted diseases, not elsewhere classified) <br>
Date A64 first reported (unspecified sexually transmitted disease) <br>
Source of report of A64 (unspecified sexually transmitted disease) <br>
Date A66 first reported (yaws) <br>
Source of report of A66 (yaws) <br>
Date A67 first reported (pinta [carate]) <br>
Source of report of A67 (pinta [carate]) <br>
Date A68 first reported (relapsing fevers) <br>
Source of report of A68 (relapsing fevers) <br>
Date A69 first reported (other spirochaetal infections) <br>
Source of report of A69 (other spirochaetal infections) <br>
Date A70 first reported (chlamydia psittaci infection) <br>
Source of report of A70 (chlamydia psittaci infection) <br>
Date A71 first reported (trachoma) <br>
Source of report of A71 (trachoma) <br>
Date A74 first reported (other diseases caused by chlamydiae) <br>
Source of report of A74 (other diseases caused by chlamydiae) <br>
Date A75 first reported (typhus fever) <br>
Source of report of A75 (typhus fever) <br>
Date A77 first reported (spotted fever [tick-borne rickettsioses]) <br>
Source of report of A77 (spotted fever [tick-borne rickettsioses]) <br>
Date A78 first reported (q fever) <br>
Source of report of A78 (q fever) <br>
Date A79 first reported (other rickettsioses) <br>
Source of report of A79 (other rickettsioses) <br>
Date A80 first reported (acute poliomyelitis) <br>
Source of report of A80 (acute poliomyelitis) <br>
Date A81 first reported (atypical virus infections of central nervous system) <br>
Source of report of A81 (atypical virus infections of central nervous system) <br>
Date A82 first reported (rabies) <br>
Source of report of A82 (rabies) <br>
Date A83 first reported (mosquito-borne viral encephalitis) <br>
Source of report of A83 (mosquito-borne viral encephalitis) <br>
Date A84 first reported (tick-borne viral encephalitis) <br>
Source of report of A84 (tick-borne viral encephalitis) <br>
Date A85 first reported (other viral encephalitis, not elsewhere classified) <br>
Source of report of A85 (other viral encephalitis, not elsewhere classified) <br>
Date A86 first reported (unspecified viral encephalitis) <br>
Source of report of A86 (unspecified viral encephalitis) <br>
Date A87 first reported (viral meningitis) <br>
Source of report of A87 (viral meningitis) <br>
Date A88 first reported (other viral infections of central nervous system, not elsewhere classified) <br>
Source of report of A88 (other viral infections of central nervous system, not elsewhere classified) <br>
Date A89 first reported (unspecified viral infection of central nervous system) <br>
Source of report of A89 (unspecified viral infection of central nervous system) <br>
Date A90 first reported (dengue fever [classical dengue]) <br>
Source of report of A90 (dengue fever [classical dengue]) <br>
Date A91 first reported (dengue haemorrhagic fever) <br>
Source of report of A91 (dengue haemorrhagic fever) <br>
Date A92 first reported (other mosquito-borne viral fevers) <br>
Source of report of A92 (other mosquito-borne viral fevers) <br>
Date A93 first reported (other arthropod-borne viral fevers, not elsewhere classified) <br>
Source of report of A93 (other arthropod-borne viral fevers, not elsewhere classified) <br>
Date A94 first reported (unspecified arthropod-borne viral fever) <br>
Source of report of A94 (unspecified arthropod-borne viral fever) <br>
Date A95 first reported (yellow fever) <br>
Source of report of A95 (yellow fever) <br>
Date A97 first reported (dengue) <br>
Source of report of A97 (dengue) <br>
Date A98 first reported (other viral haemorrhagic fevers, not elsewhere classified) <br>
Source of report of A98 (other viral haemorrhagic fevers, not elsewhere classified) <br>
Date B00 first reported (herpesviral [herpes simplex] infections) <br>
Source of report of B00 (herpesviral [herpes simplex] infections) <br>
Date B01 first reported (varicella [chickenpox]) <br>
Source of report of B01 (varicella [chickenpox]) <br>
Date B02 first reported (zoster [herpes zoster]) <br>
Source of report of B02 (zoster [herpes zoster]) <br>
Date B03 first reported (smallpox) <br>
Source of report of B03 (smallpox) <br>
Date B05 first reported (measles) <br>
Source of report of B05 (measles) <br>
Date B06 first reported (rubella [german measles]) <br>
Source of report of B06 (rubella [german measles]) <br>
Date B07 first reported (viral warts) <br>
Source of report of B07 (viral warts) <br>
Date B08 first reported (other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified) <br>
Source of report of B08 (other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified) <br>
Date B09 first reported (unspecified viral infection characterised by skin and mucous membrane lesions) <br>
Source of report of B09 (unspecified viral infection characterised by skin and mucous membrane lesions) <br>
Date B15 first reported (acute hepatitis a) <br>
Source of report of B15 (acute hepatitis a) <br>
Date B16 first reported (acute hepatitis b) <br>
Source of report of B16 (acute hepatitis b) <br>
Date B17 first reported (other acute viral hepatitis) <br>
Source of report of B17 (other acute viral hepatitis) <br>
Date B18 first reported (chronic viral hepatitis) <br>
Source of report of B18 (chronic viral hepatitis) <br>
Date B19 first reported (unspecified viral hepatitis) <br>
Source of report of B19 (unspecified viral hepatitis) <br>
Date B20 first reported (human immunodeficiency virus [hiv] disease resulting in infectious and parasitic diseases) <br>
Source of report of B20 (human immunodeficiency virus [hiv] disease resulting in infectious and parasitic diseases) <br>
Date B21 first reported (human immunodeficiency virus [hiv] disease resulting in malignant neoplasms) <br>
Source of report of B21 (human immunodeficiency virus [hiv] disease resulting in malignant neoplasms) <br>
Date B22 first reported (human immunodeficiency virus [hiv] disease resulting in other specified diseases) <br>
Source of report of B22 (human immunodeficiency virus [hiv] disease resulting in other specified diseases) <br>
Date B23 first reported (human immunodeficiency virus [hiv] disease resulting in other conditions) <br>
Source of report of B23 (human immunodeficiency virus [hiv] disease resulting in other conditions) <br>
Date B24 first reported (unspecified human immunodeficiency virus [hiv] disease) <br>
Source of report of B24 (unspecified human immunodeficiency virus [hiv] disease) <br>
Date B25 first reported (cytomegaloviral disease) <br>
Source of report of B25 (cytomegaloviral disease) <br>
Date B26 first reported (mumps) <br>
Source of report of B26 (mumps) <br>
Date B27 first reported (infectious mononucleosis) <br>
Source of report of B27 (infectious mononucleosis) <br>
Date B30 first reported (viral conjunctivitis) <br>
Source of report of B30 (viral conjunctivitis) <br>
Date B33 first reported (other viral diseases, not elsewhere classified) <br>
Source of report of B33 (other viral diseases, not elsewhere classified) <br>
Date B34 first reported (viral infection of unspecified site) <br>
Source of report of B34 (viral infection of unspecified site) <br>
Date B35 first reported (dermatophytosis) <br>
Source of report of B35 (dermatophytosis) <br>
Date B36 first reported (other superficial mycoses) <br>
Source of report of B36 (other superficial mycoses) <br>
Date B37 first reported (candidiasis) <br>
Source of report of B37 (candidiasis) <br>
Date B38 first reported (coccidioidomycosis) <br>
Source of report of B38 (coccidioidomycosis) <br>
Date B39 first reported (histoplasmosis) <br>
Source of report of B39 (histoplasmosis) <br>
Date B40 first reported (blastomycosis) <br>
Source of report of B40 (blastomycosis) <br>
Date B42 first reported (sporotrichosis) <br>
Source of report of B42 (sporotrichosis) <br>
Date B43 first reported (chromomycosis and phaeomycotic abscess) <br>
Source of report of B43 (chromomycosis and phaeomycotic abscess) <br>
Date B44 first reported (aspergillosis) <br>
Source of report of B44 (aspergillosis) <br>
Date B45 first reported (cryptococcosis) <br>
Source of report of B45 (cryptococcosis) <br>
Date B46 first reported (zygomycosis) <br>
Source of report of B46 (zygomycosis) <br>
Date B47 first reported (mycetoma) <br>
Source of report of B47 (mycetoma) <br>
Date B48 first reported (other mycoses, not elsewhere classified) <br>
Source of report of B48 (other mycoses, not elsewhere classified) <br>
Date B49 first reported (unspecified mycosis) <br>
Source of report of B49 (unspecified mycosis) <br>
Date B50 first reported (plasmodium falciparum malaria) <br>
Source of report of B50 (plasmodium falciparum malaria) <br>
Date B51 first reported (plasmodium vivax malaria) <br>
Source of report of B51 (plasmodium vivax malaria) <br>
Date B52 first reported (plasmodium malariae malaria) <br>
Source of report of B52 (plasmodium malariae malaria) <br>
Date B53 first reported (other parasitologically confirmed malaria) <br>
Source of report of B53 (other parasitologically confirmed malaria) <br>
Date B54 first reported (unspecified malaria) <br>
Source of report of B54 (unspecified malaria) <br>
Date B55 first reported (leishmaniasis) <br>
Source of report of B55 (leishmaniasis) <br>
Date B57 first reported (chagas' disease) <br>
Source of report of B57 (chagas' disease) <br>
Date B58 first reported (toxoplasmosis) <br>
Source of report of B58 (toxoplasmosis) <br>
Date B59 first reported (pneumocystosis) <br>
Source of report of B59 (pneumocystosis) <br>
Date B60 first reported (other protozoal diseases, not elsewhere classified) <br>
Source of report of B60 (other protozoal diseases, not elsewhere classified) <br>
Date B65 first reported (schistosomiasis [bilharziasis]) <br>
Source of report of B65 (schistosomiasis [bilharziasis]) <br>
Date B66 first reported (other fluke infections) <br>
Source of report of B66 (other fluke infections) <br>
Date B67 first reported (echinococcosis) <br>
Source of report of B67 (echinococcosis) <br>
Date B68 first reported (taeniasis) <br>
Source of report of B68 (taeniasis) <br>
Date B69 first reported (cysticercosis) <br>
Source of report of B69 (cysticercosis) <br>
Date B71 first reported (other cestode infections) <br>
Source of report of B71 (other cestode infections) <br>
Date B73 first reported (onchocerciasis) <br>
Source of report of B73 (onchocerciasis) <br>
Date B74 first reported (filariasis) <br>
Source of report of B74 (filariasis) <br>
Date B75 first reported (trichinellosis) <br>
Source of report of B75 (trichinellosis) <br>
Date B76 first reported (hookworm diseases) <br>
Source of report of B76 (hookworm diseases) <br>
Date B77 first reported (ascariasis) <br>
Source of report of B77 (ascariasis) <br>
Date B78 first reported (strongyloidiasis) <br>
Source of report of B78 (strongyloidiasis) <br>
Date B79 first reported (trichuriasis) <br>
Source of report of B79 (trichuriasis) <br>
Date B80 first reported (enterobiasis) <br>
Source of report of B80 (enterobiasis) <br>
Date B81 first reported (other intestinal helminthiases, not elsewhere classified) <br>
Source of report of B81 (other intestinal helminthiases, not elsewhere classified) <br>
Date B82 first reported (unspecified intestinal parasitism) <br>
Source of report of B82 (unspecified intestinal parasitism) <br>
Date B83 first reported (other helminthiases) <br>
Source of report of B83 (other helminthiases) <br>
Date B85 first reported (pediculosis and phthiriasis) <br>
Source of report of B85 (pediculosis and phthiriasis) <br>
Date B86 first reported (scabies) <br>
Source of report of B86 (scabies) <br>
Date B87 first reported (myiasis) <br>
Source of report of B87 (myiasis) <br>
Date B88 first reported (other infestations) <br>
Source of report of B88 (other infestations) <br>
Date B89 first reported (unspecified parasitic disease) <br>
Source of report of B89 (unspecified parasitic disease) <br>
Date B90 first reported (sequelae of tuberculosis) <br>
Source of report of B90 (sequelae of tuberculosis) <br>
Date B91 first reported (sequelae of poliomyelitis) <br>
Source of report of B91 (sequelae of poliomyelitis) <br>
Date B94 first reported (sequelae of other and unspecified infectious and parasitic diseases) <br>
Source of report of B94 (sequelae of other and unspecified infectious and parasitic diseases) <br>
Date B95 first reported (streptococcus and staphylococcus as the cause of diseases classified to other chapters) <br>
Source of report of B95 (streptococcus and staphylococcus as the cause of diseases classified to other chapters) <br>
Date B96 first reported (other bacterial agents as the cause of diseases classified to other chapters) <br>
Source of report of B96 (other bacterial agents as the cause of diseases classified to other chapters) <br>
Date B97 first reported (viral agents as the cause of diseases classified to other chapters) <br>
Source of report of B97 (viral agents as the cause of diseases classified to other chapters) <br>
Date B98 first reported (other specified infectious agents as the cause of diseases classified to other chapters) <br>
Source of report of B98 (other specified infectious agents as the cause of diseases classified to other chapters) <br>
Date B99 first reported (other and unspecified infectious diseases) <br>
Source of report of B99 (other and unspecified infectious diseases) <br>
Date D50 first reported (iron deficiency anaemia) <br>
Source of report of D50 (iron deficiency anaemia) <br>
Date D51 first reported (vitamin b12 deficiency anaemia) <br>
Source of report of D51 (vitamin b12 deficiency anaemia) <br>
Date D52 first reported (folate deficiency anaemia) <br>
Source of report of D52 (folate deficiency anaemia) <br>
Date D53 first reported (other nutritional anaemias) <br>
Source of report of D53 (other nutritional anaemias) <br>
Date D55 first reported (anaemia due to enzyme disorders) <br>
Source of report of D55 (anaemia due to enzyme disorders) <br>
Date D56 first reported (thalassaemia) <br>
Source of report of D56 (thalassaemia) <br>
Date D57 first reported (sickle-cell disorders) <br>
Source of report of D57 (sickle-cell disorders) <br>
Date D58 first reported (other hereditary haemolytic anaemias) <br>
Source of report of D58 (other hereditary haemolytic anaemias) <br>
Date D59 first reported (acquired haemolytic anaemia) <br>
Source of report of D59 (acquired haemolytic anaemia) <br>
Date D60 first reported (acquired pure red cell aplasia [erythroblastopenia]) <br>
Source of report of D60 (acquired pure red cell aplasia [erythroblastopenia]) <br>
Date D61 first reported (other aplastic anaemias) <br>
Source of report of D61 (other aplastic anaemias) <br>
Date D62 first reported (acute posthaemorrhagic anaemia) <br>
Source of report of D62 (acute posthaemorrhagic anaemia) <br>
Date D63 first reported (anaemia in chronic diseases classified elsewhere) <br>
Source of report of D63 (anaemia in chronic diseases classified elsewhere) <br>
Date D64 first reported (other anaemias) <br>
Source of report of D64 (other anaemias) <br>
Date D65 first reported (disseminated intravascular coagulation [defibrination syndrome]) <br>
Source of report of D65 (disseminated intravascular coagulation [defibrination syndrome]) <br>
Date D66 first reported (hereditary factor viii deficiency) <br>
Source of report of D66 (hereditary factor viii deficiency) <br>
Date D67 first reported (hereditary factor ix deficiency) <br>
Source of report of D67 (hereditary factor ix deficiency) <br>
Date D68 first reported (other coagulation defects) <br>
Source of report of D68 (other coagulation defects) <br>
Date D69 first reported (purpura and other haemorrhagic conditions) <br>
Source of report of D69 (purpura and other haemorrhagic conditions) <br>
Date D70 first reported (agranulocytosis) <br>
Source of report of D70 (agranulocytosis) <br>
Date D71 first reported (functional disorders of polymorphonuclear neutrophils) <br>
Source of report of D71 (functional disorders of polymorphonuclear neutrophils) <br>
Date D72 first reported (other disorders of white blood cells) <br>
Source of report of D72 (other disorders of white blood cells) <br>
Date D73 first reported (diseases of spleen) <br>
Source of report of D73 (diseases of spleen) <br>
Date D74 first reported (methaemoglobinaemia) <br>
Source of report of D74 (methaemoglobinaemia) <br>
Date D75 first reported (other diseases of blood and blood-forming organs) <br>
Source of report of D75 (other diseases of blood and blood-forming organs) <br>
Date D76 first reported (certain diseases involving lymphoreticular tissue and reticulohistiocytic system) <br>
Source of report of D76 (certain diseases involving lymphoreticular tissue and reticulohistiocytic system) <br>
Date D77 first reported (other disorders of blood and blood-forming organs in diseases classified elsewhere) <br>
Source of report of D77 (other disorders of blood and blood-forming organs in diseases classified elsewhere) <br>
Date D80 first reported (immunodeficiency with predominantly antibody defects) <br>
Source of report of D80 (immunodeficiency with predominantly antibody defects) <br>
Date D81 first reported (combined immunodeficiencies) <br>
Source of report of D81 (combined immunodeficiencies) <br>
Date D82 first reported (immunodeficiency associated with other major defects) <br>
Source of report of D82 (immunodeficiency associated with other major defects) <br>
Date D83 first reported (common variable immunodeficiency) <br>
Source of report of D83 (common variable immunodeficiency) <br>
Date D84 first reported (other immunodeficiencies) <br>
Source of report of D84 (other immunodeficiencies) <br>
Date D86 first reported (sarcoidosis) <br>
Source of report of D86 (sarcoidosis) <br>
Date D89 first reported (other disorders involving the immune mechanism, not elsewhere classified) <br>
Source of report of D89 (other disorders involving the immune mechanism, not elsewhere classified) <br>
Date E01 first reported (iodine-deficiency-related thyroid disorders and allied conditions) <br>
Source of report of E01 (iodine-deficiency-related thyroid disorders and allied conditions) <br>
Date E02 first reported (subclinical iodine-deficiency hypothyroidism) <br>
Source of report of E02 (subclinical iodine-deficiency hypothyroidism) <br>
Date E03 first reported (other hypothyroidism) <br>
Source of report of E03 (other hypothyroidism) <br>
Date E04 first reported (other non-toxic goitre) <br>
Source of report of E04 (other non-toxic goitre) <br>
Date E05 first reported (thyrotoxicosis [hyperthyroidism]) <br>
Source of report of E05 (thyrotoxicosis [hyperthyroidism]) <br>
Date E06 first reported (thyroiditis) <br>
Source of report of E06 (thyroiditis) <br>
Date E07 first reported (other disorders of thyroid) <br>
Source of report of E07 (other disorders of thyroid) <br>
Date E10 first reported (insulin-dependent diabetes mellitus) <br>
Source of report of E10 (insulin-dependent diabetes mellitus) <br>
Date E11 first reported (non-insulin-dependent diabetes mellitus) <br>
Source of report of E11 (non-insulin-dependent diabetes mellitus) <br>
Date E12 first reported (malnutrition-related diabetes mellitus) <br>
Source of report of E12 (malnutrition-related diabetes mellitus) <br>
Date E13 first reported (other specified diabetes mellitus) <br>
Source of report of E13 (other specified diabetes mellitus) <br>
Date E14 first reported (unspecified diabetes mellitus) <br>
Source of report of E14 (unspecified diabetes mellitus) <br>
Date E15 first reported (nondiabetic hypoglycaemic coma) <br>
Source of report of E15 (nondiabetic hypoglycaemic coma) <br>
Date E16 first reported (other disorders of pancreatic internal secretion) <br>
Source of report of E16 (other disorders of pancreatic internal secretion) <br>
Date E20 first reported (hypoparathyroidism) <br>
Source of report of E20 (hypoparathyroidism) <br>
Date E21 first reported (hyperparathyroidism and other disorders of parathyroid gland) <br>
Source of report of E21 (hyperparathyroidism and other disorders of parathyroid gland) <br>
Date E22 first reported (hyperfunction of pituitary gland) <br>
Source of report of E22 (hyperfunction of pituitary gland) <br>
Date E23 first reported (hypofunction and other disorders of pituitary gland) <br>
Source of report of E23 (hypofunction and other disorders of pituitary gland) <br>
Date E24 first reported (cushing's syndrome) <br>
Source of report of E24 (cushing's syndrome) <br>
Date E25 first reported (adrenogenital disorders) <br>
Source of report of E25 (adrenogenital disorders) <br>
Date E26 first reported (hyperaldosteronism) <br>
Source of report of E26 (hyperaldosteronism) <br>
Date E27 first reported (other disorders of adrenal gland) <br>
Source of report of E27 (other disorders of adrenal gland) <br>
Date E28 first reported (ovarian dysfunction) <br>
Source of report of E28 (ovarian dysfunction) <br>
Date E29 first reported (testicular dysfunction) <br>
Source of report of E29 (testicular dysfunction) <br>
Date E30 first reported (disorders of puberty, not elsewhere classified) <br>
Source of report of E30 (disorders of puberty, not elsewhere classified) <br>
Date E31 first reported (polyglandular dysfunction) <br>
Source of report of E31 (polyglandular dysfunction) <br>
Date E32 first reported (diseases of thymus) <br>
Source of report of E32 (diseases of thymus) <br>
Date E34 first reported (other endocrine disorders) <br>
Source of report of E34 (other endocrine disorders) <br>
Date E35 first reported (disorders of endocrine glands in diseases classified elsewhere) <br>
Source of report of E35 (disorders of endocrine glands in diseases classified elsewhere) <br>
Date E40 first reported (kwashiorkor) <br>
Source of report of E40 (kwashiorkor) <br>
Date E41 first reported (nutritional marasmus) <br>
Source of report of E41 (nutritional marasmus) <br>
Date E43 first reported (unspecified severe protein-energy malnutrition) <br>
Source of report of E43 (unspecified severe protein-energy malnutrition) <br>
Date E44 first reported (protein-energy malnutrition of moderate and mild degree) <br>
Source of report of E44 (protein-energy malnutrition of moderate and mild degree) <br>
Date E45 first reported (retarded development following protein-energy malnutrition) <br>
Source of report of E45 (retarded development following protein-energy malnutrition) <br>
Date E46 first reported (unspecified protein-energy malnutrition) <br>
Source of report of E46 (unspecified protein-energy malnutrition) <br>
Date E50 first reported (vitamin a deficiency) <br>
Source of report of E50 (vitamin a deficiency) <br>
Date E51 first reported (thiamine deficiency) <br>
Source of report of E51 (thiamine deficiency) <br>
Date E52 first reported (niacin deficiency [pellagra]) <br>
Source of report of E52 (niacin deficiency [pellagra]) <br>
Date E53 first reported (deficiency of other b group vitamins) <br>
Source of report of E53 (deficiency of other b group vitamins) <br>
Date E54 first reported (ascorbic acid deficiency) <br>
Source of report of E54 (ascorbic acid deficiency) <br>
Date E55 first reported (vitamin d deficiency) <br>
Source of report of E55 (vitamin d deficiency) <br>
Date E56 first reported (other vitamin deficiencies) <br>
Source of report of E56 (other vitamin deficiencies) <br>
Date E58 first reported (dietary calcium deficiency) <br>
Source of report of E58 (dietary calcium deficiency) <br>
Date E59 first reported (dietary selenium deficiency) <br>
Source of report of E59 (dietary selenium deficiency) <br>
Date E60 first reported (dietary zinc deficiency) <br>
Source of report of E60 (dietary zinc deficiency) <br>
Date E61 first reported (deficiency of other nutrient elements) <br>
Source of report of E61 (deficiency of other nutrient elements) <br>
Date E63 first reported (other nutritional deficiencies) <br>
Source of report of E63 (other nutritional deficiencies) <br>
Date E64 first reported (sequelae of malnutrition and other nutritional deficiencies) <br>
Source of report of E64 (sequelae of malnutrition and other nutritional deficiencies) <br>
Date E65 first reported (localised adiposity) <br>
Source of report of E65 (localised adiposity) <br>
Date E66 first reported (obesity) <br>
Source of report of E66 (obesity) <br>
Date E67 first reported (other hyperalimentation) <br>
Source of report of E67 (other hyperalimentation) <br>
Date E68 first reported (sequelae of hyperalimentation) <br>
Source of report of E68 (sequelae of hyperalimentation) <br>
Date E70 first reported (disorders of aromatic amino-acid metabolism) <br>
Source of report of E70 (disorders of aromatic amino-acid metabolism) <br>
Date E71 first reported (disorders of branched-chain amino-acid metabolism and fatty-acid metabolism) <br>
Source of report of E71 (disorders of branched-chain amino-acid metabolism and fatty-acid metabolism) <br>
Date E72 first reported (other disorders of amino-acid metabolism) <br>
Source of report of E72 (other disorders of amino-acid metabolism) <br>
Date E73 first reported (lactose intolerance) <br>
Source of report of E73 (lactose intolerance) <br>
Date E74 first reported (other disorders of carbohydrate metabolism) <br>
Source of report of E74 (other disorders of carbohydrate metabolism) <br>
Date E75 first reported (disorders of sphingolipid metabolism and other lipid storage disorders) <br>
Source of report of E75 (disorders of sphingolipid metabolism and other lipid storage disorders) <br>
Date E76 first reported (disorders of glycosaminoglycan metabolism) <br>
Source of report of E76 (disorders of glycosaminoglycan metabolism) <br>
Date E77 first reported (disorders of glycoprotein metabolism) <br>
Source of report of E77 (disorders of glycoprotein metabolism) <br>
Date E78 first reported (disorders of lipoprotein metabolism and other lipidaemias) <br>
Source of report of E78 (disorders of lipoprotein metabolism and other lipidaemias) <br>
Date E79 first reported (disorders of purine and pyrimidine metabolism) <br>
Source of report of E79 (disorders of purine and pyrimidine metabolism) <br>
Date E80 first reported (disorders of porphyrin and bilirubin metabolism) <br>
Source of report of E80 (disorders of porphyrin and bilirubin metabolism) <br>
Date E83 first reported (disorders of mineral metabolism) <br>
Source of report of E83 (disorders of mineral metabolism) <br>
Date E84 first reported (cystic fibrosis) <br>
Source of report of E84 (cystic fibrosis) <br>
Date E85 first reported (amyloidosis) <br>
Source of report of E85 (amyloidosis) <br>
Date E86 first reported (volume depletion) <br>
Source of report of E86 (volume depletion) <br>
Date E87 first reported (other disorders of fluid, electrolyte and acid-base balance) <br>
Source of report of E87 (other disorders of fluid, electrolyte and acid-base balance) <br>
Date E88 first reported (other metabolic disorders) <br>
Source of report of E88 (other metabolic disorders) <br>
Date E89 first reported (postprocedural endocrine and metabolic disorders, not elsewhere classified) <br>
Source of report of E89 (postprocedural endocrine and metabolic disorders, not elsewhere classified) <br>
Date F00 first reported (dementia in alzheimer's disease) <br>
Source of report of F00 (dementia in alzheimer's disease) <br>
Date F01 first reported (vascular dementia) <br>
Source of report of F01 (vascular dementia) <br>
Date F02 first reported (dementia in other diseases classified elsewhere) <br>
Source of report of F02 (dementia in other diseases classified elsewhere) <br>
Date F03 first reported (unspecified dementia) <br>
Source of report of F03 (unspecified dementia) <br>
Date F04 first reported (organic amnesic syndrome, not induced by alcohol and other psychoactive substances) <br>
Source of report of F04 (organic amnesic syndrome, not induced by alcohol and other psychoactive substances) <br>
Date F05 first reported (delirium, not induced by alcohol and other psychoactive substances) <br>
Source of report of F05 (delirium, not induced by alcohol and other psychoactive substances) <br>
Date F06 first reported (other mental disorders due to brain damage and dysfunction and to physical disease) <br>
Source of report of F06 (other mental disorders due to brain damage and dysfunction and to physical disease) <br>
Date F07 first reported (personality and behavioural disorders due to brain disease, damage and dysfunction) <br>
Source of report of F07 (personality and behavioural disorders due to brain disease, damage and dysfunction) <br>
Date F09 first reported (unspecified organic or symptomatic mental disorder) <br>
Source of report of F09 (unspecified organic or symptomatic mental disorder) <br>
Date F10 first reported (mental and behavioural disorders due to use of alcohol) <br>
Source of report of F10 (mental and behavioural disorders due to use of alcohol) <br>
Date F11 first reported (mental and behavioural disorders due to use of opioids) <br>
Source of report of F11 (mental and behavioural disorders due to use of opioids) <br>
Date F12 first reported (mental and behavioural disorders due to use of cannabinoids) <br>
Source of report of F12 (mental and behavioural disorders due to use of cannabinoids) <br>
Date F13 first reported (mental and behavioural disorders due to use of sedatives or hypnotics) <br>
Source of report of F13 (mental and behavioural disorders due to use of sedatives or hypnotics) <br>
Date F14 first reported (mental and behavioural disorders due to use of cocaine) <br>
Source of report of F14 (mental and behavioural disorders due to use of cocaine) <br>
Date F15 first reported (mental and behavioural disorders due to use of other stimulants, including caffeine) <br>
Source of report of F15 (mental and behavioural disorders due to use of other stimulants, including caffeine) <br>
Date F16 first reported (mental and behavioural disorders due to use of hallucinogens) <br>
Source of report of F16 (mental and behavioural disorders due to use of hallucinogens) <br>
Date F17 first reported (mental and behavioural disorders due to use of tobacco) <br>
Source of report of F17 (mental and behavioural disorders due to use of tobacco) <br>
Date F18 first reported (mental and behavioural disorders due to use of volatile solvents) <br>
Source of report of F18 (mental and behavioural disorders due to use of volatile solvents) <br>
Date F19 first reported (mental and behavioural disorders due to multiple drug use and use of other psychoactive substances) <br>
Source of report of F19 (mental and behavioural disorders due to multiple drug use and use of other psychoactive substances) <br>
Date F20 first reported (schizophrenia) <br>
Source of report of F20 (schizophrenia) <br>
Date F21 first reported (schizotypal disorder) <br>
Source of report of F21 (schizotypal disorder) <br>
Date F22 first reported (persistent delusional disorders) <br>
Source of report of F22 (persistent delusional disorders) <br>
Date F23 first reported (acute and transient psychotic disorders) <br>
Source of report of F23 (acute and transient psychotic disorders) <br>
Date F24 first reported (induced delusional disorder) <br>
Source of report of F24 (induced delusional disorder) <br>
Date F25 first reported (schizoaffective disorders) <br>
Source of report of F25 (schizoaffective disorders) <br>
Date F28 first reported (other nonorganic psychotic disorders) <br>
Source of report of F28 (other nonorganic psychotic disorders) <br>
Date F29 first reported (unspecified nonorganic psychosis) <br>
Source of report of F29 (unspecified nonorganic psychosis) <br>
Date F30 first reported (manic episode) <br>
Source of report of F30 (manic episode) <br>
Date F31 first reported (bipolar affective disorder) <br>
Source of report of F31 (bipolar affective disorder) <br>
Date F32 first reported (depressive episode) <br>
Source of report of F32 (depressive episode) <br>
Date F33 first reported (recurrent depressive disorder) <br>
Source of report of F33 (recurrent depressive disorder) <br>
Date F34 first reported (persistent mood [affective] disorders) <br>
Source of report of F34 (persistent mood [affective] disorders) <br>
Date F38 first reported (other mood [affective] disorders) <br>
Source of report of F38 (other mood [affective] disorders) <br>
Date F39 first reported (unspecified mood [affective] disorder) <br>
Source of report of F39 (unspecified mood [affective] disorder) <br>
Date F40 first reported (phobic anxiety disorders) <br>
Source of report of F40 (phobic anxiety disorders) <br>
Date F41 first reported (other anxiety disorders) <br>
Source of report of F41 (other anxiety disorders) <br>
Date F42 first reported (obsessive-compulsive disorder) <br>
Source of report of F42 (obsessive-compulsive disorder) <br>
Date F43 first reported (reaction to severe stress, and adjustment disorders) <br>
Source of report of F43 (reaction to severe stress, and adjustment disorders) <br>
Date F44 first reported (dissociative [conversion] disorders) <br>
Source of report of F44 (dissociative [conversion] disorders) <br>
Date F45 first reported (somatoform disorders) <br>
Source of report of F45 (somatoform disorders) <br>
Date F48 first reported (other neurotic disorders) <br>
Source of report of F48 (other neurotic disorders) <br>
Date F50 first reported (eating disorders) <br>
Source of report of F50 (eating disorders) <br>
Date F51 first reported (nonorganic sleep disorders) <br>
Source of report of F51 (nonorganic sleep disorders) <br>
Date F52 first reported (sexual dysfunction, not caused by organic disorder or disease) <br>
Source of report of F52 (sexual dysfunction, not caused by organic disorder or disease) <br>
Date F53 first reported (mental and behavioural disorders associated with the puerperium, not elsewhere classified) <br>
Source of report of F53 (mental and behavioural disorders associated with the puerperium, not elsewhere classified) <br>
Date F54 first reported (psychological and behavioural factors associated with disorders or diseases classified elsewhere) <br>
Source of report of F54 (psychological and behavioural factors associated with disorders or diseases classified elsewhere) <br>
Date F55 first reported (abuse of non-dependence-producing substances) <br>
Source of report of F55 (abuse of non-dependence-producing substances) <br>
Date F59 first reported (unspecified behavioural syndromes associated with physiological disturbances and physical factors) <br>
Source of report of F59 (unspecified behavioural syndromes associated with physiological disturbances and physical factors) <br>
Date F60 first reported (specific personality disorders) <br>
Source of report of F60 (specific personality disorders) <br>
Date F61 first reported (mixed and other personality disorders) <br>
Source of report of F61 (mixed and other personality disorders) <br>
Date F62 first reported (enduring personality changes, not attributable to brain damage and disease) <br>
Source of report of F62 (enduring personality changes, not attributable to brain damage and disease) <br>
Date F63 first reported (habit and impulse disorders) <br>
Source of report of F63 (habit and impulse disorders) <br>
Date F64 first reported (gender identity disorders) <br>
Source of report of F64 (gender identity disorders) <br>
Date F65 first reported (disorders of sexual preference) <br>
Source of report of F65 (disorders of sexual preference) <br>
Date F66 first reported (psychological and behavioural disorders associated with sexual development and orientation) <br>
Source of report of F66 (psychological and behavioural disorders associated with sexual development and orientation) <br>
Date F68 first reported (other disorders of adult personality and behaviour) <br>
Source of report of F68 (other disorders of adult personality and behaviour) <br>
Date F69 first reported (unspecified disorder of adult personality and behaviour) <br>
Source of report of F69 (unspecified disorder of adult personality and behaviour) <br>
Date F70 first reported (mild mental retardation) <br>
Source of report of F70 (mild mental retardation) <br>
Date F71 first reported (moderate mental retardation) <br>
Source of report of F71 (moderate mental retardation) <br>
Date F72 first reported (severe mental retardation) <br>
Source of report of F72 (severe mental retardation) <br>
Date F78 first reported (other mental retardation) <br>
Source of report of F78 (other mental retardation) <br>
Date F79 first reported (unspecified mental retardation) <br>
Source of report of F79 (unspecified mental retardation) <br>
Date F80 first reported (specific developmental disorders of speech and language) <br>
Source of report of F80 (specific developmental disorders of speech and language) <br>
Date F81 first reported (specific developmental disorders of scholastic skills) <br>
Source of report of F81 (specific developmental disorders of scholastic skills) <br>
Date F82 first reported (specific developmental disorder of motor function) <br>
Source of report of F82 (specific developmental disorder of motor function) <br>
Date F83 first reported (mixed specific developmental disorders) <br>
Source of report of F83 (mixed specific developmental disorders) <br>
Date F84 first reported (pervasive developmental disorders) <br>
Source of report of F84 (pervasive developmental disorders) <br>
Date F88 first reported (other disorders of psychological development) <br>
Source of report of F88 (other disorders of psychological development) <br>
Date F89 first reported (unspecified disorder of psychological development) <br>
Source of report of F89 (unspecified disorder of psychological development) <br>
Date F90 first reported (hyperkinetic disorders) <br>
Source of report of F90 (hyperkinetic disorders) <br>
Date F91 first reported (conduct disorders) <br>
Source of report of F91 (conduct disorders) <br>
Date F92 first reported (mixed disorders of conduct and emotions) <br>
Source of report of F92 (mixed disorders of conduct and emotions) <br>
Date F93 first reported (emotional disorders with onset specific to childhood) <br>
Source of report of F93 (emotional disorders with onset specific to childhood) <br>
Date F94 first reported (disorders of social functioning with onset specific to childhood and adolescence) <br>
Source of report of F94 (disorders of social functioning with onset specific to childhood and adolescence) <br>
Date F95 first reported (tic disorders) <br>
Source of report of F95 (tic disorders) <br>
Date F98 first reported (other behavioural and emotional disorders with onset usually occurring in childhood and adolescence) <br>
Source of report of F98 (other behavioural and emotional disorders with onset usually occurring in childhood and adolescence) <br>
Date F99 first reported (mental disorder, not otherwise specified) <br>
Source of report of F99 (mental disorder, not otherwise specified) <br>
Date G00 first reported (bacterial meningitis, not elsewhere classified) <br>
Source of report of G00 (bacterial meningitis, not elsewhere classified) <br>
Date G01 first reported (meningitis in bacterial diseases classified elsewhere) <br>
Source of report of G01 (meningitis in bacterial diseases classified elsewhere) <br>
Date G02 first reported (meningitis in other infectious and parasitic diseases classified elsewhere) <br>
Source of report of G02 (meningitis in other infectious and parasitic diseases classified elsewhere) <br>
Date G03 first reported (meningitis due to other and unspecified causes) <br>
Source of report of G03 (meningitis due to other and unspecified causes) <br>
Date G04 first reported (encephalitis, myelitis and encephalomyelitis) <br>
Source of report of G04 (encephalitis, myelitis and encephalomyelitis) <br>
Date G05 first reported (encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere) <br>
Source of report of G05 (encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere) <br>
Date G06 first reported (intracranial and intraspinal abscess and granuloma) <br>
Source of report of G06 (intracranial and intraspinal abscess and granuloma) <br>
Date G07 first reported (intracranial and intraspinal abscess and granuloma in diseases classified elsewhere) <br>
Source of report of G07 (intracranial and intraspinal abscess and granuloma in diseases classified elsewhere) <br>
Date G08 first reported (intracranial and intraspinal phlebitis and thrombophlebitis) <br>
Source of report of G08 (intracranial and intraspinal phlebitis and thrombophlebitis) <br>
Date G09 first reported (sequelae of inflammatory diseases of central nervous system) <br>
Source of report of G09 (sequelae of inflammatory diseases of central nervous system) <br>
Date G10 first reported (huntington's disease) <br>
Source of report of G10 (huntington's disease) <br>
Date G11 first reported (hereditary ataxia) <br>
Source of report of G11 (hereditary ataxia) <br>
Date G12 first reported (spinal muscular atrophy and related syndromes) <br>
Source of report of G12 (spinal muscular atrophy and related syndromes) <br>
Date G13 first reported (systemic atrophies primarily affecting central nervous system in diseases classified elsewhere) <br>
Source of report of G13 (systemic atrophies primarily affecting central nervous system in diseases classified elsewhere) <br>
Date G14 first reported (postpolio syndrome) <br>
Source of report of G14 (postpolio syndrome) <br>
Date G20 first reported (parkinson's disease) <br>
Source of report of G20 (parkinson's disease) <br>
Date G21 first reported (secondary parkinsonism) <br>
Source of report of G21 (secondary parkinsonism) <br>
Date G22 first reported (parkinsonism in diseases classified elsewhere) <br>
Source of report of G22 (parkinsonism in diseases classified elsewhere) <br>
Date G23 first reported (other degenerative diseases of basal ganglia) <br>
Source of report of G23 (other degenerative diseases of basal ganglia) <br>
Date G24 first reported (dystonia) <br>
Source of report of G24 (dystonia) <br>
Date G25 first reported (other extrapyramidal and movement disorders) <br>
Source of report of G25 (other extrapyramidal and movement disorders) <br>
Date G30 first reported (alzheimer's disease) <br>
Source of report of G30 (alzheimer's disease) <br>
Date G31 first reported (other degenerative diseases of nervous system, not elsewhere classified) <br>
Source of report of G31 (other degenerative diseases of nervous system, not elsewhere classified) <br>
Date G32 first reported (other degenerative disorders of nervous system in diseases classified elsewhere) <br>
Source of report of G32 (other degenerative disorders of nervous system in diseases classified elsewhere) <br>
Date G35 first reported (multiple sclerosis) <br>
Source of report of G35 (multiple sclerosis) <br>
Date G36 first reported (other acute disseminated demyelination) <br>
Source of report of G36 (other acute disseminated demyelination) <br>
Date G37 first reported (other demyelinating diseases of central nervous system) <br>
Source of report of G37 (other demyelinating diseases of central nervous system) <br>
Date G40 first reported (epilepsy) <br>
Source of report of G40 (epilepsy) <br>
Date G41 first reported (status epilepticus) <br>
Source of report of G41 (status epilepticus) <br>
Date G43 first reported (migraine) <br>
Source of report of G43 (migraine) <br>
Date G44 first reported (other headache syndromes) <br>
Source of report of G44 (other headache syndromes) <br>
Date G45 first reported (transient cerebral ischaemic attacks and related syndromes) <br>
Source of report of G45 (transient cerebral ischaemic attacks and related syndromes) <br>
Date G46 first reported (vascular syndromes of brain in cerebrovascular diseases) <br>
Source of report of G46 (vascular syndromes of brain in cerebrovascular diseases) <br>
Date G47 first reported (sleep disorders) <br>
Source of report of G47 (sleep disorders) <br>
Date G50 first reported (disorders of trigeminal nerve) <br>
Source of report of G50 (disorders of trigeminal nerve) <br>
Date G51 first reported (facial nerve disorders) <br>
Source of report of G51 (facial nerve disorders) <br>
Date G52 first reported (disorders of other cranial nerves) <br>
Source of report of G52 (disorders of other cranial nerves) <br>
Date G53 first reported (cranial nerve disorders in diseases classified elsewhere) <br>
Source of report of G53 (cranial nerve disorders in diseases classified elsewhere) <br>
Date G54 first reported (nerve root and plexus disorders) <br>
Source of report of G54 (nerve root and plexus disorders) <br>
Date G55 first reported (nerve root and plexus compressions in diseases classified elsewhere) <br>
Source of report of G55 (nerve root and plexus compressions in diseases classified elsewhere) <br>
Date G56 first reported (mononeuropathies of upper limb) <br>
Source of report of G56 (mononeuropathies of upper limb) <br>
Date G57 first reported (mononeuropathies of lower limb) <br>
Source of report of G57 (mononeuropathies of lower limb) <br>
Date G58 first reported (other mononeuropathies) <br>
Source of report of G58 (other mononeuropathies) <br>
Date G59 first reported (mononeuropathy in diseases classified elsewhere) <br>
Source of report of G59 (mononeuropathy in diseases classified elsewhere) <br>
Date G60 first reported (hereditary and idiopathic neuropathy) <br>
Source of report of G60 (hereditary and idiopathic neuropathy) <br>
Date G61 first reported (inflammatory polyneuropathy) <br>
Source of report of G61 (inflammatory polyneuropathy) <br>
Date G62 first reported (other polyneuropathies) <br>
Source of report of G62 (other polyneuropathies) <br>
Date G63 first reported (polyneuropathy in diseases classified elsewhere) <br>
Source of report of G63 (polyneuropathy in diseases classified elsewhere) <br>
Date G64 first reported (other disorders of peripheral nervous system) <br>
Source of report of G64 (other disorders of peripheral nervous system) <br>
Date G70 first reported (myasthenia gravis and other myoneural disorders) <br>
Source of report of G70 (myasthenia gravis and other myoneural disorders) <br>
Date G71 first reported (primary disorders of muscles) <br>
Source of report of G71 (primary disorders of muscles) <br>
Date G72 first reported (other myopathies) <br>
Source of report of G72 (other myopathies) <br>
Date G73 first reported (disorders of myoneural junction and muscle in diseases classified elsewhere) <br>
Source of report of G73 (disorders of myoneural junction and muscle in diseases classified elsewhere) <br>
Date G80 first reported (infantile cerebral palsy) <br>
Source of report of G80 (infantile cerebral palsy) <br>
Date G81 first reported (hemiplegia) <br>
Source of report of G81 (hemiplegia) <br>
Date G82 first reported (paraplegia and tetraplegia) <br>
Source of report of G82 (paraplegia and tetraplegia) <br>
Date G83 first reported (other paralytic syndromes) <br>
Source of report of G83 (other paralytic syndromes) <br>
Date G90 first reported (disorders of autonomic nervous system) <br>
Source of report of G90 (disorders of autonomic nervous system) <br>
Date G91 first reported (hydrocephalus) <br>
Source of report of G91 (hydrocephalus) <br>
Date G92 first reported (toxic encephalopathy) <br>
Source of report of G92 (toxic encephalopathy) <br>
Date G93 first reported (other disorders of brain) <br>
Source of report of G93 (other disorders of brain) <br>
Date G94 first reported (other disorders of brain in diseases classified elsewhere) <br>
Source of report of G94 (other disorders of brain in diseases classified elsewhere) <br>
Date G95 first reported (other diseases of spinal cord) <br>
Source of report of G95 (other diseases of spinal cord) <br>
Date G96 first reported (other disorders of central nervous system) <br>
Source of report of G96 (other disorders of central nervous system) <br>
Date G97 first reported (postprocedural disorders of nervous system, not elsewhere classified) <br>
Source of report of G97 (postprocedural disorders of nervous system, not elsewhere classified) <br>
Date G98 first reported (other disorders of nervous system, not elsewhere classified) <br>
Source of report of G98 (other disorders of nervous system, not elsewhere classified) <br>
Date G99 first reported (other disorders of nervous system in diseases classified elsewhere) <br>
Source of report of G99 (other disorders of nervous system in diseases classified elsewhere) <br>
Date H00 first reported (hordeolum and chalazion) <br>
Source of report of H00 (hordeolum and chalazion) <br>
Date H01 first reported (other inflammation of eyelid) <br>
Source of report of H01 (other inflammation of eyelid) <br>
Date H02 first reported (other disorders of eyelid) <br>
Source of report of H02 (other disorders of eyelid) <br>
Date H03 first reported (disorders of eyelid in diseases classified elsewhere) <br>
Source of report of H03 (disorders of eyelid in diseases classified elsewhere) <br>
Date H04 first reported (disorders of lachrymal system) <br>
Source of report of H04 (disorders of lachrymal system) <br>
Date H05 first reported (disorders of orbit) <br>
Source of report of H05 (disorders of orbit) <br>
Date H06 first reported (disorders of lachrymal system and orbit in diseases classified elsewhere) <br>
Source of report of H06 (disorders of lachrymal system and orbit in diseases classified elsewhere) <br>
Date H10 first reported (conjunctivitis) <br>
Source of report of H10 (conjunctivitis) <br>
Date H11 first reported (other disorders of conjunctiva) <br>
Source of report of H11 (other disorders of conjunctiva) <br>
Date H13 first reported (disorders of conjunctiva in diseases classified elsewhere) <br>
Source of report of H13 (disorders of conjunctiva in diseases classified elsewhere) <br>
Date H15 first reported (disorders of sclera) <br>
Source of report of H15 (disorders of sclera) <br>
Date H16 first reported (keratitis) <br>
Source of report of H16 (keratitis) <br>
Date H17 first reported (corneal scars and opacities) <br>
Source of report of H17 (corneal scars and opacities) <br>
Date H18 first reported (other disorders of cornea) <br>
Source of report of H18 (other disorders of cornea) <br>
Date H19 first reported (disorders of sclera and cornea in diseases classified elsewhere) <br>
Source of report of H19 (disorders of sclera and cornea in diseases classified elsewhere) <br>
Date H20 first reported (iridocyclitis) <br>
Source of report of H20 (iridocyclitis) <br>
Date H21 first reported (other disorders of iris and ciliary body) <br>
Source of report of H21 (other disorders of iris and ciliary body) <br>
Date H22 first reported (disorders of iris and ciliary body in diseases classified elsewhere) <br>
Source of report of H22 (disorders of iris and ciliary body in diseases classified elsewhere) <br>
Date H25 first reported (senile cataract) <br>
Source of report of H25 (senile cataract) <br>
Date H26 first reported (other cataract) <br>
Source of report of H26 (other cataract) <br>
Date H27 first reported (other disorders of lens) <br>
Source of report of H27 (other disorders of lens) <br>
Date H28 first reported (cataract and other disorders of lens in diseases classified elsewhere) <br>
Source of report of H28 (cataract and other disorders of lens in diseases classified elsewhere) <br>
Date H30 first reported (chorioretinal inflammation) <br>
Source of report of H30 (chorioretinal inflammation) <br>
Date H31 first reported (other disorders of choroid) <br>
Source of report of H31 (other disorders of choroid) <br>
Date H32 first reported (chorioretinal disorders in diseases classified elsewhere) <br>
Source of report of H32 (chorioretinal disorders in diseases classified elsewhere) <br>
Date H33 first reported (retinal detachments and breaks) <br>
Source of report of H33 (retinal detachments and breaks) <br>
Date H34 first reported (retinal vascular occlusions) <br>
Source of report of H34 (retinal vascular occlusions) <br>
Date H35 first reported (other retinal disorders) <br>
Source of report of H35 (other retinal disorders) <br>
Date H36 first reported (retinal disorders in diseases classified elsewhere) <br>
Source of report of H36 (retinal disorders in diseases classified elsewhere) <br>
Date H40 first reported (glaucoma) <br>
Source of report of H40 (glaucoma) <br>
Date H42 first reported (glaucoma in diseases classified elsewhere) <br>
Source of report of H42 (glaucoma in diseases classified elsewhere) <br>
Date H43 first reported (disorders of vitreous body) <br>
Source of report of H43 (disorders of vitreous body) <br>
Date H44 first reported (disorders of globe) <br>
Source of report of H44 (disorders of globe) <br>
Date H45 first reported (disorders of vitreous body and globe in diseases classified elsewhere) <br>
Source of report of H45 (disorders of vitreous body and globe in diseases classified elsewhere) <br>
Date H46 first reported (optic neuritis) <br>
Source of report of H46 (optic neuritis) <br>
Date H47 first reported (other disorders of optic [2nd] nerve and visual pathways) <br>
Source of report of H47 (other disorders of optic [2nd] nerve and visual pathways) <br>
Date H48 first reported (disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere) <br>
Source of report of H48 (disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere) <br>
Date H49 first reported (paralytic strabismus) <br>
Source of report of H49 (paralytic strabismus) <br>
Date H50 first reported (other strabismus) <br>
Source of report of H50 (other strabismus) <br>
Date H51 first reported (other disorders of binocular movement) <br>
Source of report of H51 (other disorders of binocular movement) <br>
Date H52 first reported (disorders of refraction and accommodation) <br>
Source of report of H52 (disorders of refraction and accommodation) <br>
Date H53 first reported (visual disturbances) <br>
Source of report of H53 (visual disturbances) <br>
Date H54 first reported (blindness and low vision) <br>
Source of report of H54 (blindness and low vision) <br>
Date H55 first reported (nystagmus and other irregular eye movements) <br>
Source of report of H55 (nystagmus and other irregular eye movements) <br>
Date H57 first reported (other disorders of eye and adnexa) <br>
Source of report of H57 (other disorders of eye and adnexa) <br>
Date H58 first reported (other disorders of eye and adnexa in diseases classified elsewhere) <br>
Source of report of H58 (other disorders of eye and adnexa in diseases classified elsewhere) <br>
Date H59 first reported (postprocedural disorders of eye and adnexa, not elsewhere classified) <br>
Source of report of H59 (postprocedural disorders of eye and adnexa, not elsewhere classified) <br>
Date H60 first reported (otitis externa) <br>
Source of report of H60 (otitis externa) <br>
Date H61 first reported (other disorders of external ear) <br>
Source of report of H61 (other disorders of external ear) <br>
Date H62 first reported (disorders of external ear in diseases classified elsewhere) <br>
Source of report of H62 (disorders of external ear in diseases classified elsewhere) <br>
Date H65 first reported (nonsuppurative otitis media) <br>
Source of report of H65 (nonsuppurative otitis media) <br>
Date H66 first reported (suppurative and unspecified otitis media) <br>
Source of report of H66 (suppurative and unspecified otitis media) <br>
Date H67 first reported (otitis media in diseases classified elsewhere) <br>
Source of report of H67 (otitis media in diseases classified elsewhere) <br>
Date H68 first reported (eustachian salpingitis and obstruction) <br>
Source of report of H68 (eustachian salpingitis and obstruction) <br>
Date H69 first reported (other disorders of eustachian tube) <br>
Source of report of H69 (other disorders of eustachian tube) <br>
Date H70 first reported (mastoiditis and related conditions) <br>
Source of report of H70 (mastoiditis and related conditions) <br>
Date H71 first reported (cholesteatoma of middle ear) <br>
Source of report of H71 (cholesteatoma of middle ear) <br>
Date H72 first reported (perforation of tympanic membrane) <br>
Source of report of H72 (perforation of tympanic membrane) <br>
Date H73 first reported (other disorders of tympanic membrane) <br>
Source of report of H73 (other disorders of tympanic membrane) <br>
Date H74 first reported (other disorders of middle ear and mastoid) <br>
Source of report of H74 (other disorders of middle ear and mastoid) <br>
Date H75 first reported (other disorders of middle ear and mastoid in diseases classified elsewhere) <br>
Source of report of H75 (other disorders of middle ear and mastoid in diseases classified elsewhere) <br>
Date H80 first reported (otosclerosis) <br>
Source of report of H80 (otosclerosis) <br>
Date H81 first reported (disorders of vestibular function) <br>
Source of report of H81 (disorders of vestibular function) <br>
Date H82 first reported (vertiginous syndromes in diseases classified elsewhere) <br>
Source of report of H82 (vertiginous syndromes in diseases classified elsewhere) <br>
Date H83 first reported (other diseases of inner ear) <br>
Source of report of H83 (other diseases of inner ear) <br>
Date H90 first reported (conductive and sensorineural hearing loss) <br>
Source of report of H90 (conductive and sensorineural hearing loss) <br>
Date H91 first reported (other hearing loss) <br>
Source of report of H91 (other hearing loss) <br>
Date H92 first reported (otalgia and effusion of ear) <br>
Source of report of H92 (otalgia and effusion of ear) <br>
Date H93 first reported (other disorders of ear, not elsewhere classified) <br>
Source of report of H93 (other disorders of ear, not elsewhere classified) <br>
Date H94 first reported (other disorders of ear in diseases classified elsewhere) <br>
Source of report of H94 (other disorders of ear in diseases classified elsewhere) <br>
Date H95 first reported (postprocedural disorders of ear and mastoid process, not elsewhere classified) <br>
Source of report of H95 (postprocedural disorders of ear and mastoid process, not elsewhere classified) <br>
Date I00 first reported (rheumatic fever without mention of heart involvement) <br>
Source of report of I00 (rheumatic fever without mention of heart involvement) <br>
Date I01 first reported (rheumatic fever with heart involvement) <br>
Source of report of I01 (rheumatic fever with heart involvement) <br>
Date I02 first reported (rheumatic chorea) <br>
Source of report of I02 (rheumatic chorea) <br>
Date I05 first reported (rheumatic mitral valve diseases) <br>
Source of report of I05 (rheumatic mitral valve diseases) <br>
Date I06 first reported (rheumatic aortic valve diseases) <br>
Source of report of I06 (rheumatic aortic valve diseases) <br>
Date I07 first reported (rheumatic tricuspid valve diseases) <br>
Source of report of I07 (rheumatic tricuspid valve diseases) <br>
Date I08 first reported (multiple valve diseases) <br>
Source of report of I08 (multiple valve diseases) <br>
Date I09 first reported (other rheumatic heart diseases) <br>
Source of report of I09 (other rheumatic heart diseases) <br>
Date I10 first reported (essential (primary) hypertension) <br>
Source of report of I10 (essential (primary) hypertension) <br>
Date I11 first reported (hypertensive heart disease) <br>
Source of report of I11 (hypertensive heart disease) <br>
Date I12 first reported (hypertensive renal disease) <br>
Source of report of I12 (hypertensive renal disease) <br>
Date I13 first reported (hypertensive heart and renal disease) <br>
Source of report of I13 (hypertensive heart and renal disease) <br>
Date I15 first reported (secondary hypertension) <br>
Source of report of I15 (secondary hypertension) <br>
Date I20 first reported (angina pectoris) <br>
Source of report of I20 (angina pectoris) <br>
Date I21 first reported (acute myocardial infarction) <br>
Source of report of I21 (acute myocardial infarction) <br>
Date I22 first reported (subsequent myocardial infarction) <br>
Source of report of I22 (subsequent myocardial infarction) <br>
Date I23 first reported (certain current complications following acute myocardial infarction) <br>
Source of report of I23 (certain current complications following acute myocardial infarction) <br>
Date I24 first reported (other acute ischaemic heart diseases) <br>
Source of report of I24 (other acute ischaemic heart diseases) <br>
Date I25 first reported (chronic ischaemic heart disease) <br>
Source of report of I25 (chronic ischaemic heart disease) <br>
Date I26 first reported (pulmonary embolism) <br>
Source of report of I26 (pulmonary embolism) <br>
Date I27 first reported (other pulmonary heart diseases) <br>
Source of report of I27 (other pulmonary heart diseases) <br>
Date I28 first reported (other diseases of pulmonary vessels) <br>
Source of report of I28 (other diseases of pulmonary vessels) <br>
Date I30 first reported (acute pericarditis) <br>
Source of report of I30 (acute pericarditis) <br>
Date I31 first reported (other diseases of pericardium) <br>
Source of report of I31 (other diseases of pericardium) <br>
Date I32 first reported (pericarditis in diseases classified elsewhere) <br>
Source of report of I32 (pericarditis in diseases classified elsewhere) <br>
Date I33 first reported (acute and subacute endocarditis) <br>
Source of report of I33 (acute and subacute endocarditis) <br>
Date I34 first reported (nonrheumatic mitral valve disorders) <br>
Source of report of I34 (nonrheumatic mitral valve disorders) <br>
Date I35 first reported (nonrheumatic aortic valve disorders) <br>
Source of report of I35 (nonrheumatic aortic valve disorders) <br>
Date I36 first reported (nonrheumatic tricuspid valve disorders) <br>
Source of report of I36 (nonrheumatic tricuspid valve disorders) <br>
Date I37 first reported (pulmonary valve disorders) <br>
Source of report of I37 (pulmonary valve disorders) <br>
Date I38 first reported (endocarditis, valve unspecified) <br>
Source of report of I38 (endocarditis, valve unspecified) <br>
Date I39 first reported (endocarditis and heart valve disorders in diseases classified elsewhere) <br>
Source of report of I39 (endocarditis and heart valve disorders in diseases classified elsewhere) <br>
Date I40 first reported (acute myocarditis) <br>
Source of report of I40 (acute myocarditis) <br>
Date I41 first reported (myocarditis in diseases classified elsewhere) <br>
Source of report of I41 (myocarditis in diseases classified elsewhere) <br>
Date I42 first reported (cardiomyopathy) <br>
Source of report of I42 (cardiomyopathy) <br>
Date I43 first reported (cardiomyopathy in diseases classified elsewhere) <br>
Source of report of I43 (cardiomyopathy in diseases classified elsewhere) <br>
Date I44 first reported (atrioventricular and left bundle-branch block) <br>
Source of report of I44 (atrioventricular and left bundle-branch block) <br>
Date I45 first reported (other conduction disorders) <br>
Source of report of I45 (other conduction disorders) <br>
Date I46 first reported (cardiac arrest) <br>
Source of report of I46 (cardiac arrest) <br>
Date I47 first reported (paroxysmal tachycardia) <br>
Source of report of I47 (paroxysmal tachycardia) <br>
Date I48 first reported (atrial fibrillation and flutter) <br>
Source of report of I48 (atrial fibrillation and flutter) <br>
Date I49 first reported (other cardiac arrhythmias) <br>
Source of report of I49 (other cardiac arrhythmias) <br>
Date I50 first reported (heart failure) <br>
Source of report of I50 (heart failure) <br>
Date I51 first reported (complications and ill-defined descriptions of heart disease) <br>
Source of report of I51 (complications and ill-defined descriptions of heart disease) <br>
Date I52 first reported (other heart disorders in diseases classified elsewhere) <br>
Source of report of I52 (other heart disorders in diseases classified elsewhere) <br>
Date I60 first reported (subarachnoid haemorrhage) <br>
Source of report of I60 (subarachnoid haemorrhage) <br>
Date I61 first reported (intracerebral haemorrhage) <br>
Source of report of I61 (intracerebral haemorrhage) <br>
Date I62 first reported (other nontraumatic intracranial haemorrhage) <br>
Source of report of I62 (other nontraumatic intracranial haemorrhage) <br>
Date I63 first reported (cerebral infarction) <br>
Source of report of I63 (cerebral infarction) <br>
Date I64 first reported (stroke, not specified as haemorrhage or infarction) <br>
Source of report of I64 (stroke, not specified as haemorrhage or infarction) <br>
Date I65 first reported (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction) <br>
Source of report of I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction) <br>
Date I66 first reported (occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction) <br>
Source of report of I66 (occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction) <br>
Date I67 first reported (other cerebrovascular diseases) <br>
Source of report of I67 (other cerebrovascular diseases) <br>
Date I68 first reported (cerebrovascular disorders in diseases classified elsewhere) <br>
Source of report of I68 (cerebrovascular disorders in diseases classified elsewhere) <br>
Date I69 first reported (sequelae of cerebrovascular disease) <br>
Source of report of I69 (sequelae of cerebrovascular disease) <br>
Date I70 first reported (atherosclerosis) <br>
Source of report of I70 (atherosclerosis) <br>
Date I71 first reported (aortic aneurysm and dissection) <br>
Source of report of I71 (aortic aneurysm and dissection) <br>
Date I72 first reported (other aneurysm) <br>
Source of report of I72 (other aneurysm) <br>
Date I73 first reported (other peripheral vascular diseases) <br>
Source of report of I73 (other peripheral vascular diseases) <br>
Date I74 first reported (arterial embolism and thrombosis) <br>
Source of report of I74 (arterial embolism and thrombosis) <br>
Date I77 first reported (other disorders of arteries and arterioles) <br>
Source of report of I77 (other disorders of arteries and arterioles) <br>
Date I78 first reported (diseases of capillaries) <br>
Source of report of I78 (diseases of capillaries) <br>
Date I79 first reported (disorders of arteries, arterioles and capillaries in diseases classified elsewhere) <br>
Source of report of I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere) <br>
Date I80 first reported (phlebitis and thrombophlebitis) <br>
Source of report of I80 (phlebitis and thrombophlebitis) <br>
Date I81 first reported (portal vein thrombosis) <br>
Source of report of I81 (portal vein thrombosis) <br>
Date I82 first reported (other venous embolism and thrombosis) <br>
Source of report of I82 (other venous embolism and thrombosis) <br>
Date I83 first reported (varicose veins of lower extremities) <br>
Source of report of I83 (varicose veins of lower extremities) <br>
Date I84 first reported (haemorrhoids) <br>
Source of report of I84 (haemorrhoids) <br>
Date I85 first reported (oesophageal varices) <br>
Source of report of I85 (oesophageal varices) <br>
Date I86 first reported (varicose veins of other sites) <br>
Source of report of I86 (varicose veins of other sites) <br>
Date I87 first reported (other disorders of veins) <br>
Source of report of I87 (other disorders of veins) <br>
Date I88 first reported (nonspecific lymphadenitis) <br>
Source of report of I88 (nonspecific lymphadenitis) <br>
Date I89 first reported (other non-infective disorders of lymphatic vessels and lymph nodes) <br>
Source of report of I89 (other non-infective disorders of lymphatic vessels and lymph nodes) <br>
Date I95 first reported (hypotension) <br>
Source of report of I95 (hypotension) <br>
Date I97 first reported (postprocedural disorders of circulatory system, not elsewhere classified) <br>
Source of report of I97 (postprocedural disorders of circulatory system, not elsewhere classified) <br>
Date I98 first reported (other disorders of circulatory system in diseases classified elsewhere) <br>
Source of report of I98 (other disorders of circulatory system in diseases classified elsewhere) <br>
Date I99 first reported (other and unspecified disorders of circulatory system) <br>
Source of report of I99 (other and unspecified disorders of circulatory system) <br>
Date J00 first reported (acute nasopharyngitis [common cold]) <br>
Source of report of J00 (acute nasopharyngitis [common cold]) <br>
Date J01 first reported (acute sinusitis) <br>
Source of report of J01 (acute sinusitis) <br>
Date J02 first reported (acute pharyngitis) <br>
Source of report of J02 (acute pharyngitis) <br>
Date J03 first reported (acute tonsillitis) <br>
Source of report of J03 (acute tonsillitis) <br>
Date J04 first reported (acute laryngitis and tracheitis) <br>
Source of report of J04 (acute laryngitis and tracheitis) <br>
Date J05 first reported (acute obstructive laryngitis [croup] and epiglottitis) <br>
Source of report of J05 (acute obstructive laryngitis [croup] and epiglottitis) <br>
Date J06 first reported (acute upper respiratory infections of multiple and unspecified sites) <br>
Source of report of J06 (acute upper respiratory infections of multiple and unspecified sites) <br>
Date J09 first reported (influenza due to certain identified influenza virus) <br>
Source of report of J09 (influenza due to certain identified influenza virus) <br>
Date J10 first reported (influenza due to identified influenza virus) <br>
Source of report of J10 (influenza due to identified influenza virus) <br>
Date J11 first reported (influenza, virus not identified) <br>
Source of report of J11 (influenza, virus not identified) <br>
Date J12 first reported (viral pneumonia, not elsewhere classified) <br>
Source of report of J12 (viral pneumonia, not elsewhere classified) <br>
Date J13 first reported (pneumonia due to streptococcus pneumoniae) <br>
Source of report of J13 (pneumonia due to streptococcus pneumoniae) <br>
Date J14 first reported (pneumonia due to haemophilus influenzae) <br>
Source of report of J14 (pneumonia due to haemophilus influenzae) <br>
Date J15 first reported (bacterial pneumonia, not elsewhere classified) <br>
Source of report of J15 (bacterial pneumonia, not elsewhere classified) <br>
Date J16 first reported (pneumonia due to other infectious organisms, not elsewhere classified) <br>
Source of report of J16 (pneumonia due to other infectious organisms, not elsewhere classified) <br>
Date J17 first reported (pneumonia in diseases classified elsewhere) <br>
Source of report of J17 (pneumonia in diseases classified elsewhere) <br>
Date J18 first reported (pneumonia, organism unspecified) <br>
Source of report of J18 (pneumonia, organism unspecified) <br>
Date J20 first reported (acute bronchitis) <br>
Source of report of J20 (acute bronchitis) <br>
Date J21 first reported (acute bronchiolitis) <br>
Source of report of J21 (acute bronchiolitis) <br>
Date J22 first reported (unspecified acute lower respiratory infection) <br>
Source of report of J22 (unspecified acute lower respiratory infection) <br>
Date J30 first reported (vasomotor and allergic rhinitis) <br>
Source of report of J30 (vasomotor and allergic rhinitis) <br>
Date J31 first reported (chronic rhinitis, nasopharyngitis and pharyngitis) <br>
Source of report of J31 (chronic rhinitis, nasopharyngitis and pharyngitis) <br>
Date J32 first reported (chronic sinusitis) <br>
Source of report of J32 (chronic sinusitis) <br>
Date J33 first reported (nasal polyp) <br>
Source of report of J33 (nasal polyp) <br>
Date J34 first reported (other disorders of nose and nasal sinuses) <br>
Source of report of J34 (other disorders of nose and nasal sinuses) <br>
Date J35 first reported (chronic diseases of tonsils and adenoids) <br>
Source of report of J35 (chronic diseases of tonsils and adenoids) <br>
Date J36 first reported (peritonsillar abscess) <br>
Source of report of J36 (peritonsillar abscess) <br>
Date J37 first reported (chronic laryngitis and laryngotracheitis) <br>
Source of report of J37 (chronic laryngitis and laryngotracheitis) <br>
Date J38 first reported (diseases of vocal cords and larynx, not elsewhere classified) <br>
Source of report of J38 (diseases of vocal cords and larynx, not elsewhere classified) <br>
Date J39 first reported (other diseases of upper respiratory tract) <br>
Source of report of J39 (other diseases of upper respiratory tract) <br>
Date J40 first reported (bronchitis, not specified as acute or chronic) <br>
Source of report of J40 (bronchitis, not specified as acute or chronic) <br>
Date J41 first reported (simple and mucopurulent chronic bronchitis) <br>
Source of report of J41 (simple and mucopurulent chronic bronchitis) <br>
Date J42 first reported (unspecified chronic bronchitis) <br>
Source of report of J42 (unspecified chronic bronchitis) <br>
Date J43 first reported (emphysema) <br>
Source of report of J43 (emphysema) <br>
Date J44 first reported (other chronic obstructive pulmonary disease) <br>
Source of report of J44 (other chronic obstructive pulmonary disease) <br>
Date J45 first reported (asthma) <br>
Source of report of J45 (asthma) <br>
Date J46 first reported (status asthmaticus) <br>
Source of report of J46 (status asthmaticus) <br>
Date J47 first reported (bronchiectasis) <br>
Source of report of J47 (bronchiectasis) <br>
Date J60 first reported (coalworker's pneumoconiosis) <br>
Source of report of J60 (coalworker's pneumoconiosis) <br>
Date J61 first reported (pneumoconiosis due to asbestos and other mineral fibres) <br>
Source of report of J61 (pneumoconiosis due to asbestos and other mineral fibres) <br>
Date J62 first reported (pneumoconiosis due to dust containing silica) <br>
Source of report of J62 (pneumoconiosis due to dust containing silica) <br>
Date J63 first reported (pneumoconiosis due to other inorganic dusts) <br>
Source of report of J63 (pneumoconiosis due to other inorganic dusts) <br>
Date J64 first reported (unspecified pneumoconiosis) <br>
Source of report of J64 (unspecified pneumoconiosis) <br>
Date J66 first reported (airway disease due to specific organic dust) <br>
Source of report of J66 (airway disease due to specific organic dust) <br>
Date J67 first reported (hypersensitivity pneumonitis due to organic dust) <br>
Source of report of J67 (hypersensitivity pneumonitis due to organic dust) <br>
Date J68 first reported (respiratory conditions due to inhalation of chemicals, gases, fumes and vapours) <br>
Source of report of J68 (respiratory conditions due to inhalation of chemicals, gases, fumes and vapours) <br>
Date J69 first reported (pneumonitis due to solids and liquids) <br>
Source of report of J69 (pneumonitis due to solids and liquids) <br>
Date J70 first reported (respiratory conditions due to other external agents) <br>
Source of report of J70 (respiratory conditions due to other external agents) <br>
Date J80 first reported (adult respiratory distress syndrome) <br>
Source of report of J80 (adult respiratory distress syndrome) <br>
Date J81 first reported (pulmonary oedema) <br>
Source of report of J81 (pulmonary oedema) <br>
Date J82 first reported (pulmonary eosinophilia, not elsewhere classified) <br>
Source of report of J82 (pulmonary eosinophilia, not elsewhere classified) <br>
Date J84 first reported (other interstitial pulmonary diseases) <br>
Source of report of J84 (other interstitial pulmonary diseases) <br>
Date J85 first reported (abscess of lung and mediastinum) <br>
Source of report of J85 (abscess of lung and mediastinum) <br>
Date J86 first reported (pyothorax) <br>
Source of report of J86 (pyothorax) <br>
Date J90 first reported (pleural effusion, not elsewhere classified) <br>
Source of report of J90 (pleural effusion, not elsewhere classified) <br>
Date J91 first reported (pleural effusion in conditions classified elsewhere) <br>
Source of report of J91 (pleural effusion in conditions classified elsewhere) <br>
Date J92 first reported (pleural plaque) <br>
Source of report of J92 (pleural plaque) <br>
Date J93 first reported (pneumothorax) <br>
Source of report of J93 (pneumothorax) <br>
Date J94 first reported (other pleural conditions) <br>
Source of report of J94 (other pleural conditions) <br>
Date J95 first reported (postprocedural respiratory disorders, not elsewhere classified) <br>
Source of report of J95 (postprocedural respiratory disorders, not elsewhere classified) <br>
Date J96 first reported (respiratory failure, not elsewhere classified) <br>
Source of report of J96 (respiratory failure, not elsewhere classified) <br>
Date J98 first reported (other respiratory disorders) <br>
Source of report of J98 (other respiratory disorders) <br>
Date J99 first reported (respiratory disorders in diseases classified elsewhere) <br>
Source of report of J99 (respiratory disorders in diseases classified elsewhere) <br>
Date K00 first reported (disorders of tooth development and eruption) <br>
Source of report of K00 (disorders of tooth development and eruption) <br>
Date K01 first reported (embedded and impacted teeth) <br>
Source of report of K01 (embedded and impacted teeth) <br>
Date K02 first reported (dental caries) <br>
Source of report of K02 (dental caries) <br>
Date K03 first reported (other diseases of hard tissues of teeth) <br>
Source of report of K03 (other diseases of hard tissues of teeth) <br>
Date K04 first reported (diseases of pulp and periapical tissues) <br>
Source of report of K04 (diseases of pulp and periapical tissues) <br>
Date K05 first reported (gingivitis and periodontal diseases) <br>
Source of report of K05 (gingivitis and periodontal diseases) <br>
Date K06 first reported (other disorders of gingiva and edentulous alveolar ridge) <br>
Source of report of K06 (other disorders of gingiva and edentulous alveolar ridge) <br>
Date K07 first reported (dentofacial anomalies [including malocclusion]) <br>
Source of report of K07 (dentofacial anomalies [including malocclusion]) <br>
Date K08 first reported (other disorders of teeth and supporting structures) <br>
Source of report of K08 (other disorders of teeth and supporting structures) <br>
Date K09 first reported (cysts of oral region, not elsewhere classified) <br>
Source of report of K09 (cysts of oral region, not elsewhere classified) <br>
Date K10 first reported (other diseases of jaws) <br>
Source of report of K10 (other diseases of jaws) <br>
Date K11 first reported (diseases of salivary glands) <br>
Source of report of K11 (diseases of salivary glands) <br>
Date K12 first reported (stomatitis and related lesions) <br>
Source of report of K12 (stomatitis and related lesions) <br>
Date K13 first reported (other diseases of lip and oral mucosa) <br>
Source of report of K13 (other diseases of lip and oral mucosa) <br>
Date K14 first reported (diseases of tongue) <br>
Source of report of K14 (diseases of tongue) <br>
Date K20 first reported (oesophagitis) <br>
Source of report of K20 (oesophagitis) <br>
Date K21 first reported (gastro-oesophageal reflux disease) <br>
Source of report of K21 (gastro-oesophageal reflux disease) <br>
Date K22 first reported (other diseases of oesophagus) <br>
Source of report of K22 (other diseases of oesophagus) <br>
Date K23 first reported (disorders of oesophagus in diseases classified elsewhere) <br>
Source of report of K23 (disorders of oesophagus in diseases classified elsewhere) <br>
Date K25 first reported (gastric ulcer) <br>
Source of report of K25 (gastric ulcer) <br>
Date K26 first reported (duodenal ulcer) <br>
Source of report of K26 (duodenal ulcer) <br>
Date K27 first reported (peptic ulcer, site unspecified) <br>
Source of report of K27 (peptic ulcer, site unspecified) <br>
Date K28 first reported (gastrojejunal ulcer) <br>
Source of report of K28 (gastrojejunal ulcer) <br>
Date K29 first reported (gastritis and duodenitis) <br>
Source of report of K29 (gastritis and duodenitis) <br>
Date K30 first reported (dyspepsia) <br>
Source of report of K30 (dyspepsia) <br>
Date K31 first reported (other diseases of stomach and duodenum) <br>
Source of report of K31 (other diseases of stomach and duodenum) <br>
Date K35 first reported (acute appendicitis) <br>
Source of report of K35 (acute appendicitis) <br>
Date K36 first reported (other appendicitis) <br>
Source of report of K36 (other appendicitis) <br>
Date K37 first reported (unspecified appendicitis) <br>
Source of report of K37 (unspecified appendicitis) <br>
Date K38 first reported (other diseases of appendix) <br>
Source of report of K38 (other diseases of appendix) <br>
Date K40 first reported (inguinal hernia) <br>
Source of report of K40 (inguinal hernia) <br>
Date K41 first reported (femoral hernia) <br>
Source of report of K41 (femoral hernia) <br>
Date K42 first reported (umbilical hernia) <br>
Source of report of K42 (umbilical hernia) <br>
Date K43 first reported (ventral hernia) <br>
Source of report of K43 (ventral hernia) <br>
Date K44 first reported (diaphragmatic hernia) <br>
Source of report of K44 (diaphragmatic hernia) <br>
Date K45 first reported (other abdominal hernia) <br>
Source of report of K45 (other abdominal hernia) <br>
Date K46 first reported (unspecified abdominal hernia) <br>
Source of report of K46 (unspecified abdominal hernia) <br>
Date K50 first reported (crohn's disease [regional enteritis]) <br>
Source of report of K50 (crohn's disease [regional enteritis]) <br>
Date K51 first reported (ulcerative colitis) <br>
Source of report of K51 (ulcerative colitis) <br>
Date K52 first reported (other non-infective gastro-enteritis and colitis) <br>
Source of report of K52 (other non-infective gastro-enteritis and colitis) <br>
Date K55 first reported (vascular disorders of intestine) <br>
Source of report of K55 (vascular disorders of intestine) <br>
Date K56 first reported (paralytic ileus and intestinal obstruction without hernia) <br>
Source of report of K56 (paralytic ileus and intestinal obstruction without hernia) <br>
Date K57 first reported (diverticular disease of intestine) <br>
Source of report of K57 (diverticular disease of intestine) <br>
Date K58 first reported (irritable bowel syndrome) <br>
Source of report of K58 (irritable bowel syndrome) <br>
Date K59 first reported (other functional intestinal disorders) <br>
Source of report of K59 (other functional intestinal disorders) <br>
Date K60 first reported (fissure and fistula of anal and rectal regions) <br>
Source of report of K60 (fissure and fistula of anal and rectal regions) <br>
Date K61 first reported (abscess of anal and rectal regions) <br>
Source of report of K61 (abscess of anal and rectal regions) <br>
Date K62 first reported (other diseases of anus and rectum) <br>
Source of report of K62 (other diseases of anus and rectum) <br>
Date K63 first reported (other diseases of intestine) <br>
Source of report of K63 (other diseases of intestine) <br>
Date K64 first reported (haemorrhoids and perianal venous thrombosis) <br>
Source of report of K64 (haemorrhoids and perianal venous thrombosis) <br>
Date K65 first reported (peritonitis) <br>
Source of report of K65 (peritonitis) <br>
Date K66 first reported (other disorders of peritoneum) <br>
Source of report of K66 (other disorders of peritoneum) <br>
Date K67 first reported (disorders of peritoneum in infectious diseases classified elsewhere) <br>
Source of report of K67 (disorders of peritoneum in infectious diseases classified elsewhere) <br>
Date K70 first reported (alcoholic liver disease) <br>
Source of report of K70 (alcoholic liver disease) <br>
Date K71 first reported (toxic liver disease) <br>
Source of report of K71 (toxic liver disease) <br>
Date K72 first reported (hepatic failure, not elsewhere classified) <br>
Source of report of K72 (hepatic failure, not elsewhere classified) <br>
Date K73 first reported (chronic hepatitis, not elsewhere classified) <br>
Source of report of K73 (chronic hepatitis, not elsewhere classified) <br>
Date K74 first reported (fibrosis and cirrhosis of liver) <br>
Source of report of K74 (fibrosis and cirrhosis of liver) <br>
Date K75 first reported (other inflammatory liver diseases) <br>
Source of report of K75 (other inflammatory liver diseases) <br>
Date K76 first reported (other diseases of liver) <br>
Source of report of K76 (other diseases of liver) <br>
Date K77 first reported (liver disorders in diseases classified elsewhere) <br>
Source of report of K77 (liver disorders in diseases classified elsewhere) <br>
Date K80 first reported (cholelithiasis) <br>
Source of report of K80 (cholelithiasis) <br>
Date K81 first reported (cholecystitis) <br>
Source of report of K81 (cholecystitis) <br>
Date K82 first reported (other diseases of gallbladder) <br>
Source of report of K82 (other diseases of gallbladder) <br>
Date K83 first reported (other diseases of biliary tract) <br>
Source of report of K83 (other diseases of biliary tract) <br>
Date K85 first reported (acute pancreatitis) <br>
Source of report of K85 (acute pancreatitis) <br>
Date K86 first reported (other diseases of pancreas) <br>
Source of report of K86 (other diseases of pancreas) <br>
Date K87 first reported (disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere) <br>
Source of report of K87 (disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere) <br>
Date K90 first reported (intestinal malabsorption) <br>
Source of report of K90 (intestinal malabsorption) <br>
Date K91 first reported (postprocedural disorders of digestive system, not elsewhere classified) <br>
Source of report of K91 (postprocedural disorders of digestive system, not elsewhere classified) <br>
Date K92 first reported (other diseases of digestive system) <br>
Source of report of K92 (other diseases of digestive system) <br>
Date K93 first reported (disorders of other digestive organs in diseases classified elsewhere) <br>
Source of report of K93 (disorders of other digestive organs in diseases classified elsewhere) <br>
Date L00 first reported (staphylococcal scalded skin syndrome) <br>
Source of report of L00 (staphylococcal scalded skin syndrome) <br>
Date L01 first reported (impetigo) <br>
Source of report of L01 (impetigo) <br>
Date L02 first reported (cutaneous abscess, furuncle and carbuncle) <br>
Source of report of L02 (cutaneous abscess, furuncle and carbuncle) <br>
Date L03 first reported (cellulitis) <br>
Source of report of L03 (cellulitis) <br>
Date L04 first reported (acute lymphadenitis) <br>
Source of report of L04 (acute lymphadenitis) <br>
Date L05 first reported (pilonidal cyst) <br>
Source of report of L05 (pilonidal cyst) <br>
Date L08 first reported (other local infections of skin and subcutaneous tissue) <br>
Source of report of L08 (other local infections of skin and subcutaneous tissue) <br>
Date L10 first reported (pemphigus) <br>
Source of report of L10 (pemphigus) <br>
Date L11 first reported (other acantholytic disorders) <br>
Source of report of L11 (other acantholytic disorders) <br>
Date L12 first reported (pemphigoid) <br>
Source of report of L12 (pemphigoid) <br>
Date L13 first reported (other bullous disorders) <br>
Source of report of L13 (other bullous disorders) <br>
Date L14 first reported (bullous disorders in diseases classified elsewhere) <br>
Source of report of L14 (bullous disorders in diseases classified elsewhere) <br>
Date L20 first reported (atopic dermatitis) <br>
Source of report of L20 (atopic dermatitis) <br>
Date L21 first reported (seborrhoeic dermatitis) <br>
Source of report of L21 (seborrhoeic dermatitis) <br>
Date L22 first reported (diaper [napkin] dermatitis) <br>
Source of report of L22 (diaper [napkin] dermatitis) <br>
Date L23 first reported (allergic contact dermatitis) <br>
Source of report of L23 (allergic contact dermatitis) <br>
Date L24 first reported (irritant contact dermatitis) <br>
Source of report of L24 (irritant contact dermatitis) <br>
Date L25 first reported (unspecified contact dermatitis) <br>
Source of report of L25 (unspecified contact dermatitis) <br>
Date L26 first reported (exfoliative dermatitis) <br>
Source of report of L26 (exfoliative dermatitis) <br>
Date L27 first reported (dermatitis due to substances taken internally) <br>
Source of report of L27 (dermatitis due to substances taken internally) <br>
Date L28 first reported (lichen simplex chronicus and prurigo) <br>
Source of report of L28 (lichen simplex chronicus and prurigo) <br>
Date L29 first reported (pruritus) <br>
Source of report of L29 (pruritus) <br>
Date L30 first reported (other dermatitis) <br>
Source of report of L30 (other dermatitis) <br>
Date L40 first reported (psoriasis) <br>
Source of report of L40 (psoriasis) <br>
Date L41 first reported (parapsoriasis) <br>
Source of report of L41 (parapsoriasis) <br>
Date L42 first reported (pityriasis rosea) <br>
Source of report of L42 (pityriasis rosea) <br>
Date L43 first reported (lichen planus) <br>
Source of report of L43 (lichen planus) <br>
Date L44 first reported (other papulosquamous disorders) <br>
Source of report of L44 (other papulosquamous disorders) <br>
Date L50 first reported (urticaria) <br>
Source of report of L50 (urticaria) <br>
Date L51 first reported (erythema multiforme) <br>
Source of report of L51 (erythema multiforme) <br>
Date L52 first reported (erythema nodosum) <br>
Source of report of L52 (erythema nodosum) <br>
Date L53 first reported (other erythematous conditions) <br>
Source of report of L53 (other erythematous conditions) <br>
Date L54 first reported (erythema in diseases classified elsewhere) <br>
Source of report of L54 (erythema in diseases classified elsewhere) <br>
Date L55 first reported (sunburn) <br>
Source of report of L55 (sunburn) <br>
Date L56 first reported (other acute skin changes due to ultraviolet radiation) <br>
Source of report of L56 (other acute skin changes due to ultraviolet radiation) <br>
Date L57 first reported (skin changes due to chronic exposure to nonionising radiation) <br>
Source of report of L57 (skin changes due to chronic exposure to nonionising radiation) <br>
Date L58 first reported (radiodermatitis) <br>
Source of report of L58 (radiodermatitis) <br>
Date L59 first reported (other disorders of skin and subcutaneous tissue related to radiation) <br>
Source of report of L59 (other disorders of skin and subcutaneous tissue related to radiation) <br>
Date L60 first reported (nail disorders) <br>
Source of report of L60 (nail disorders) <br>
Date L62 first reported (nail disorders in diseases classified elsewhere) <br>
Source of report of L62 (nail disorders in diseases classified elsewhere) <br>
Date L63 first reported (alopecia areata) <br>
Source of report of L63 (alopecia areata) <br>
Date L64 first reported (androgenic alopecia) <br>
Source of report of L64 (androgenic alopecia) <br>
Date L65 first reported (other nonscarring hair loss) <br>
Source of report of L65 (other nonscarring hair loss) <br>
Date L66 first reported (cicatricial alopecia [scarring hair loss]) <br>
Source of report of L66 (cicatricial alopecia [scarring hair loss]) <br>
Date L67 first reported (hair colour and hair shaft abnormalities) <br>
Source of report of L67 (hair colour and hair shaft abnormalities) <br>
Date L68 first reported (hypertrichosis) <br>
Source of report of L68 (hypertrichosis) <br>
Date L70 first reported (acne) <br>
Source of report of L70 (acne) <br>
Date L71 first reported (rosacea) <br>
Source of report of L71 (rosacea) <br>
Date L72 first reported (follicular cysts of skin and subcutaneous tissue) <br>
Source of report of L72 (follicular cysts of skin and subcutaneous tissue) <br>
Date L73 first reported (other follicular disorders) <br>
Source of report of L73 (other follicular disorders) <br>
Date L74 first reported (eccrine sweat disorders) <br>
Source of report of L74 (eccrine sweat disorders) <br>
Date L75 first reported (apocrine sweat disorders) <br>
Source of report of L75 (apocrine sweat disorders) <br>
Date L80 first reported (vitiligo) <br>
Source of report of L80 (vitiligo) <br>
Date L81 first reported (other disorders of pigmentation) <br>
Source of report of L81 (other disorders of pigmentation) <br>
Date L82 first reported (seborrhoeic keratosis) <br>
Source of report of L82 (seborrhoeic keratosis) <br>
Date L83 first reported (acanthosis nigricans) <br>
Source of report of L83 (acanthosis nigricans) <br>
Date L84 first reported (corns and callosities) <br>
Source of report of L84 (corns and callosities) <br>
Date L85 first reported (other epidermal thickening) <br>
Source of report of L85 (other epidermal thickening) <br>
Date L86 first reported (keratoderma in diseases classified elsewhere) <br>
Source of report of L86 (keratoderma in diseases classified elsewhere) <br>
Date L87 first reported (transepidermal elimination disorders) <br>
Source of report of L87 (transepidermal elimination disorders) <br>
Date L88 first reported (pyoderma gangrenosum) <br>
Source of report of L88 (pyoderma gangrenosum) <br>
Date L89 first reported (decubitus ulcer) <br>
Source of report of L89 (decubitus ulcer) <br>
Date L90 first reported (atrophic disorders of skin) <br>
Source of report of L90 (atrophic disorders of skin) <br>
Date L91 first reported (hypertrophic disorders of skin) <br>
Source of report of L91 (hypertrophic disorders of skin) <br>
Date L92 first reported (granulomatous disorders of skin and subcutaneous tissue) <br>
Source of report of L92 (granulomatous disorders of skin and subcutaneous tissue) <br>
Date L93 first reported (lupus erythematosus) <br>
Source of report of L93 (lupus erythematosus) <br>
Date L94 first reported (other localised connective tissue disorders) <br>
Source of report of L94 (other localised connective tissue disorders) <br>
Date L95 first reported (vasculitis limited to skin, not elsewhere classified) <br>
Source of report of L95 (vasculitis limited to skin, not elsewhere classified) <br>
Date L97 first reported (ulcer of lower limb, not elsewhere classified) <br>
Source of report of L97 (ulcer of lower limb, not elsewhere classified) <br>
Date L98 first reported (other disorders of skin and subcutaneous tissue, not elsewhere classified) <br>
Source of report of L98 (other disorders of skin and subcutaneous tissue, not elsewhere classified) <br>
Date L99 first reported (other disorders of skin and subcutaneous tissue in diseases classified elsewhere) <br>
Source of report of L99 (other disorders of skin and subcutaneous tissue in diseases classified elsewhere) <br>
Date M00 first reported (pyogenic arthritis) <br>
Source of report of M00 (pyogenic arthritis) <br>
Date M01 first reported (direct infections of joint in infectious and parasitic diseases classified elsewhere) <br>
Source of report of M01 (direct infections of joint in infectious and parasitic diseases classified elsewhere) <br>
Date M02 first reported (reactive arthropathies) <br>
Source of report of M02 (reactive arthropathies) <br>
Date M03 first reported (postinfective and reactive arthropathies in diseases classified elsewhere) <br>
Source of report of M03 (postinfective and reactive arthropathies in diseases classified elsewhere) <br>
Date M05 first reported (seropositive rheumatoid arthritis) <br>
Source of report of M05 (seropositive rheumatoid arthritis) <br>
Date M06 first reported (other rheumatoid arthritis) <br>
Source of report of M06 (other rheumatoid arthritis) <br>
Date M07 first reported (psoriatic and enteropathic arthropathies) <br>
Source of report of M07 (psoriatic and enteropathic arthropathies) <br>
Date M08 first reported (juvenile arthritis) <br>
Source of report of M08 (juvenile arthritis) <br>
Date M09 first reported (juvenile arthritis in diseases classified elsewhere) <br>
Source of report of M09 (juvenile arthritis in diseases classified elsewhere) <br>
Date M10 first reported (gout) <br>
Source of report of M10 (gout) <br>
Date M11 first reported (other crystal arthropathies) <br>
Source of report of M11 (other crystal arthropathies) <br>
Date M12 first reported (other specific arthropathies) <br>
Source of report of M12 (other specific arthropathies) <br>
Date M13 first reported (other arthritis) <br>
Source of report of M13 (other arthritis) <br>
Date M14 first reported (arthropathies in other diseases classified elsewhere) <br>
Source of report of M14 (arthropathies in other diseases classified elsewhere) <br>
Date M15 first reported (polyarthrosis) <br>
Source of report of M15 (polyarthrosis) <br>
Date M16 first reported (coxarthrosis [arthrosis of hip]) <br>
Source of report of M16 (coxarthrosis [arthrosis of hip]) <br>
Date M17 first reported (gonarthrosis [arthrosis of knee]) <br>
Source of report of M17 (gonarthrosis [arthrosis of knee]) <br>
Date M18 first reported (arthrosis of first carpometacarpal joint) <br>
Source of report of M18 (arthrosis of first carpometacarpal joint) <br>
Date M19 first reported (other arthrosis) <br>
Source of report of M19 (other arthrosis) <br>
Date M20 first reported (acquired deformities of fingers and toes) <br>
Source of report of M20 (acquired deformities of fingers and toes) <br>
Date M21 first reported (other acquired deformities of limbs) <br>
Source of report of M21 (other acquired deformities of limbs) <br>
Date M22 first reported (disorders of patella) <br>
Source of report of M22 (disorders of patella) <br>
Date M23 first reported (internal derangement of knee) <br>
Source of report of M23 (internal derangement of knee) <br>
Date M24 first reported (other specific joint derangements) <br>
Source of report of M24 (other specific joint derangements) <br>
Date M25 first reported (other joint disorders, not elsewhere classified) <br>
Source of report of M25 (other joint disorders, not elsewhere classified) <br>
Date M30 first reported (polyarteritis nodosa and related conditions) <br>
Source of report of M30 (polyarteritis nodosa and related conditions) <br>
Date M31 first reported (other necrotising vasculopathies) <br>
Source of report of M31 (other necrotising vasculopathies) <br>
Date M32 first reported (systemic lupus erythematosus) <br>
Source of report of M32 (systemic lupus erythematosus) <br>
Date M33 first reported (dermatopolymyositis) <br>
Source of report of M33 (dermatopolymyositis) <br>
Date M34 first reported (systemic sclerosis) <br>
Source of report of M34 (systemic sclerosis) <br>
Date M35 first reported (other systemic involvement of connective tissue) <br>
Source of report of M35 (other systemic involvement of connective tissue) <br>
Date M36 first reported (systemic disorders of connective tissue in diseases classified elsewhere) <br>
Source of report of M36 (systemic disorders of connective tissue in diseases classified elsewhere) <br>
Date M40 first reported (kyphosis and lordosis) <br>
Source of report of M40 (kyphosis and lordosis) <br>
Date M41 first reported (scoliosis) <br>
Source of report of M41 (scoliosis) <br>
Date M42 first reported (spinal osteochondrosis) <br>
Source of report of M42 (spinal osteochondrosis) <br>
Date M43 first reported (other deforming dorsopathies) <br>
Source of report of M43 (other deforming dorsopathies) <br>
Date M45 first reported (ankylosing spondylitis) <br>
Source of report of M45 (ankylosing spondylitis) <br>
Date M46 first reported (other inflammatory spondylopathies) <br>
Source of report of M46 (other inflammatory spondylopathies) <br>
Date M47 first reported (spondylosis) <br>
Source of report of M47 (spondylosis) <br>
Date M48 first reported (other spondylopathies) <br>
Source of report of M48 (other spondylopathies) <br>
Date M49 first reported (spondylopathies in diseases classified elsewhere) <br>
Source of report of M49 (spondylopathies in diseases classified elsewhere) <br>
Date M50 first reported (cervical disk disorders) <br>
Source of report of M50 (cervical disk disorders) <br>
Date M51 first reported (other intervertebral disk disorders) <br>
Source of report of M51 (other intervertebral disk disorders) <br>
Date M53 first reported (other dorsopathies, not elsewhere classified) <br>
Source of report of M53 (other dorsopathies, not elsewhere classified) <br>
Date M54 first reported (dorsalgia) <br>
Source of report of M54 (dorsalgia) <br>
Date M60 first reported (myositis) <br>
Source of report of M60 (myositis) <br>
Date M61 first reported (calcification and ossification of muscle) <br>
Source of report of M61 (calcification and ossification of muscle) <br>
Date M62 first reported (other disorders of muscle) <br>
Source of report of M62 (other disorders of muscle) <br>
Date M63 first reported (disorders of muscle in diseases classified elsewhere) <br>
Source of report of M63 (disorders of muscle in diseases classified elsewhere) <br>
Date M65 first reported (synovitis and tenosynovitis) <br>
Source of report of M65 (synovitis and tenosynovitis) <br>
Date M66 first reported (spontaneous rupture of synovium and tendon) <br>
Source of report of M66 (spontaneous rupture of synovium and tendon) <br>
Date M67 first reported (other disorders of synovium and tendon) <br>
Source of report of M67 (other disorders of synovium and tendon) <br>
Date M68 first reported (disorders of synovium and tendon in diseases classified elsewhere) <br>
Source of report of M68 (disorders of synovium and tendon in diseases classified elsewhere) <br>
Date M70 first reported (soft tissue disorders related to use, overuse and pressure) <br>
Source of report of M70 (soft tissue disorders related to use, overuse and pressure) <br>
Date M71 first reported (other bursopathies) <br>
Source of report of M71 (other bursopathies) <br>
Date M72 first reported (fibroblastic disorders) <br>
Source of report of M72 (fibroblastic disorders) <br>
Date M73 first reported (soft tissue disorders in diseases classified elsewhere) <br>
Source of report of M73 (soft tissue disorders in diseases classified elsewhere) <br>
Date M75 first reported (shoulder lesions) <br>
Source of report of M75 (shoulder lesions) <br>
Date M76 first reported (enthesopathies of lower limb, excluding foot) <br>
Source of report of M76 (enthesopathies of lower limb, excluding foot) <br>
Date M77 first reported (other enthesopathies) <br>
Source of report of M77 (other enthesopathies) <br>
Date M79 first reported (other soft tissue disorders, not elsewhere classified) <br>
Source of report of M79 (other soft tissue disorders, not elsewhere classified) <br>
Date M80 first reported (osteoporosis with pathological fracture) <br>
Source of report of M80 (osteoporosis with pathological fracture) <br>
Date M81 first reported (osteoporosis without pathological fracture) <br>
Source of report of M81 (osteoporosis without pathological fracture) <br>
Date M82 first reported (osteoporosis in diseases classified elsewhere) <br>
Source of report of M82 (osteoporosis in diseases classified elsewhere) <br>
Date M83 first reported (adult osteomalacia) <br>
Source of report of M83 (adult osteomalacia) <br>
Date M84 first reported (disorders of continuity of bone) <br>
Source of report of M84 (disorders of continuity of bone) <br>
Date M85 first reported (other disorders of bone density and structure) <br>
Source of report of M85 (other disorders of bone density and structure) <br>
Date M86 first reported (osteomyelitis) <br>
Source of report of M86 (osteomyelitis) <br>
Date M87 first reported (osteonecrosis) <br>
Source of report of M87 (osteonecrosis) <br>
Date M88 first reported (paget's disease of bone [osteitis deformans]) <br>
Source of report of M88 (paget's disease of bone [osteitis deformans]) <br>
Date M89 first reported (other disorders of bone) <br>
Source of report of M89 (other disorders of bone) <br>
Date M90 first reported (osteopathies in diseases classified elsewhere) <br>
Source of report of M90 (osteopathies in diseases classified elsewhere) <br>
Date M91 first reported (juvenile osteochondrosis of hip and pelvis) <br>
Source of report of M91 (juvenile osteochondrosis of hip and pelvis) <br>
Date M92 first reported (other juvenile osteochondrosis) <br>
Source of report of M92 (other juvenile osteochondrosis) <br>
Date M93 first reported (other osteochondropathies) <br>
Source of report of M93 (other osteochondropathies) <br>
Date M94 first reported (other disorders of cartilage) <br>
Source of report of M94 (other disorders of cartilage) <br>
Date M95 first reported (other acquired deformities of musculoskeletal system and connective tissue) <br>
Source of report of M95 (other acquired deformities of musculoskeletal system and connective tissue) <br>
Date M96 first reported (postprocedural musculoskeletal disorders, not elsewhere classified) <br>
Source of report of M96 (postprocedural musculoskeletal disorders, not elsewhere classified) <br>
Date M99 first reported (biomechanical lesions, not elsewhere classified) <br>
Source of report of M99 (biomechanical lesions, not elsewhere classified) <br>
Date N00 first reported (acute nephritic syndrome) <br>
Source of report of N00 (acute nephritic syndrome) <br>
Date N01 first reported (rapidly progressive nephritic syndrome) <br>
Source of report of N01 (rapidly progressive nephritic syndrome) <br>
Date N02 first reported (recurrent and persistent haematuria) <br>
Source of report of N02 (recurrent and persistent haematuria) <br>
Date N03 first reported (chronic nephritic syndrome) <br>
Source of report of N03 (chronic nephritic syndrome) <br>
Date N04 first reported (nephrotic syndrome) <br>
Source of report of N04 (nephrotic syndrome) <br>
Date N05 first reported (unspecified nephritic syndrome) <br>
Source of report of N05 (unspecified nephritic syndrome) <br>
Date N06 first reported (isolated proteinuria with specified morphological lesion) <br>
Source of report of N06 (isolated proteinuria with specified morphological lesion) <br>
Date N07 first reported (hereditary nephropathy, not elsewhere classified) <br>
Source of report of N07 (hereditary nephropathy, not elsewhere classified) <br>
Date N08 first reported (glomerular disorders in diseases classified elsewhere) <br>
Source of report of N08 (glomerular disorders in diseases classified elsewhere) <br>
Date N10 first reported (acute tubulo-interstitial nephritis) <br>
Source of report of N10 (acute tubulo-interstitial nephritis) <br>
Date N11 first reported (chronic tubulo-interstitial nephritis) <br>
Source of report of N11 (chronic tubulo-interstitial nephritis) <br>
Date N12 first reported (tubulo-interstitial nephritis, not specified as acute or chronic) <br>
Source of report of N12 (tubulo-interstitial nephritis, not specified as acute or chronic) <br>
Date N13 first reported (obstructive and reflux uropathy) <br>
Source of report of N13 (obstructive and reflux uropathy) <br>
Date N14 first reported (drug- and heavy-metal-induced tubulo-interstitial and tubular conditions) <br>
Source of report of N14 (drug- and heavy-metal-induced tubulo-interstitial and tubular conditions) <br>
Date N15 first reported (other renal tubulo-interstitial diseases) <br>
Source of report of N15 (other renal tubulo-interstitial diseases) <br>
Date N16 first reported (renal tubulo-interstitial disorders in diseases classified elsewhere) <br>
Source of report of N16 (renal tubulo-interstitial disorders in diseases classified elsewhere) <br>
Date N17 first reported (acute renal failure) <br>
Source of report of N17 (acute renal failure) <br>
Date N18 first reported (chronic renal failure) <br>
Source of report of N18 (chronic renal failure) <br>
Date N19 first reported (unspecified renal failure) <br>
Source of report of N19 (unspecified renal failure) <br>
Date N20 first reported (calculus of kidney and ureter) <br>
Source of report of N20 (calculus of kidney and ureter) <br>
Date N21 first reported (calculus of lower urinary tract) <br>
Source of report of N21 (calculus of lower urinary tract) <br>
Date N22 first reported (calculus of urinary tract in diseases classified elsewhere) <br>
Source of report of N22 (calculus of urinary tract in diseases classified elsewhere) <br>
Date N23 first reported (unspecified renal colic) <br>
Source of report of N23 (unspecified renal colic) <br>
Date N25 first reported (disorders resulting from impaired renal tubular function) <br>
Source of report of N25 (disorders resulting from impaired renal tubular function) <br>
Date N26 first reported (unspecified contracted kidney) <br>
Source of report of N26 (unspecified contracted kidney) <br>
Date N27 first reported (small kidney of unknown cause) <br>
Source of report of N27 (small kidney of unknown cause) <br>
Date N28 first reported (other disorders of kidney and ureter, not elsewhere classified) <br>
Source of report of N28 (other disorders of kidney and ureter, not elsewhere classified) <br>
Date N29 first reported (other disorders of kidney and ureter in diseases classified elsewhere) <br>
Source of report of N29 (other disorders of kidney and ureter in diseases classified elsewhere) <br>
Date N30 first reported (cystitis) <br>
Source of report of N30 (cystitis) <br>
Date N31 first reported (neuromuscular dysfunction of bladder, not elsewhere classified) <br>
Source of report of N31 (neuromuscular dysfunction of bladder, not elsewhere classified) <br>
Date N32 first reported (other disorders of bladder) <br>
Source of report of N32 (other disorders of bladder) <br>
Date N33 first reported (bladder disorders in diseases classified elsewhere) <br>
Source of report of N33 (bladder disorders in diseases classified elsewhere) <br>
Date N34 first reported (urethritis and urethral syndrome) <br>
Source of report of N34 (urethritis and urethral syndrome) <br>
Date N35 first reported (urethral stricture) <br>
Source of report of N35 (urethral stricture) <br>
Date N36 first reported (other disorders of urethra) <br>
Source of report of N36 (other disorders of urethra) <br>
Date N37 first reported (urethral disorders in diseases classified elsewhere) <br>
Source of report of N37 (urethral disorders in diseases classified elsewhere) <br>
Date N39 first reported (other disorders of urinary system) <br>
Source of report of N39 (other disorders of urinary system) <br>
Date N40 first reported (hyperplasia of prostate) <br>
Source of report of N40 (hyperplasia of prostate) <br>
Date N41 first reported (inflammatory diseases of prostate) <br>
Source of report of N41 (inflammatory diseases of prostate) <br>
Date N42 first reported (other disorders of prostate) <br>
Source of report of N42 (other disorders of prostate) <br>
Date N43 first reported (hydrocele and spermatocele) <br>
Source of report of N43 (hydrocele and spermatocele) <br>
Date N44 first reported (torsion of testis) <br>
Source of report of N44 (torsion of testis) <br>
Date N45 first reported (orchitis and epididymitis) <br>
Source of report of N45 (orchitis and epididymitis) <br>
Date N46 first reported (male infertility) <br>
Source of report of N46 (male infertility) <br>
Date N47 first reported (redundant prepuce, phimosis and paraphimosis) <br>
Source of report of N47 (redundant prepuce, phimosis and paraphimosis) <br>
Date N48 first reported (other disorders of penis) <br>
Source of report of N48 (other disorders of penis) <br>
Date N49 first reported (inflammatory disorders of male genital organs, not elsewhere classified) <br>
Source of report of N49 (inflammatory disorders of male genital organs, not elsewhere classified) <br>
Date N50 first reported (other disorders of male genital organs) <br>
Source of report of N50 (other disorders of male genital organs) <br>
Date N51 first reported (disorders of male genital organs in diseases classified elsewhere) <br>
Source of report of N51 (disorders of male genital organs in diseases classified elsewhere) <br>
Date N60 first reported (benign mammary dysplasia) <br>
Source of report of N60 (benign mammary dysplasia) <br>
Date N61 first reported (inflammatory disorders of breast) <br>
Source of report of N61 (inflammatory disorders of breast) <br>
Date N62 first reported (hypertrophy of breast) <br>
Source of report of N62 (hypertrophy of breast) <br>
Date N63 first reported (unspecified lump in breast) <br>
Source of report of N63 (unspecified lump in breast) <br>
Date N64 first reported (other disorders of breast) <br>
Source of report of N64 (other disorders of breast) <br>
Date N70 first reported (salpingitis and oophoritis) <br>
Source of report of N70 (salpingitis and oophoritis) <br>
Date N71 first reported (inflammatory disease of uterus, except cervix) <br>
Source of report of N71 (inflammatory disease of uterus, except cervix) <br>
Date N72 first reported (inflammatory disease of cervix uteri) <br>
Source of report of N72 (inflammatory disease of cervix uteri) <br>
Date N73 first reported (other female pelvic inflammatory diseases) <br>
Source of report of N73 (other female pelvic inflammatory diseases) <br>
Date N74 first reported (female pelvic inflammatory disorders in diseases classified elsewhere) <br>
Source of report of N74 (female pelvic inflammatory disorders in diseases classified elsewhere) <br>
Date N75 first reported (diseases of bartholin's gland) <br>
Source of report of N75 (diseases of bartholin's gland) <br>
Date N76 first reported (other inflammation of vagina and vulva) <br>
Source of report of N76 (other inflammation of vagina and vulva) <br>
Date N77 first reported (vulvovaginal ulceration and inflammation in diseases classified elsewhere) <br>
Source of report of N77 (vulvovaginal ulceration and inflammation in diseases classified elsewhere) <br>
Date N80 first reported (endometriosis) <br>
Source of report of N80 (endometriosis) <br>
Date N81 first reported (female genital prolapse) <br>
Source of report of N81 (female genital prolapse) <br>
Date N82 first reported (fistulae involving female genital tract) <br>
Source of report of N82 (fistulae involving female genital tract) <br>
Date N83 first reported (noninflammatory disorders of ovary, fallopian tube and broad ligament) <br>
Source of report of N83 (noninflammatory disorders of ovary, fallopian tube and broad ligament) <br>
Date N84 first reported (polyp of female genital tract) <br>
Source of report of N84 (polyp of female genital tract) <br>
Date N85 first reported (other noninflammatory disorders of uterus, except cervix) <br>
Source of report of N85 (other noninflammatory disorders of uterus, except cervix) <br>
Date N86 first reported (erosion and ectropion of cervix uteri) <br>
Source of report of N86 (erosion and ectropion of cervix uteri) <br>
Date N87 first reported (dysplasia of cervix uteri) <br>
Source of report of N87 (dysplasia of cervix uteri) <br>
Date N88 first reported (other noninflammatory disorders of cervix uteri) <br>
Source of report of N88 (other noninflammatory disorders of cervix uteri) <br>
Date N89 first reported (other noninflammatory disorders of vagina) <br>
Source of report of N89 (other noninflammatory disorders of vagina) <br>
Date N90 first reported (other noninflammatory disorders of vulva and perineum) <br>
Source of report of N90 (other noninflammatory disorders of vulva and perineum) <br>
Date N91 first reported (absent, scanty and rare menstruation) <br>
Source of report of N91 (absent, scanty and rare menstruation) <br>
Date N92 first reported (excessive, frequent and irregular menstruation) <br>
Source of report of N92 (excessive, frequent and irregular menstruation) <br>
Date N93 first reported (other abnormal uterine and vaginal bleeding) <br>
Source of report of N93 (other abnormal uterine and vaginal bleeding) <br>
Date N94 first reported (pain and other conditions associated with female genital organs and menstrual cycle) <br>
Source of report of N94 (pain and other conditions associated with female genital organs and menstrual cycle) <br>
Date N95 first reported (menopausal and other perimenopausal disorders) <br>
Source of report of N95 (menopausal and other perimenopausal disorders) <br>
Date N96 first reported (habitual aborter) <br>
Source of report of N96 (habitual aborter) <br>
Date N97 first reported (female infertility) <br>
Source of report of N97 (female infertility) <br>
Date N98 first reported (complications associated with artificial fertilisation) <br>
Source of report of N98 (complications associated with artificial fertilisation) <br>
Date N99 first reported (postprocedural disorders of genito-urinary system, not elsewhere classified) <br>
Source of report of N99 (postprocedural disorders of genito-urinary system, not elsewhere classified) <br>
Date O00 first reported (ectopic pregnancy) <br>
Source of report of O00 (ectopic pregnancy) <br>
Date O01 first reported (hydatidiform mole) <br>
Source of report of O01 (hydatidiform mole) <br>
Date O02 first reported (other abnormal products of conception) <br>
Source of report of O02 (other abnormal products of conception) <br>
Date O03 first reported (spontaneous abortion) <br>
Source of report of O03 (spontaneous abortion) <br>
Date O04 first reported (medical abortion) <br>
Source of report of O04 (medical abortion) <br>
Date O05 first reported (other abortion) <br>
Source of report of O05 (other abortion) <br>
Date O06 first reported (unspecified abortion) <br>
Source of report of O06 (unspecified abortion) <br>
Date O07 first reported (failed attempted abortion) <br>
Source of report of O07 (failed attempted abortion) <br>
Date O08 first reported (complications following abortion and ectopic and molar pregnancy) <br>
Source of report of O08 (complications following abortion and ectopic and molar pregnancy) <br>
Date O10 first reported (pre-existing hypertension complicating pregnancy, childbirth and the puerperium) <br>
Source of report of O10 (pre-existing hypertension complicating pregnancy, childbirth and the puerperium) <br>
Date O11 first reported (pre-existing hypertensive disorder with superimposed proteinuria) <br>
Source of report of O11 (pre-existing hypertensive disorder with superimposed proteinuria) <br>
Date O12 first reported (gestational [pregnancy-induced] oedema and proteinuria without hypertension) <br>
Source of report of O12 (gestational [pregnancy-induced] oedema and proteinuria without hypertension) <br>
Date O13 first reported (gestational [pregnancy-induced] hypertension without significant proteinuria) <br>
Source of report of O13 (gestational [pregnancy-induced] hypertension without significant proteinuria) <br>
Date O14 first reported (gestational [pregnancy-induced] hypertension with significant proteinuria) <br>
Source of report of O14 (gestational [pregnancy-induced] hypertension with significant proteinuria) <br>
Date O15 first reported (eclampsia) <br>
Source of report of O15 (eclampsia) <br>
Date O16 first reported (unspecified maternal hypertension) <br>
Source of report of O16 (unspecified maternal hypertension) <br>
Date O20 first reported (haemorrhage in early pregnancy) <br>
Source of report of O20 (haemorrhage in early pregnancy) <br>
Date O21 first reported (excessive vomiting in pregnancy) <br>
Source of report of O21 (excessive vomiting in pregnancy) <br>
Date O22 first reported (venous complications in pregnancy) <br>
Source of report of O22 (venous complications in pregnancy) <br>
Date O23 first reported (infections of genito-urinary tract in pregnancy) <br>
Source of report of O23 (infections of genito-urinary tract in pregnancy) <br>
Date O24 first reported (diabetes mellitus in pregnancy) <br>
Source of report of O24 (diabetes mellitus in pregnancy) <br>
Date O25 first reported (malnutrition in pregnancy) <br>
Source of report of O25 (malnutrition in pregnancy) <br>
Date O26 first reported (maternal care for other conditions predominantly related to pregnancy) <br>
Source of report of O26 (maternal care for other conditions predominantly related to pregnancy) <br>
Date O28 first reported (abnormal findings on antenatal screening of mother) <br>
Source of report of O28 (abnormal findings on antenatal screening of mother) <br>
Date O29 first reported (complications of anaesthesia during pregnancy) <br>
Source of report of O29 (complications of anaesthesia during pregnancy) <br>
Date O30 first reported (multiple gestation) <br>
Source of report of O30 (multiple gestation) <br>
Date O31 first reported (complications specific to multiple gestation) <br>
Source of report of O31 (complications specific to multiple gestation) <br>
Date O32 first reported (maternal care for known or suspected malpresentation of foetus) <br>
Source of report of O32 (maternal care for known or suspected malpresentation of foetus) <br>
Date O33 first reported (maternal care for known or suspected disproportion) <br>
Source of report of O33 (maternal care for known or suspected disproportion) <br>
Date O34 first reported (maternal care for known or suspected abnormality of pelvic organs) <br>
Source of report of O34 (maternal care for known or suspected abnormality of pelvic organs) <br>
Date O35 first reported (maternal care for known or suspected foetal abnormality and damage) <br>
Source of report of O35 (maternal care for known or suspected foetal abnormality and damage) <br>
Date O36 first reported (maternal care for other known or suspected foetal problems) <br>
Source of report of O36 (maternal care for other known or suspected foetal problems) <br>
Date O40 first reported (polyhydramnios) <br>
Source of report of O40 (polyhydramnios) <br>
Date O41 first reported (other disorders of amniotic fluid and membranes) <br>
Source of report of O41 (other disorders of amniotic fluid and membranes) <br>
Date O42 first reported (premature rupture of membranes) <br>
Source of report of O42 (premature rupture of membranes) <br>
Date O43 first reported (placental disorders) <br>
Source of report of O43 (placental disorders) <br>
Date O44 first reported (placenta praevia) <br>
Source of report of O44 (placenta praevia) <br>
Date O45 first reported (premature separation of placenta [abruptio placentae]) <br>
Source of report of O45 (premature separation of placenta [abruptio placentae]) <br>
Date O46 first reported (antepartum haemorrhage, not elsewhere classified) <br>
Source of report of O46 (antepartum haemorrhage, not elsewhere classified) <br>
Date O47 first reported (false labour) <br>
Source of report of O47 (false labour) <br>
Date O48 first reported (prolonged pregnancy) <br>
Source of report of O48 (prolonged pregnancy) <br>
Date O60 first reported (preterm delivery) <br>
Source of report of O60 (preterm delivery) <br>
Date O61 first reported (failed induction of labour) <br>
Source of report of O61 (failed induction of labour) <br>
Date O62 first reported (abnormalities of forces of labour) <br>
Source of report of O62 (abnormalities of forces of labour) <br>
Date O63 first reported (long labour) <br>
Source of report of O63 (long labour) <br>
Date O64 first reported (obstructed labour due to malposition and malpresentation of foetus) <br>
Source of report of O64 (obstructed labour due to malposition and malpresentation of foetus) <br>
Date O65 first reported (obstructed labour due to maternal pelvic abnormality) <br>
Source of report of O65 (obstructed labour due to maternal pelvic abnormality) <br>
Date O66 first reported (other obstructed labour) <br>
Source of report of O66 (other obstructed labour) <br>
Date O67 first reported (labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified) <br>
Source of report of O67 (labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified) <br>
Date O68 first reported (labour and delivery complicated by foetal stress [distress]) <br>
Source of report of O68 (labour and delivery complicated by foetal stress [distress]) <br>
Date O69 first reported (labour and delivery complicated by umbilical cord complications) <br>
Source of report of O69 (labour and delivery complicated by umbilical cord complications) <br>
Date O70 first reported (perineal laceration during delivery) <br>
Source of report of O70 (perineal laceration during delivery) <br>
Date O71 first reported (other obstetric trauma) <br>
Source of report of O71 (other obstetric trauma) <br>
Date O72 first reported (postpartum haemorrhage) <br>
Source of report of O72 (postpartum haemorrhage) <br>
Date O73 first reported (retained placenta and membranes, without haemorrhage) <br>
Source of report of O73 (retained placenta and membranes, without haemorrhage) <br>
Date O74 first reported (complications of anaesthesia during labour and delivery) <br>
Source of report of O74 (complications of anaesthesia during labour and delivery) <br>
Date O75 first reported (other complications of labour and delivery, not elsewhere classified) <br>
Source of report of O75 (other complications of labour and delivery, not elsewhere classified) <br>
Date O80 first reported (single spontaneous delivery) <br>
Source of report of O80 (single spontaneous delivery) <br>
Date O81 first reported (single delivery by forceps and vacuum extractor) <br>
Source of report of O81 (single delivery by forceps and vacuum extractor) <br>
Date O82 first reported (single delivery by caesarean section) <br>
Source of report of O82 (single delivery by caesarean section) <br>
Date O83 first reported (other assisted single delivery) <br>
Source of report of O83 (other assisted single delivery) <br>
Date O84 first reported (multiple delivery) <br>
Source of report of O84 (multiple delivery) <br>
Date O85 first reported (puerperal sepsis) <br>
Source of report of O85 (puerperal sepsis) <br>
Date O86 first reported (other puerperal infections) <br>
Source of report of O86 (other puerperal infections) <br>
Date O87 first reported (venous complications in the puerperium) <br>
Source of report of O87 (venous complications in the puerperium) <br>
Date O88 first reported (obstetric embolism) <br>
Source of report of O88 (obstetric embolism) <br>
Date O89 first reported (complications of anaesthesia during the puerperium) <br>
Source of report of O89 (complications of anaesthesia during the puerperium) <br>
Date O90 first reported (complications of the puerperium, not elsewhere classified) <br>
Source of report of O90 (complications of the puerperium, not elsewhere classified) <br>
Date O91 first reported (infections of breast associated with childbirth) <br>
Source of report of O91 (infections of breast associated with childbirth) <br>
Date O92 first reported (other disorders of breast and lactation associated with childbirth) <br>
Source of report of O92 (other disorders of breast and lactation associated with childbirth) <br>
Date O94 first reported (sequelae of complication of pregnancy, childbirth and the puerperium) <br>
Source of report of O94 (sequelae of complication of pregnancy, childbirth and the puerperium) <br>
Date O96 first reported (death from any obstetric cause occurring more than 42 days but less than one year after delivery) <br>
Source of report of O96 (death from any obstetric cause occurring more than 42 days but less than one year after delivery) <br>
Date O98 first reported (maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium) <br>
Source of report of O98 (maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium) <br>
Date O99 first reported (other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium) <br>
Source of report of O99 (other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium) <br>
Date P00 first reported (foetus and newborn affected by maternal conditions that may be unrelated to present pregnancy) <br>
Source of report of P00 (foetus and newborn affected by maternal conditions that may be unrelated to present pregnancy) <br>
Date P02 first reported (foetus and newborn affected by complications of placenta, cord and membranes) <br>
Source of report of P02 (foetus and newborn affected by complications of placenta, cord and membranes) <br>
Date P03 first reported (foetus and newborn affected by other complications of labour and delivery) <br>
Source of report of P03 (foetus and newborn affected by other complications of labour and delivery) <br>
Date P04 first reported (foetus and newborn affected by noxious influences transmitted via placenta or breast milk) <br>
Source of report of P04 (foetus and newborn affected by noxious influences transmitted via placenta or breast milk) <br>
Date P05 first reported (slow foetal growth and foetal malnutrition) <br>
Source of report of P05 (slow foetal growth and foetal malnutrition) <br>
Date P07 first reported (disorders related to short gestation and low birth weight, not elsewhere classified) <br>
Source of report of P07 (disorders related to short gestation and low birth weight, not elsewhere classified) <br>
Date P08 first reported (disorders related to long gestation and high birth weight) <br>
Source of report of P08 (disorders related to long gestation and high birth weight) <br>
Date P10 first reported (intracranial laceration and haemorrhage due to birth injury) <br>
Source of report of P10 (intracranial laceration and haemorrhage due to birth injury) <br>
Date P11 first reported (other birth injuries to central nervous system) <br>
Source of report of P11 (other birth injuries to central nervous system) <br>
Date P12 first reported (birth injury to scalp) <br>
Source of report of P12 (birth injury to scalp) <br>
Date P13 first reported (birth injury to skeleton) <br>
Source of report of P13 (birth injury to skeleton) <br>
Date P14 first reported (birth injury to peripheral nervous system) <br>
Source of report of P14 (birth injury to peripheral nervous system) <br>
Date P15 first reported (other birth injuries) <br>
Source of report of P15 (other birth injuries) <br>
Date P20 first reported (intra-uterine hypoxia) <br>
Source of report of P20 (intra-uterine hypoxia) <br>
Date P21 first reported (birth asphyxia) <br>
Source of report of P21 (birth asphyxia) <br>
Date P22 first reported (respiratory distress of newborn) <br>
Source of report of P22 (respiratory distress of newborn) <br>
Date P23 first reported (congenital pneumonia) <br>
Source of report of P23 (congenital pneumonia) <br>
Date P24 first reported (neonatal aspiration syndromes) <br>
Source of report of P24 (neonatal aspiration syndromes) <br>
Date P25 first reported (interstitial emphysema and related conditions originating in the perinatal period) <br>
Source of report of P25 (interstitial emphysema and related conditions originating in the perinatal period) <br>
Date P26 first reported (pulmonary haemorrhage originating in the perinatal period) <br>
Source of report of P26 (pulmonary haemorrhage originating in the perinatal period) <br>
Date P27 first reported (chronic respiratory disease originating in the perinatal period) <br>
Source of report of P27 (chronic respiratory disease originating in the perinatal period) <br>
Date P28 first reported (other respiratory conditions originating in the perinatal period) <br>
Source of report of P28 (other respiratory conditions originating in the perinatal period) <br>
Date P29 first reported (cardiovascular disorders originating in the perinatal period) <br>
Source of report of P29 (cardiovascular disorders originating in the perinatal period) <br>
Date P35 first reported (congenital viral diseases) <br>
Source of report of P35 (congenital viral diseases) <br>
Date P36 first reported (bacterial sepsis of newborn) <br>
Source of report of P36 (bacterial sepsis of newborn) <br>
Date P37 first reported (other congenital infectious and parasitic diseases) <br>
Source of report of P37 (other congenital infectious and parasitic diseases) <br>
Date P38 first reported (omphalitis of newborn with or without mild haemorrhage) <br>
Source of report of P38 (omphalitis of newborn with or without mild haemorrhage) <br>
Date P39 first reported (other infections specific to the perinatal period) <br>
Source of report of P39 (other infections specific to the perinatal period) <br>
Date P50 first reported (foetal blood loss) <br>
Source of report of P50 (foetal blood loss) <br>
Date P51 first reported (umbilical haemorrhage of newborn) <br>
Source of report of P51 (umbilical haemorrhage of newborn) <br>
Date P52 first reported (intracranial nontraumatic haemorrhage of foetus and newborn) <br>
Source of report of P52 (intracranial nontraumatic haemorrhage of foetus and newborn) <br>
Date P53 first reported (haemorrhagic disease of foetus and newborn) <br>
Source of report of P53 (haemorrhagic disease of foetus and newborn) <br>
Date P54 first reported (other neonatal haemorrhages) <br>
Source of report of P54 (other neonatal haemorrhages) <br>
Date P55 first reported (haemolytic disease of foetus and newborn) <br>
Source of report of P55 (haemolytic disease of foetus and newborn) <br>
Date P58 first reported (neonatal jaundice due to other excessive haemolysis) <br>
Source of report of P58 (neonatal jaundice due to other excessive haemolysis) <br>
Date P59 first reported (neonatal jaundice from other and unspecified causes) <br>
Source of report of P59 (neonatal jaundice from other and unspecified causes) <br>
Date P61 first reported (other perinatal haematological disorders) <br>
Source of report of P61 (other perinatal haematological disorders) <br>
Date P70 first reported (transitory disorders of carbohydrate metabolism specific to foetus and newborn) <br>
Source of report of P70 (transitory disorders of carbohydrate metabolism specific to foetus and newborn) <br>
Date P71 first reported (transitory neonatal disorders of calcium and magnesium metabolism) <br>
Source of report of P71 (transitory neonatal disorders of calcium and magnesium metabolism) <br>
Date P78 first reported (other perinatal digestive system disorders) <br>
Source of report of P78 (other perinatal digestive system disorders) <br>
Date P83 first reported (other conditions of integument specific to foetus and newborn) <br>
Source of report of P83 (other conditions of integument specific to foetus and newborn) <br>
Date P91 first reported (other disturbances of cerebral status of newborn) <br>
Source of report of P91 (other disturbances of cerebral status of newborn) <br>
Date P92 first reported (feeding problems of newborn) <br>
Source of report of P92 (feeding problems of newborn) <br>
Date P94 first reported (disorders of muscle tone of newborn) <br>
Source of report of P94 (disorders of muscle tone of newborn) <br>
Date P95 first reported (foetal death of unspecified cause) <br>
Source of report of P95 (foetal death of unspecified cause) <br>
Date P96 first reported (other conditions originating in the perinatal period) <br>
Source of report of P96 (other conditions originating in the perinatal period) <br>
Date Q00 first reported (anencephaly and similar malformations) <br>
Source of report of Q00 (anencephaly and similar malformations) <br>
Date Q01 first reported (encephalocele) <br>
Source of report of Q01 (encephalocele) <br>
Date Q02 first reported (microcephaly) <br>
Source of report of Q02 (microcephaly) <br>
Date Q03 first reported (congenital hydrocephalus) <br>
Source of report of Q03 (congenital hydrocephalus) <br>
Date Q04 first reported (other congenital malformations of brain) <br>
Source of report of Q04 (other congenital malformations of brain) <br>
Date Q05 first reported (spina bifida) <br>
Source of report of Q05 (spina bifida) <br>
Date Q06 first reported (other congenital malformations of spinal cord) <br>
Source of report of Q06 (other congenital malformations of spinal cord) <br>
Date Q07 first reported (other congenital malformations of nervous system) <br>
Source of report of Q07 (other congenital malformations of nervous system) <br>
Date Q10 first reported (congenital malformations of eyelid, lachrymal apparatus and orbit) <br>
Source of report of Q10 (congenital malformations of eyelid, lachrymal apparatus and orbit) <br>
Date Q11 first reported (anophthalmos, microphthalmos and macrophthalmos) <br>
Source of report of Q11 (anophthalmos, microphthalmos and macrophthalmos) <br>
Date Q12 first reported (congenital lens malformations) <br>
Source of report of Q12 (congenital lens malformations) <br>
Date Q13 first reported (congenital malformations of anterior segment of eye) <br>
Source of report of Q13 (congenital malformations of anterior segment of eye) <br>
Date Q14 first reported (congenital malformations of posterior segment of eye) <br>
Source of report of Q14 (congenital malformations of posterior segment of eye) <br>
Date Q15 first reported (other congenital malformations of eye) <br>
Source of report of Q15 (other congenital malformations of eye) <br>
Date Q16 first reported (congenital malformations of ear causing impairment of hearing) <br>
Source of report of Q16 (congenital malformations of ear causing impairment of hearing) <br>
Date Q17 first reported (other congenital malformations of ear) <br>
Source of report of Q17 (other congenital malformations of ear) <br>
Date Q18 first reported (other congenital malformations of face and neck) <br>
Source of report of Q18 (other congenital malformations of face and neck) <br>
Date Q20 first reported (congenital malformations of cardiac chambers and connexions) <br>
Source of report of Q20 (congenital malformations of cardiac chambers and connexions) <br>
Date Q21 first reported (congenital malformations of cardiac septa) <br>
Source of report of Q21 (congenital malformations of cardiac septa) <br>
Date Q22 first reported (congenital malformations of pulmonary and tricuspid valves) <br>
Source of report of Q22 (congenital malformations of pulmonary and tricuspid valves) <br>
Date Q23 first reported (congenital malformations of aortic and mitral valves) <br>
Source of report of Q23 (congenital malformations of aortic and mitral valves) <br>
Date Q24 first reported (other congenital malformations of heart) <br>
Source of report of Q24 (other congenital malformations of heart) <br>
Date Q25 first reported (congenital malformations of great arteries) <br>
Source of report of Q25 (congenital malformations of great arteries) <br>
Date Q26 first reported (congenital malformations of great veins) <br>
Source of report of Q26 (congenital malformations of great veins) <br>
Date Q27 first reported (other congenital malformations of peripheral vascular system) <br>
Source of report of Q27 (other congenital malformations of peripheral vascular system) <br>
Date Q28 first reported (other congenital malformations of circulatory system) <br>
Source of report of Q28 (other congenital malformations of circulatory system) <br>
Date Q30 first reported (congenital malformations of nose) <br>
Source of report of Q30 (congenital malformations of nose) <br>
Date Q31 first reported (congenital malformations of larynx) <br>
Source of report of Q31 (congenital malformations of larynx) <br>
Date Q32 first reported (congenital malformations of trachea and bronchus) <br>
Source of report of Q32 (congenital malformations of trachea and bronchus) <br>
Date Q33 first reported (congenital malformations of lung) <br>
Source of report of Q33 (congenital malformations of lung) <br>
Date Q34 first reported (other congenital malformations of respiratory system) <br>
Source of report of Q34 (other congenital malformations of respiratory system) <br>
Date Q35 first reported (cleft palate) <br>
Source of report of Q35 (cleft palate) <br>
Date Q36 first reported (cleft lip) <br>
Source of report of Q36 (cleft lip) <br>
Date Q37 first reported (cleft palate with cleft lip) <br>
Source of report of Q37 (cleft palate with cleft lip) <br>
Date Q38 first reported (other congenital malformations of tongue, mouth and pharynx) <br>
Source of report of Q38 (other congenital malformations of tongue, mouth and pharynx) <br>
Date Q39 first reported (congenital malformations of oesophagus) <br>
Source of report of Q39 (congenital malformations of oesophagus) <br>
Date Q40 first reported (other congenital malformations of upper alimentary tract) <br>
Source of report of Q40 (other congenital malformations of upper alimentary tract) <br>
Date Q41 first reported (congenital absence, atresia and stenosis of small intestine) <br>
Source of report of Q41 (congenital absence, atresia and stenosis of small intestine) <br>
Date Q42 first reported (congenital absence, atresia and stenosis of large intestine) <br>
Source of report of Q42 (congenital absence, atresia and stenosis of large intestine) <br>
Date Q43 first reported (other congenital malformations of intestine) <br>
Source of report of Q43 (other congenital malformations of intestine) <br>
Date Q44 first reported (congenital malformations of gallbladder, bile ducts and liver) <br>
Source of report of Q44 (congenital malformations of gallbladder, bile ducts and liver) <br>
Date Q45 first reported (other congenital malformations of digestive system) <br>
Source of report of Q45 (other congenital malformations of digestive system) <br>
Date Q50 first reported (congenital malformations of ovaries, fallopian tubes and broad ligaments) <br>
Source of report of Q50 (congenital malformations of ovaries, fallopian tubes and broad ligaments) <br>
Date Q51 first reported (congenital malformations of uterus and cervix) <br>
Source of report of Q51 (congenital malformations of uterus and cervix) <br>
Date Q52 first reported (other congenital malformations of female genitalia) <br>
Source of report of Q52 (other congenital malformations of female genitalia) <br>
Date Q53 first reported (undescended testicle) <br>
Source of report of Q53 (undescended testicle) <br>
Date Q54 first reported (hypospadias) <br>
Source of report of Q54 (hypospadias) <br>
Date Q55 first reported (other congenital malformations of male genital organs) <br>
Source of report of Q55 (other congenital malformations of male genital organs) <br>
Date Q56 first reported (indeterminate sex and pseudohermaphroditism) <br>
Source of report of Q56 (indeterminate sex and pseudohermaphroditism) <br>
Date Q60 first reported (renal agenesis and other reduction defects of kidney) <br>
Source of report of Q60 (renal agenesis and other reduction defects of kidney) <br>
Date Q61 first reported (cystic kidney disease) <br>
Source of report of Q61 (cystic kidney disease) <br>
Date Q62 first reported (congenital obstructive defects of renal pelvis and congenital malformations of ureter) <br>
Source of report of Q62 (congenital obstructive defects of renal pelvis and congenital malformations of ureter) <br>
Date Q63 first reported (other congenital malformations of kidney) <br>
Source of report of Q63 (other congenital malformations of kidney) <br>
Date Q64 first reported (other congenital malformations of urinary system) <br>
Source of report of Q64 (other congenital malformations of urinary system) <br>
Date Q65 first reported (congenital deformities of hip) <br>
Source of report of Q65 (congenital deformities of hip) <br>
Date Q66 first reported (congenital deformities of feet) <br>
Source of report of Q66 (congenital deformities of feet) <br>
Date Q67 first reported (congenital musculoskeletal deformities of head, face, spine and chest) <br>
Source of report of Q67 (congenital musculoskeletal deformities of head, face, spine and chest) <br>
Date Q68 first reported (other congenital musculoskeletal deformities) <br>
Source of report of Q68 (other congenital musculoskeletal deformities) <br>
Date Q69 first reported (polydactyly) <br>
Source of report of Q69 (polydactyly) <br>
Date Q70 first reported (syndactyly) <br>
Source of report of Q70 (syndactyly) <br>
Date Q71 first reported (reduction defects of upper limb) <br>
Source of report of Q71 (reduction defects of upper limb) <br>
Date Q72 first reported (reduction defects of lower limb) <br>
Source of report of Q72 (reduction defects of lower limb) <br>
Date Q73 first reported (reduction defects of unspecified limb) <br>
Source of report of Q73 (reduction defects of unspecified limb) <br>
Date Q74 first reported (other congenital malformations of limb(s)) <br>
Source of report of Q74 (other congenital malformations of limb(s)) <br>
Date Q75 first reported (other congenital malformations of skull and face bones) <br>
Source of report of Q75 (other congenital malformations of skull and face bones) <br>
Date Q76 first reported (congenital malformations of spine and bony thorax) <br>
Source of report of Q76 (congenital malformations of spine and bony thorax) <br>
Date Q77 first reported (osteochondrodysplasia with defects of growth of tubular bones and spine) <br>
Source of report of Q77 (osteochondrodysplasia with defects of growth of tubular bones and spine) <br>
Date Q78 first reported (other osteochondrodysplasias) <br>
Source of report of Q78 (other osteochondrodysplasias) <br>
Date Q79 first reported (congenital malformations of musculoskeletal system, not elsewhere classified) <br>
Source of report of Q79 (congenital malformations of musculoskeletal system, not elsewhere classified) <br>
Date Q80 first reported (congenital ichthyosis) <br>
Source of report of Q80 (congenital ichthyosis) <br>
Date Q81 first reported (epidermolysis bullosa) <br>
Source of report of Q81 (epidermolysis bullosa) <br>
Date Q82 first reported (other congenital malformations of skin) <br>
Source of report of Q82 (other congenital malformations of skin) <br>
Date Q83 first reported (congenital malformations of breast) <br>
Source of report of Q83 (congenital malformations of breast) <br>
Date Q84 first reported (other congenital malformations of integument) <br>
Source of report of Q84 (other congenital malformations of integument) <br>
Date Q85 first reported (phakomatoses, not elsewhere classified) <br>
Source of report of Q85 (phakomatoses, not elsewhere classified) <br>
Date Q86 first reported (congenital malformation syndromes due to known exogenous causes, not elsewhere classified) <br>
Source of report of Q86 (congenital malformation syndromes due to known exogenous causes, not elsewhere classified) <br>
Date Q87 first reported (other specified congenital malformation syndromes affecting multiple systems) <br>
Source of report of Q87 (other specified congenital malformation syndromes affecting multiple systems) <br>
Date Q89 first reported (other congenital malformations, not elsewhere classified) <br>
Source of report of Q89 (other congenital malformations, not elsewhere classified) <br>
Date Q90 first reported (down's syndrome) <br>
Source of report of Q90 (down's syndrome) <br>
Date Q91 first reported (edwards' syndrome and patau's syndrome) <br>
Source of report of Q91 (edwards' syndrome and patau's syndrome) <br>
Date Q92 first reported (other trisomies and partial trisomies of the autosomes, not elsewhere classified) <br>
Source of report of Q92 (other trisomies and partial trisomies of the autosomes, not elsewhere classified) <br>
Date Q93 first reported (monosomies and deletions from the autosomes, not elsewhere classified) <br>
Source of report of Q93 (monosomies and deletions from the autosomes, not elsewhere classified) <br>
Date Q95 first reported (balanced rearrangements and structural markers, not elsewhere classified) <br>
Source of report of Q95 (balanced rearrangements and structural markers, not elsewhere classified) <br>
Date Q96 first reported (turner's syndrome) <br>
Source of report of Q96 (turner's syndrome) <br>
Date Q97 first reported (other sex chromosome abnormalities, female phenotype, not elsewhere classified) <br>
Source of report of Q97 (other sex chromosome abnormalities, female phenotype, not elsewhere classified) <br>
Date Q98 first reported (other sex chromosome abnormalities, male phenotype, not elsewhere classified) <br>
Source of report of Q98 (other sex chromosome abnormalities, male phenotype, not elsewhere classified) <br>
Date Q99 first reported (other chromosome abnormalities, not elsewhere classified) <br>
Source of report of Q99 (other chromosome abnormalities, not elsewhere classified) <br>
